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Abstract 	
This thesis investigates the utility of cardiac magnetic resonance imaging (CMR) to assess right 
ventricular function and dynamic right ventricular (RV) reserve, in health and in acute and 
chronic pulmonary hypertension. 
 
Right ventricular function is a strong predictor of prognosis, in patients with pulmonary arterial 
hypertension (PAH), but there are currently no available clinical tests that can predict which 
right ventricle is destined to fail, despite medical therapy.  RV reserve, or the ability of the RV 
to augment during exercise, has recently gained more attention as a potential marker vascular-
ventricular uncoupling, and CMR potentially offers a novel, accurate and reproducible method 
to assess this. 
 
Exercise CMR is in its developmental stages, and while several groups have used it in healthy 
volunteers and patients to study dynamic biventricular function, approaches have varied.  We 
set out to develop a novel and robust exercise CMR methodology and demonstrate its accuracy 
and reproducibility.  Furthermore, we aimed to show how timing of acquisition and respiratory 
variation, are important considerations, potentially affect key pathophysiological changes.  In 
Chapter 3, we outline the developmental considerations and demonstrate intra-observer, inter-
observer, inter-study and inter-test reproducibility. 
 
In Chapter 4, we show how the RV remodels after pulmonary thromboendarterectomy in 
patients with chronic thromboembolic pulmonary hypertension, in a retrospective analysis of 
CMRs acquired before and after surgery.  Importantly, we demonstrate how biventricular 
interactions, expressed as a composite measure of RV end diastolic volume to left ventricular 
(LV) end diastolic volume ratio, correlates with change in 6MWD, but parameters of each 
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ventricular alone do not.  Furthermore, we demonstrate a correlation between left atrial size 
and left ventricular end diastolic index, showing that under-filling is likely to be an important 
pathophysiological explanation of a reduction in LV size, in these patients.  LV under-filling 
from increased RV pressure, and biventricular interactions, continue to remain key themes 
throughout the following experiments. 
 
While exercise CMR is a new technique, so is assessment of RV reserve and there are no 
normal values available.  Furthermore, there is conflicting evidence in the literature, as to 
normal cardiovascular changes that occur during exercise in normal hearts.  We demonstrate 
in Chapter 5 that an increase in RV forward flow is due to a decrease in RV end systolic volume 
and an increase in RV ejection fraction, leading to an increase in LV end diastolic volume.  LV 
ejection fraction increases as a result of an increase in left ventricular end diastolic volume and 
a decrease in left ventricular end systolic volume.  Understanding normal exercise physiology, 
during continuous steady state exercise, is key to interpreting pathophysiological changes. 
 
Acute normobaric hypoxia causes hypoxic pulmonary vasoconstriction and an increase in 
pulmonary vascular resistance and pulmonary pressures.  It offers a model in which RV reserve 
in healthy controls can be studied.  It has been hypothesised that the reduction in VO2 max in 
acute hypoxic exercise is a consequence of a reduction in RV forward flow, however this has 
never been definitively documented in an imaging study.  We show, for the first time using 
exercise CMR in Chapter 6, that exercise during acute hypoxia leads to a reduction in RV 
forward flow, a blunting of the rise in RV ejection fraction and LV under-filling with a 
reduction in LV forward flow. We also show that there is a blunting of the rise in MPA average 
blood velocity on exercise during acute hypoxia, and hypothesise that this could be a novel 
CMR parameter to assess pulmonary vascular distensibility. 
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Identifying patients whose RV will continue to fail despite medical therapy has remained 
elusive.  We go on to demonstrate in Chapter 7 that our approach to exercise CMR is not only 
feasible in patients with pulmonary arterial hypertensoin, but that exercise in these patients, 
considered stable on medical therapy with normal resting RV ejection fraction, unmasks 
impaired right ventricular reserve.  Furthermore, we demonstrate that there is heterogeneity of 
response that cannot be predicted by routine clinical tests and resting biventricular function.  
This information could potentially be clinically valuable, and we outline where this research 
will take us to next in Chapter 8, where we hope to demonstrate change in right ventricular 
reserve before and after medical therapy, in patients with inoperable chronic thromboembolic 
pulmonary hypertension, predicts long term clinical outcomes on follow up. 
 
Together, these studies demonstrate how CMR can accurately and non-invasively assess RV 
remodeling and RV reserve, its impact on the LV, and unmask right ventricular – vascular 
uncoupling which is otherwise not present at rest, in patients with acute and/or chronic 
pulmonary arterial hypertension. 
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Chapter 1 - Introduction 
1.1 Right Ventricular Structure and Function 
 
1.1.1 Right Ventricular Anatomy 
 
The right ventricle (RV), the most anterior chamber of the heart, lies immediately behind the 
sternum.  It has a complex shape, crescenteric in cross section, triangular when viewed from 
the side and in general, can be divided in to three parts.  These consist of 1) An inlet which 
consists of the tricuspid valve, the chordae tendinae and the papillary muscles; 2) A 
trabeculated apical myocardium and; 3) The infundibulum or conus which is the smooth 
outflow region, leading to the pulmonary orifice and pulmonary trunk (1, 2) (Figure 1A and 
B).  Furthermore, the RV can be divided in to anterior, lateral and inferior sections, as well as 
basal, mid and apical (2, 3). 
 
The crista supraventricularis separates the tricuspid and pulmonary valves and has 3 
components; the parietal band, infundibular septum and septal band.   The infundibular septum 
separates the two ventricular outflow tracts, the parietal band is a free wall structure and the 
septal band forms a Y shaped muscle that cradles the infundibular septum.  The septal band 
extends inferiorly and becomes continuous with the moderator band, an intracavitary muscle 
which attaches to the anterior tricuspid papillary muscle (2, 3) (Figure 1C). 
 
The tricuspid valve is made up of the annulus, leaflets, commissures, chordae tendinae and 
papillary muscles.  The anterior tricuspid leaflet is the largest and most mobile and forms a 
curtain that partially separates the inflow and outflow tracts of the RV.  The posterior leaflet is 
the smallest and the septal leaflet is the least mobile due to its direct chordal attachments to the 
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ventricular septum.  The annulus is uniquely fibroadipose in nature(3). The pulmonary valve 
is composed of the annulus, cusps and commissures.  The semilunar valves have no chordae 
tendinae and are equal in size (3). 
 
The RV has several unique features which distinguishes it from the left ventricle (LV): 1) The 
septal leaflet has a more apical hinge relative to the anterior leaflet of the mitral valve 2) The 
presence of the moderator band 3) The presence of 3 papillary muscles 4) The trileaflet 
configuration of the tricuspid valve with septal papillary attachments 5) The presence of coarse 
trabeculations (2). 
 
The blood supply of the RV varies according to whether the coronary system is left or right-
sided dominant.  80% of the population has a right dominant system, where the right coronary 
artery supplies the majority of the RV.  The marginal branches of the right coronary artery 
supply the lateral wall and the posterior descending artery supplies the posterior and 
inferoseptal regions.  The left anterior descending artery supplies two thirds of the septum and 
the anterior wall of the RV.  The conal artery supplies the infundibulum.  Flow is equal in 
diastole and systole, however, beyond the right ventricular marginal branches, diastolic 
coronary blood flow predominates (2-4). 
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(2)2)(2)(2)(2)(2)(2)(2)(2) )  
Figure 1.1 Anatomy of the RV: A:  The inlet, trabeculated apical myocardium and 
infundibulum of the RV.  The tricuspid and pulmonary valves are separated by the 
ventriculoinfundibular fold (VIF).  B: Short-axis plane of the RV demonstrating its crescenteric 
shape C: The 4 chamber anatomic plane of the heart showing the moderater band (MB), D: 
Superficial muscle layer of the RV.  SMT indicates septomarginal trabeculation with its 
anterior (a) and posterior (p) arm.  A-S: anterosuperior leaflet of the tricuspid valve; PT, 
pulmonary trunk; Ao, aorta; RA, right atrium and LA, left atrium. (From Haddad, et al. Right 
Ventricular Function in Cardiovascular Disease, Part 1: Anatomy, Physiology, Aging and 
Functional Assessment of the Right Ventricle. Circulation, 2008) 
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1.1.2 Myofibres and RV Contraction 
 
The myocardial architecture and fibre direction are different between the LV and RV.  The RV 
myocardial fibres are constructed of two layers, whereas the LV is a three-layered structure.  
The muscle fibres in the superficial layer of the RV are circumferential, parallel to the 
atrioventricular groove (Figure 1D).  They turn obliquely towards the cardiac apex and are 
continuous with the superficial fibres of the LV.  The deep muscle fibres are aligned 
longitudinally from base to apex (1, 2).   
 
Longitudinal contraction accounts for around 80% of RV stroke volume (SV) and is a more 
accurate reflection of global RV function and acute afterload increase (5, 6).  This contrasts 
with the LV, which has oblique, longitudinal and circular orientated fibres that contribute to 
the more complex movements of torsion, translation, rotation and thickening.   
 
Contraction of the RV starts with the inlet and myocardium and ends with the infundibulum, 
which is of a longer duration than the inflow region.  Inlet and infundibular contraction are 
approximately 25-50ms apart, and peak systolic longitudinal and circumferential shortening 
occurs earliest at the apex (7).  Three separate mechanisms contribute 1) Inward movement of 
the free wall; 2) Contraction of the longitudinal fibres and; 3) Transmission of tension to the 
RV free wall secondary to LV contraction (2, 8). 
 
1.1.3 Ventricular Interaction 
 
The mutually encircling circumferential epicardial fibres and the shared interventricular 
septum and pericardial space are also important determinants of RV function.  Ventricular 
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interdependence is a term used to explain how the size, shape and compliance of one ventricle, 
affects the size, shape and function of the other, during systole and diastole, independent of 
neural, humoral or circulatory effects (2, 4, 9, 10).  For example, during diastole, competition 
for space within the limits of the pericardium may lead to impaired LV filling due to a dilated 
RV (11, 12), or during systole, enhanced LV contraction improves RV function (13) due to 
shared epicardial fibres. 
 
1.1.4 Physiology of the Right Ventricle 
 
The RV is coupled to the pulmonary circulation, which is a low pressure, high flow circuit.  
The low pressure allows the RV to function at minimal energy costs, and the low pressure 
prevents fluid extravasation in to the interstitial space.  When pulmonary vascular resistance 
(PVR) and metabolic demands are low, RV function contributes little to the flow of blood 
through the lungs and to the left heart, with filling pressures of 10mmHg.  However, exercise 
and activation of the autonomic nervous system can increase cardiac output (CO) up to 6 fold, 
increase oxygen uptake and carbon dioxide output up to 20 fold, with RV filling pressures 
increasing to 35-40mmHg.  Hence the RV is key in enabling exercise, quality of life and 
survival (1). 
 
Changes in CO involve both changes in heart rate (HR) and stroke volume (SV).  SV is 
influenced by diastolic stretch, contractility that in turn is regulated by the autonomic nervous 
system, and arterial pressure that opposes ejection.  In healthy hearts, increasing diastolic 
stretch of the myocardium, referred to as the Frank-Starling mechanism, augments the energy 
of contraction.  However, this relationship is curvilinear, and SV declines in the over-distended 
heart.  Working in opposition to the Frank-Starling law is the LaPlace relationship that states 
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that for a hollow sphere, the internal pressure is proportional to the wall tension and is inversely 
proportional to the internal radius.  Hence as the radius increases and wall curvature decreases, 
the ventricle is less able to convert wall tension in to intraventricular pressure (14, 15). 
 
Contractility can also be increased at a given initial fibre length, i.e. without chamber dilatation 
by internally circulating positive inotropes, of which noradrenaline is the most important.  
Others include adrenaline, angiotension II and extracellular calcium ions.  Sympathetic nervous 
system activation leads to a more rapid rise in ventricular pressure, an increase in ejection 
fraction (EF), a fall in diastolic volume, an increase in SV and a shortening of the duration of 
systole (14, 15).   
 
An increase in arterial pressure, often referred to as afterload, produces less muscle shortening 
and impairs SV.  The heart compensates by distention and increasing diastolic stretch to 
increase contractile energy through the Frank Starling mechanisms, and also through the Anrep 
response.  The Anrep response is an adaptation that occurs in response to an increase in 
afterload, whereby myocardial contraction increases at a lower end diastolic volume (EDV), 
due to local release of inotropic agents such as myocardial angiotensin II and endothelin 1.(14, 
15) 
 
1.2 Normal exercise physiology 
 
During exercise, there is an increase in HR, CO and SV.  The key mechanisms behind LVSV 
augmentation during exercise are divided between two theories. 1) That Frank-Starling 
mechanism and an increase in LVEDV is the most important adaptation and 2) Enhanced 
contractility as manifested by a decrease in LV end systolic volume (ESV) without an increase 
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in LVEDV predominates.  However, posture, the intensity of exercise and the type of exercise 
are all-important considerations when describing the physiological changes that occur in 
normal hearts during exercise. 
 
An increase in LVEDV during upright exercise has been uniformly reported in numerous 
studies, including males and females, and sedentary, recreationally active and professional 
athletes (16-24).  Where this has been refuted, has been in studies where supine (25, 26) or 
resistance (27-30) exercise has been studied.  There is overall agreement in the literature that 
there is a greater percentage increase in LVEDV during upright exercise than during supine 
exercise (23, 25, 31).  This can be explained by augmented preload in the supine state due to 
increased venous return.   
 
Additionally, the intensity of exercise has been recognized as an influential factor on change 
in LVEDV.  At low and moderate levels of exercise, Frank Starling mechanisms and an 
increase in LVEDV predominate, with a plateau (17, 23, 32) or even decrease (20) reported at 
peak exercise, with increasing contractility predominating at higher intensities.  However, it 
has also been shown that change in LVEDV on exercise (22, 32), rather than a decrease in 
LVESV, correlates with increase in LVSV.  Furthermore, higher levels of fitness and exercise 
training lead to greater increases in LVEDV on exercise and greater utilization of Frank-
Starling mechanisms, rather than enhancing contractility (19, 33, 34). 
 
Age has been reported to influence (16, 19, 27) and not influence (32) exercise physiology, 
with greater reliance on Frank-Starling mechanisms than contractility, demonstrated by a 
greater increase in LVEDVI and an increase in LVESVI on exercise (16, 19).  Reports on 
whether maximal cardiac output is limited by age, is mixed.  Also, it has been reported than 
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women have a greater increase in LVEDVI on exercise while men have a greater increase in 
ejection fraction (24, 35), while others have reported no differences between genders (21). 
 
While there are numerous reports on LV function during exercise, reports on normal RV 
exercise physiology are more limited.  This is probably due to the fact that radionuclide 
angiography that was largely used in the 1980s and echocardiography and invasive 
haemodynamics that was utilized more in the 1990 and 2000s, are limited in their assessment 
of RV function.  However, similar to the LV, some report an increase in RVSV driven by a 
decrease in RVESV with no increase in RVEDV on exercise (36-40), while others have 
demonstrated an increase in RVEDV and a decrease in RVESV during upright bicycle exercise 
(25, 41) and supine bicycle exercise (42).  
 
During exercise, PVR remains unchanged or decreases, due to vascular distention of compliant 
small vessels and recruitment of additional vessels of the upper portions of the lungs in upright 
exercise.  Mean pulmonary arterial pressure (mPAP) increases, doubling or tripling in heavy 
exercise, with a rapid return to baseline immediately post exercise (43, 44).  This can impose 
a significant load, on top of an increased preload from venous return, on the thin walled RV. 
It also has to be remembered that RV function is a reflection of afterload, preload, contractility 
and ventricular interdependence. Pulmonary vascular resistance (PVR) has been used to 
represent the afterload of an ejecting RV.  However, capacitance and impedance measuring 
pulsatile flow, are also key contributors, with independent relationships with RV adaptation 
and prognostic importance. 
 
1.3 Assessment of the Right Ventricle 
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An ideal measure of RV function should be safe, easy, reliable, independent of afterload, 
preload, heart size and mass and sensitive to changes in inotropy.  The gold standard of 
measuring contractility in vivo, is considered to be the maximal elastance (Emax), or the 
maximum slope of the pressure-volume relationships measured continuously during the 
cardiac cycle, and is measured in the upper left corner of the pressure-volume loop.  Accurate 
Emax can only be obtained by generating multiple pressure-volume loops at various levels of 
venous return (Figure 2), by progressive inferior vena cava occlusion (45), although the 
Valsalva manoeuvre has also been used.  Single beat methods which rely on the calculation of 
maximum pressure (Pmax) have been reported (Figure 1.2).  Pmax is calculated from a nonlinear 
extrapolation of the early and late portion of a RV pressure curve, an integration of pulmonary 
flow or direct measurement of RV volume curve, with synchronization of the signals. (46-49).  
MRI guided catheterisation has also been reported (50). 
 
Figure 1.2: Pressure volume loops of the RV under different loading conditions.  The slope of 
the maximum elastance (Emax) and maximum pressure-volume ratio (Pmax or Max PV) are 
displayed on the graph.  EEPV, end ejection pressure/volume (From Haddad, et al. Right 
Ventricular Function in Cardiovascular Disease, Part 1: Anatomy, Physiology, Aging and 
Functional Assessment of the Right Ventricle. Circulation, 2008) 
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Measurements of systolic function are ideally load independent as contractility or Emax, adapts 
to afterload after several heart beats.  Afterload can be measured as arterial elastance (Ea) that 
is defined by the ratio between pressure at Emax and SV, and it can be measured with Emax on 
the pressure-volume loop.  Ideal Emax/Ea representing optimal energy transfer from the ventricle 
to the arterial system is 1.5-2. Other measurements of afterload such as RC-time (51), preload 
recruitable stroke work (52)  and wave intensity analysis (53) have been reported.  RV systolic 
function can also be estimated from measurements during clinical right heart catheterisation 
(RHC), which is a regular part of practice.  From pulmonary pressures, right atrial pressure 
(RAP) and CO, SV and stroke work can be calculated.  
 
Studies using Emax/Ea have been reported in patients with pulmonary arterial hypertension 
(PAH) and chronic thromboembolic pulmonary hypertensive (CTEPH) disease, as well as 
other various models of pulmonary hypertension(50, 54).  Together these have demonstrated 
that at rest, RV adaptation to an increased afterload is predominantly systolic, with no increase 
in RVEDV.  RV-arterial uncoupling is characterized by increasing RV volumes.   
 
However, these approaches are invasive, time consuming, require radiation exposure and are 
ethically problematic in the setting of manipulating venous return, hence difficult to apply 
clinically and in serial follow up studies.  Brewis et al assessed 140 PAH patients using the 
gold standard measure of RV-PA coupling with Emax/Ea and measured RV function at rest 
using cardiac magnetic resonance imaging (CMR).  They found that the simple ratio of RVSV 
to ESV and RVEF were the only independent predictors of outcome, and that there was no 
added value of the invasive measurements.  Survival was poorer in patients with a fall in RVEF 
or SV:ESV during follow up (55).  This was also found by Vanderpool et al, who demonstrated 
SV:ESV as measured by CMR was the only independent predictor of transplantation free 
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survival, over gold standard invasive measures of RV function (56).  Sanz et al found that 
SV/ESV correlated with Emax/Ea calculations (57).  These studies add weight to the notion that 
finding a non-invasive measure of ventricular-vascular coupling is not only desirable but 
potentially more clinically and prognostically relevant. 
 
In clinical practice, RVEF is the most commonly used index of RV contractility.  
Echocardiography has remained the mainstay due to its availability and versatility, despite its 
significant limitations in the assessment of RV volume and RVEF.  The best correlations with 
CMR derived RV volume measurements have been with RV fractional area change (FAC) 
which expresses the % change in RV area between end diastole and end systole (58, 59), 
however, there is significant overlap between normal, mild and moderate enlargement of the 
RV, with reported r values between 0.32 to 0.88 when comparing 2D echo to CMR (60).  
Indirect measures of RV dysfunction have been developed, including tricuspid annular plane 
systolic excursion (TAPSE) (61), isovolumic contraction velocity at the tricuspid annulus (62, 
63), RV index of myocardial performance (RIMP) or Tei index (64), longitudinal strain and 
strain rate (65-67) and RA size (68).  However, reports vary as to the accuracy, reproducibility 
and prognostic utility of these measures in the assessment of the RV. While 3D echo is 
promising and correlates with CMR volumes better than 2D echo (60, 69), CMR remains the 
gold standard and considered the most reliable method for measuring RV volumes and RVEF.   
 
CMR provides highly reproducible and accurate assessment of the RV that does not rely on 
consistent acoustic windows nor operator-dependent (70, 71).  The reduction in sample size 
required by CMR interventional studies has been clearly demonstrated (72) and it provides 
prognostic value over echocardiographic measurements (57, 73-75) in PAH studies.  Although 
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RVEF can be assessed accurately using CMR, it is a single beat derived measurement, 
dependent on loading conditions and hence may not adequately reflect contractility.   
 
RV contractile reserve, or the ability of the RV to increase contractility at a given level of 
exercise or pharmacological stress test, can be used to test systolic function adaptation to 
afterload dynamically.  It has been demonstrated that exercise RV function and CO is not 
related to resting (41, 76-78) or changes (79-81) in resting haemodynamics , nor is exercise 
capacity related to resting RV function (82-84).  The assessment of RV reserve has been carried 
out in numerous ways thus far.  Stress echocardiography using exercise (85) and dobutamine 
(86), invasively measured haemodynamics on exercise (87-89) and exercise CMR have been 
utilized, all demonstrating reduced RV contractile reserve on exercise in patients with PAH 
and other pathologies (41, 76, 90). Furthermore, exercise induced RV dysfunction 
demonstrated on exercise radionuclide ventriculography, echocardiography and invasively 
measured haemodynamics have been shown to be a strong predictor of prognosis in heart 
failure (91, 92), moderate to severe mitral regurgitation (93), PAH and inoperable CTEPH (94, 
95).   
 
It has been demonstrated that dobutamine stress and true physiological stress with exercise 
cannot be used interchangeably and produce different results.  Peak CO has been shown to be 
lower using dobutamine stress, produce a lower SV increment, but increase EF and reduce 
cardiac chamber volumes hence leading to increased indices of contractility in healthy 
volunteers (96, 97).  In particular, in patients with atrially corrected transposition of the great 
arteries, exercise led to a decrease in EF on exercise, but it increased with dobutamine stress 
(96).  Exercise is a true physiological stress, and hence is preferable over dobutamine. 
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One method of assessing both exercise biventricular function and the pulmonary circulation is 
through exercise echocardiography.  Claessen et al have demonstrated that exercise RVEF as 
assessed by exercise CMR correlates strongly with exercise echocardiography RV FAC and 
moderately with exercise TAPSE (98).  An advantage of echocardiography is that it can 
provide noninvasive haemodynamic evaluation of pulmonary arterial (PA) pressures which are 
comparable to invasively derived measurements (43) and has been shown to demonstrate the 
reactivity of the pulmonary circulation to exercise in relatives carrying the BMPR2 mutation 
(99).  However, it is indisputable that echocardiography is limited by its operator and acoustic 
windows, with reported inaccuracies of systolic pulmonary arterial pressure (sPAP) in up to 
50% of cases (100, 101).  Furthermore, up to 30-40% of subjects are not suitable, with no 
visualization of the RV inflow tract (101, 102) and there is a poor understanding of what the 
normal upper limit of increases in sPAP during exercise is.  SPAP is influenced by age, gender, 
body mass index (BMI), ventricular function and physical fitness, which makes it difficult to 
define normal ranges.  Currently, there are no indices which are validated during exercise and 
because of a lack of clarity as to which echocardiographic parameter is the most useful in the 
assessment of exercise RV function (103), there is a high heterogeneity of study methods, 
protocols and estimations of haemodynamic parameters (104).  Even for the LV, exercise 
echocardiography has been shown to be unreliable for estimation of LVEDV and dependent 
considerably on the practical skills of the operator (105).  The utility of exercise CMR to assess 
RV reserve will be discussed in more detail later on. 
 
Given ventricular interdependence and the impact of the function of one ventricle on the other, 
it’s important to consider the impact of RV dysfunction on the LV.  A reduction in LV stroke 
volume and LVEDV has been proposed to be due to LV compression from RV enlargement 
and left ventricular septal bowing (12) and LV under filling (11, 106, 107), or a combination 
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of both. Furthermore, LV systolic strain is reduced and associated with early mortality in PAH 
(108) and electrophysiological remodeling of the LV in RV pressure overload has been 
demonstrated (109). 
 
1.4 Acute Hypoxia 
 
Hypoxia induces pulmonary vasoconstriction, which has marked interindividual and 
interspecies variation (110).  In humans, hypoxic vasoconstriction may be absent in 20% of 
people, but strongly present in 1-2% of cases (111, 112). Inhibition of voltage gated potassium 
channels localized in smooth muscle cells is responsible for the initial hypoxic 
vasoconstriction, leading to a rapid increase in PVR in the first 5 minutes (113), then a lower 
increase over 2 hours, with maximal response at 24 hours accompanied by early signs of 
remodeling, such as medial hypertrophy.  During hypoxic exercise, the mean pulmonary 
arterial pressure (mPAP)- flow relationship is further shifted, imposing higher pressures on the 
RV (112, 114).  
 
At rest, it is well accepted that acute hypoxia leads to an increase in mPAP, HR and CO (114-
116).  Other reported findings are an alteration of RV outflow tract flow with a decrease in 
acceleration time (AT) (115, 117), a reduction in the early to late diastolic filling (E:A) ratio 
with a decrease in early diastolic filling and an increase in late diastolic filling of both the LV 
and RV (118-121), an increase in RV dimensions, (122), no change in RV dimensions (123) 
and preserved RV and LV contractility. 
 
During acute hypoxic exercise, the maximal oxygen uptake (VO2) max and CO are lower than 
during normoxic exercise (124, 125).  At high altitudes and after a period of acclimatization, 
	 39	
this could be explained by a number of different mechanisms including hypovolaemia, 
hypocapnia, increased blood viscosity, autonomic nervous system changes and depressed 
myocardial function.  However, in the acute setting, the mechanisms are less clear and exercise 
capacity may be limited by RV flow output secondary to hypoxic pulmonary vasoconstriction.  
Studies examining RV function during exercise in acute hypoxia, have largely used 
echocardiography, which as discussed previously, has important limitations when assessing the 
RV.  Hence indirect methods of assessing RV contractility such as the RIMP (115), strain, 
strain rate as assessed by speckle tracking (118), isovolumic acceleration and TAPSE (117, 
121, 126) and assessment of diastolic function using the E:A ratio have been used.  Overall, 
these studies support the notion that HR increases, LV contractility increases (119, 127), and 
there are signs of RV strain and functional limitation but overall RV systolic function is 
preserved.  An altered LV diastolic filling pattern is also consistently reported, which has been 
hypothesised is due to diastolic dysfunction, tachycardia, altered interventricular interactions 
or hypercontractile atria. 
 
Fukada et al used a novel thoracic impedance model to continuously measure stroke volume 
and analysed healthy volunteers during acute hypoxic exercise, and they found that VO2 max, 
SV and CO at maximal exercise decreased.  They also found that SV was lower at identical 
work rates during hypoxic exercise, compared to normoxic exercise (128). However, whether 
the attenuation of VO2 max during acute hypoxia is due to reduced forward flow from the RV 
has not been definitively documented and to date, there have been no imaging studies during 
acute hypoxic exercise, which have been able to identify changes in RV stroke volume. 
 
1.5 Pulmonary Hypertension 
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Pulmonary Hypertension (PH) is defined as an increase in mPAP ≥ at rest.  It can be clinically 
classified in to 5 categories which include 1)  Pulmonary Arterial Hypertension 2) Pulmonary 
Hypertension due to left heart disease 3) Pulmonary Hypertension due to lung diseases and/or 
hypoxia 4) Chronic thromboembolic pulmonary hypertension and other pulmonary artery 
obstructions and 5) Pulmonary hypertension with unclear and/or multifactorial mechanisms. 
(129) 
 
1.5.1 Chronic Pulmonary Arterial Hypertension 
 
PAH refers to patients who have pre-capillary PH, defined by a pulmonary capillary wedge 
pressure (PCWP) ≤ 15mmHg and a PVR > 3 Wood units, and can be further divided in to 
idiopathic, heritable, induced by drugs and toxins, or associated with connective tissue disease, 
human immunodeficiency virus, portal hypertension, congenital heart disease and 
schistosomiasis (129).  In all of these settings, it is a progressive disease of the pulmonary 
vasculature, which is associated with elevated PVR, progressive RV dysfunction, RV failure 
and eventually death (130).  Drug therapies, which are licensed for PAH, slow disease 
progression and prolong life (131).  There are currently four classes of drugs, which may be 
combined if response is inadequate to monotherapy, however, the optimal timing to combine 
or switch agents is unknown and assessment of adequate response to monotherapy has to be 
individualized.  Current guidelines recommend a number of follow up investigations, however, 
none of them of been validated (132).   
 
1.5.2 Chronic Thromboembolic Pulmonary Hypertension 
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CTEPH, defined as a mean pulmonary artery pressure (mPAP) ≥25mmHg with a PCWP 
≤15mmHg and at least one segmental perfusion defect following three months of adequate 
anticoagulation, is an important, treatable cause of persistent pulmonary hypertension.(133, 
134).  Predominant mechanisms include recurrent pulmonary emboli, obliteration of central 
pulmonary arteries, pulmonary vascular remodeling and progressive small vessel arteriopathy. 
In selected cases with centrally located anatomic obstruction in one or both branch pulmonary 
arteries, surgical pulmonary thromboendarterectomy (PEA) can be performed often, but not 
always, with excellent clinical outcomes.  Subsets of patients have predominantly small vessel 
arteriopathy and are not surgical candidates with medical therapy being the standard of care 
for these patients.  This disease is often progressive with poor outcomes. 
 
1.5.3 Consequences of Pulmonary Arterial Hypertension to the Right Ventricle 
 
In both PAH and CTEPH, consequences may include progressive RV hypertrophy, dilatation 
and failure with clinical decline (133-135). In response to pressure overload the RV initially 
adapts with sarcomere synthesis and myocardial hypertrophy.  This is followed by progressive 
contractile dysfunction and chamber dilatation, which is compounded by the volume overload 
of increasing tricuspid regurgitation (130). Dilatation, pressure and volume overload and 
failure of the RV impairs LV function through interventricular interactions (136).  
 
The rate and pattern of deterioration is variable and while some RVs will adapt, others fail.  
Genetic differences, variations in RV chamber geometry, myocardial ischaemia and 
biochemical factors affecting contractility and hypertrophic growth have been hypothesized as 
potential determinant factors (136-138).  RV function is a reflection of afterload, preload, 
contractility and ventricular interdependence. Traditionally, PVR has been used to represent 
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the afterload of an ejecting RV.  However, capacitance and impedance measuring pulsatile 
flow, are also key contributors, with independent relationships with RV adaptation and 
prognostic importance (139-142). 
 
1.5.4 Exercise in the Assessment of Pulmonary Arterial Hypertension 
 
In patients with PAH, the progressive remodeling of the pulmonary arteries eventually 
restricts blood flow from the RV to the lungs, leading to an increase in physiological dead 
space due to underperfusion of well-ventilated lungs.  This reduction in blood flow to the LV, 
means that a rise in SV is limited and an increase in CO is largely reliant on HR.  The lack of 
oxygen delivery to muscles leads to an increase oxygen extraction, uptake and an increase in 
hydrogen ion concentration at lower workloads during exercise, which stimulates 
ergoreceptors and chemoreceptors, inducing a hyperventilatory response and exercise induced 
hypoxia if PAH is severe. 
 
A systematic review in 2010 found that 107 factors have been associated with mortality in 
PAH, however, only 10 factors were found to have a reproducible predictive association.  
These include the New York Heart Association functional class (NYHA), HR, six minute walk 
distance test (6MWD), pericardial effusion, mPAP, mean RAP, cardiac index (CI), stroke 
volume index (SVI), PVR and mixed venous saturations.  However, for mPAP, half as many 
studies that evaluated the variable did not find an associated with mortality and only mean 
RAP and PVR have more supporting evidence than non-supporting evidence(143). PH patient 
registries have shown that poor prognosis is associated with RV haemodynamic function and 
exercise limitation at the time of diagnosis (144, 145) and the REVEAL study demonstrated 
that PVR, NYHA class 4, a 6MWD threshold below 165m and RAP, but not mPAP were 
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associated with survival (131).  Humbert at al showed that a greater 6MWD, lower RAP and 
higher CO were associated with improved survival (146).  Similarly in CTEPH, Condliffe et 
al showed that 6MWD and gas transfer independently predicted perioperative mortality in 
operable CTEPH, while 6MWD and CI independently predicted outcome in non-operable 
disease(147).  Together these studies demonstrate that exercise capacity reflected in functional 
class and 6MWD, and variables associated with RV function such as RAP are the key 
prognostic indictors.  These papers have not included CMR assessment of RV function. 
 
RV function is a strong predictor of mortality, outperforming PVR (148-150).  On systematic 
review of CMR measurements only, RVEF as assessed by CMR is the best established and 
best predictor of mortality (151) and survival is associated with change in RVEF, and not 
change in PVR or CO.  Correlations between change in PVR and change in RVEF are reported 
to be poor (152).   Courand et al have shown that improvement in RVEF at 3-6 month follow 
up has been shown to be the best predictor of subsequent overall survival, and that 53% of 
patients with improved PVR, had decreased RVEF on follow up, once again showing a 
discrepancy between PVR and deterioration in RVEF.  Echocardiographic parameters, e.g. 
TAPSE, lost significance in multivariable analyses (153).  Also of key interest, is that at 
baseline, there are differences between 6MWD and functional class, in those whose RVEF 
deteriorate or not (75, 153).  In patients with stable disease for 5 years, subtle increases in 
RVEDVI and RVESVI herald the onset of progressive RV dysfunction, so potentially 
monitoring RV volumes can help anticipate RV decline, even at a time of apparent clinical 
stability (154). 
 
Despite this, the submaximal 6MWD has been used as the standard of care for serial follow 
up of PAH patients but while baseline values are prognostic, change in 6MWD does not 
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provide additional prognostic information beyond that obtained at baseline levels (155-157) 
and importantly does not reveal the mechanisms of RV dysfunction at increasing 
cardiovascular workload. Exercise capacity as assessed by functional class and 6MWD is 
associated with prognosis, but change in 6MWD does not correlate with prognosis (74, 158) 
and cardio-pulmonary exercise testing (CPET) only adds either marginal prognostic value 
(159), or no additional prognostic information in larger trials (160) to the 6MWD.   
 
This highlights the point that despite the fact that deterioration in RVEF is a key prognostic 
indicator, there is currently no way to determine which RV is destined to fail despite medical 
therapy.  Clinical characteristics, the 6MWD and PVR response to therapy as a traditional 
method of measuring afterload are not sensitive or adequate measures to predict this.  Hence 
assessing RV reserve on exercise as a marker of subclinical RV-PA uncoupling prior to 
deterioration of resting RV function has gained attention over recent years. 
 
Claessen et al studied 14 inoperable CTEPH patients with exercise CMR with concurrent 
invasive haemodynamic monitoring, before and after acute administration of Sildenafil.  They 
demonstrated that Sildenafil decreased RVESVi during resting and exercise, increased LVEF 
and RVEF at rest and exercise and increased SVI, which was greater during peak exercise than 
at rest.  Furthermore, resting RV and LV parameters did not correlate with CPET but RVEF 
reserve correlated moderately with peak VO2 and the ratio of minute ventilation to carbon 
dioxide output (VE/VCO2).  They also found that the reduction in total PVR during peak 
exercise correlated highly with the increase in peak exercise SVI and RVEF after Sildenafil 
(161).   Surie et al similarly studied 18 operable CTEPH patients and demonstrated, using 
exercise CMR, an improvement in exercise SVI post PEA in 14 patients while resting SVI, HR 
and CI were unchanged (162). These studies, together, demonstrate how assessment of the RV 
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and LV function during exercise post a therapeutic intervention is feasible, with changes in 
exercise RV and LV function apparent.  However, Surie et al did not assess volumes, and 
Claessen et al did not assess flow parameters. 
 
Exercise echocardiography has been used to assess the response of the RV in PAH, 
demonstrating that a drop in SV during exercise is associated with significantly worse 
outcomes (95).  Blumberg et al demonstrated that peak VO2 was the strongest predictor of 
survival and that exercise CI and the slope of pressure/flow relationship were the only 
independent prognostic indicators(94).  Transplant free survival has been shown to be 
associated with RV load adaptation at diagnosis, with no other differences in resting RV size 
and EF at baseline(163).  SPAP increase during exercise and peak VO2 per kilogram remained 
independent prognostic markers(164).  Chaout et al have demonstrated that while change in 
6MWD correlates with change in exercise CI, the most significant baseline covariates 
associated with survival are change in SPAP from rest to exercise and exercise CI measured 
invasively (165).  However, interpretation of sPAP increase on exercise needs to be interpreted 
with caution, as LV diastolic dysfunction has also been  shown to be common and associated 
with greater elevations of sPAP on exercise(104) in patients diagnosed with scleroderma 
associated PAH. 
 
Developing non-invasive assessments of RV function is an ongoing challenge in clinical 
research.  The ability to accurately and reproducibly assess RV and LV adaptation to 
pulmonary hypertensive states, and hence potentially to targeted therapies, would be 
invaluable. As CMR provides accurate assessment of RV volumes and EF, is not limited by 
acoustic windows or operator dependent, and does not make use of ionizing radiation, it 
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potentially provides a novel and exciting method to analyse dynamic RV function and is the 
ideal modality for assessing serial differences between small groups 
 
1.6 Cardiovascular Magnetic Resonance Imaging 
1.6.1 Cardiovascular Magnetic Resonance Imaging Physics 
 
CMR has evolved in the last few decades in to a sophisticated and robust method for studying 
the cardiovascular system, and is the gold standard for the quantification of RV function (166, 
167).  It has been built on a century of scientific achievements in mathematics, physics, 
chemistry and medicine.  Six Nobel Prizes have been awarded for breakthroughs related to this 
technique. 
 
MRI is based on the resonance of the protons in response to radiofrequency waves.  Hydrogen 
is used because it is the simplest and most abundant element in human tissue, water, and lipid 
molecules.  Protons have a magnetic axis, termed magnetic moment, which is normally 
randomly orientated.  When spins are placed in a magnetic field, they align and spin around an 
axis in line with the direction of the field. 
 
A MRI system is made up of three main electromagnetic components; a set of main magnet 
coils, three gradient coils and a radiofrequency transmitter coil (Figure 3).  Each generates a 
magnetic field in different directions and times, which when applied in combination, produce 
MRI signals during the readout that are used to form images.  The main magnet coils produces 
a constant, strong magnetic field, B0 and defines the operating field strength of the MRI system, 
measured in units of Tesla (T). 
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The magnetic field direction is described using three orthogonal axes, x, y and z.  When the 
patient lies supine within the centre of the bore of the magnet, the overall proton alignment is 
in the direction of the main magnetic field, B0, which is also denoted by the z axis, and at 
equilibrium has net longitudinal magnetization (Figure 3).  Applied radiofrequency pulses then 
disrupt this equilibrium, and the net magnetization moves away from its alignment with B0, in 
the plane of the x and y axes, or Mxy, or the transverse component.  For example, a 90° 
radiofrequency pulse will move all the net magnetisation from the longitudinal (z axis) through 
to the transverse (xy) plane.  These radiofrequency pulses are classified by their flip angle and 
their effect, and are known as excitation pulses.  This rotating Mxy component generates the 
detectable signal. 
 
Figure 1.3: MR System components a) Relative locations of main magnet coils, x, y and z 
gradient coils, and radiofrequency transmitter and receiver coils b) Typical arrangement for a 
cylindrical bore MR system showing the magnet bore and the reference coordinate axes with 
the static B0 field direction along the horizontal z axis (From: Ridgway, J.P. Cardiovascular 
magnetic resonance physics for clinicians: part 1, Journal of Cardiovascular Magnetic 
Resonance, 2010) 
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Immediately after the radiofrequency pulse, the spins start to relax as the energy is dissipated 
and is defined by two parameters known as T1 and T2.  T1 relaxation refers to the recovery 
along the longitudinal axis, while T2 refers to relaxation of the transverse component.  
Different tissues have varying relaxation parameters, and hence this can be used for tissue 
characterization. 
 
Localisation of anatomical position within a selected imaging slice is done with the application 
of frequency and phase encoding gradients.  Reception of the radiofrequency energy is via 
aerials known as coils, and these MR signals produced can be localized and encoded to produce 
an image, using a Fourier transformation.  However, the Fourier transform can only analyse a 
signal that changes over time.  Hence each phase encoding gradient is applied at an increasing 
strength, repetitively, by equal increments.  For each phase encoding step, the frequency or 
signal echo is measured and stored in a raw data matrix. Once all the signals for a prescribed 
number of phase encoding steps have been acquired and stored, they are then analysed together 
by a 2D Fourier transform to decode both the frequency and phase information (168, 169). 
 
K space has a central role in MRI.  MRI scanners collect data on the spatial frequencies on the 
imaged object.  They are stored in a regular grid of values forming a data matrix known as k-
space.  Each point in k space represents how much of a particular spatial frequency is contained 
within the image.  To make an image, a whole range of spatial frequencies is acquired.  Usual 
standard imaging is acquired by filling k space with equally spaced parallel lines of signal data, 
known as a Cartesian acquisition. 
 
The repetition time (TR) is an important parameter that determines how fast MR images can 
be acquired, but also affects image contrast.  The spatial resolution, or the ability to 
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discriminate between two points in space and time, depends on the field of view, and the 
number of phase and frequency encoding steps, and as a result is often limited by the image 
acquisition time.  A greater spatial resolution requires a greater number of repetitions, and 
therefore a longer image acquisition time.  It is specified by selecting the field of view (FOV) 
and the number of frequency and phase encoding points, which determines the degree of 
sampling of the MR signal, which hence specifies the extent of k space that is acquired.  
Sampling is performed long enough such that all the necessary spatial frequencies to 
reconstruct an image are collected.  Displayed resolution can be improved and is performed 
routinely with clinical MR, using zero padding and zero filling.  The more zeros appended, the 
better the reconstructed images look.  A zero padding factor of 2 is used more commonly to 
improve the displayed resolution (170). 
 
Temporal resolution is often described as the smallest increment of time over which a change 
in an imaged dynamic process can be observed.  However, this needs to be distinguished from 
the period of time for data acquisition for a given image. Interpolation methods to improve 
reconstructed temporal resolution such as view sharing can also used, and display cine images 
at less than the acquired temporal resolution and do not actually add further information but 
merely improve the visualization of the images.  For routine CMR, the MR signal are acquired 
over multiple heart beats, synchronized by ‘gating’ the images by detecting the R wave on the 
ECG.  This is then used to synchronise the MR data acquisition.  Hence the resultant image is 
an average of a heart beat, with the data acquired and averaged over multiple heart beats, 
synchronized using the ECG (171). Limitations of CMR include claustrophobia, artefacts 
caused by arrhythmia and motion, metal implants/devices contraindicating CMR and patient 
size. 
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1.6.2 Two dimensional phase-contrast imaging 
 
Cine-imaging can also be used to quantify flowing blood through a vascular lumen.  Usually, 
the magnitude of a signal coming from a voxel is used for image reconstruction.  However, this 
signal is a vector, and also possesses a direction or phase, and this is used to quantify the 
velocity of that voxel.  To do this, an additional velocity-encoding gradient switching is 
introduced, causing phase shifts proportional to blood and tissue velocities in the gradient 
direction.  Then to extract these phase shifts, the signals are acquired with and without 
switching of the velocity encoding gradient and subtracts the resulting phases.  In stationary 
tissues, this results in a net phase of zero.  However, in moving tissue, the effects of these 
gradients will not cancel each other out and a net phase difference can be detected.  Where 
there is no phase shift, this becomes a gray scale image, and where there is velocity change, 
this will be displayed as either brighter or darker, depending on the direction.  The sequence 
used is typically a spoiled gradient echo sequence (172, 173). 
 
The plane of the image must be set that it is perpendicular to the path of the flowing blood, and 
this is achieved by planning on two orthogonal views.  Hence it provides cine images of the 
velocities across the total cross sectional area of flow of interest, and then time courses, 
maximal velocities, peak velocity and mean velocities can be calculated across that cross 
sectional area (172, 173). 
 
The proportion of the phase shift in each voxel or tissue is determined by the velocity-encoding 
(VENC) value, which is pre-set by the operator.  Phase shifts are measured in degrees, and 
their values should be in the range of +/- 180 degrees.  Hence the pre-set VENC is set at what 
the user predicts is the expected peak velocity within the vessel, before starting the 
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measurement, and the peak velocity corresponds to a phase shift of 180 degrees.  If the VENC 
chosen is too low, then aliasing will occur in the opposite direction, however, when set too 
high may be insensitive to slower velocities, and hence potentially causing inaccuracies (172, 
173). 
 
1.6.3 Real time MRI 
 
Until recently, the relatively low imaging speed of cardiac MRI compared to physiological 
processes such as blood flow, a heart beat and a respiratory cycle, made dynamic MRI 
challenging.  As discussed, in order to reconstruct an image, as many points in k space are 
usually sampled over multiple heart beats, which sets the limit as to the speed of acquisition.  
Various techniques such as parallel imaging, sampling data using alternative trajectories, k-t 
acceleration, compressed sensing and extra dimensional reconstruction, have been developed 
to overcome these limitation.  Central to these techniques is k space under sampling.  This 
technique reduces the amount of k space acquired and uses prior information to reconstruct the 
image.  However, it can lead to artifacts and the choice of under sampling influences the degree 
and type of artifact (Figure 4). 
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Figure 1.4: Undersampling techniques used for imaging of cardiac function a) Regular 
Cartesian undersampling e.g. for parallel imaging, which involves (for example) acquiring one 
out of every four lines and can result in foldover artefacts in the reconstructed image. B) Shows 
uniform radial undersampling which leads to low-value streaking artefacts c) Random 
Cartesian undersampling which leads to noise-like artefacts. (From Axel and Otazo, 
Accelerated MRI for the assessment of cardiac function, British Journal of Radiology, 2016) 
 
There are two main approaches to parallel imaging – SENSE and GRAPPA.  SENSE imaging 
makes use of detecting multiple simultaneous acquisitions with different coils to remove 
regular aliasing and the images are reconstructed from the signals detected with the different 
coil elements.  GRAPPA uses the varying spatial response patterns of the coil elements to 
estimate the missing data points from the k-space data. 
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Each coil had different spatial sensitivity patterns, and hence can provide additional effective 
spatial information that can produce images without aliasing, even in the setting of under-
sampling, as each coil element will have different relative intensities of the aliased component 
of the images.  Theoretically, this should mean that the acceleration factor of a parallel-imaging 
scan is equal to the number of coils used.  However, this is actually limited by the change in 
signal to noise ratio.  Saying this, however, the greater the number of coils, the less likely there 
will be aliasing in an under sampled acquisition and the maximum acceleration factor in 
parallel imaging is limited to the number of independent coils along the phase-encoding 
dimension (174-176).  Figure 5 shows a 32 elements cardiac coil used in the Philips Achieva 
1.5T, at the Robert-Steiner Unit, Hammersmith Hospital. 
 
Figure 1.5: A 32- element cardiac-coil used to obtain high resolution imaging with high 
acceleration factors (Philips sensitivity encoding (SENSE) Cardiac coil for Achieva 1.5T. 
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1.6.4 Exercise MRI 
 
Thus far, accelerated Cartesian (26, 37-40, 42) and non Cartesian imaging (177-180) 
approaches have been used by several authors, with some being conventional, retrospectively 
acquired gated images (29, 30) or triggered real time (26, 40, 42), while others have used ‘true’ 
real time imaging with no triggering (37).  There has been little published in regards to 
comparison between the different techniques.   
 
Lurz et al reported their radial k-t imaging against ‘standard’ (accelerated Cartesian 
acquisition) real time.  Their standard real time approach had a voxel size of 3.1 x 3.9 x 10mm 
and a temporal resolution of 80ms, while their radial k-t SENSE sequence had a voxel size of 
3 x 3 x 10 and a temporal resolution of 35.5.  They reported that their radial k-t SENSE 
sequence was more accurate and reproducible than the standard real time sequence, with 
accuracy defined as RVSV = LVSV.  However, the spatial resolution of their standard sequence 
was poor, and they only allowed 30 seconds to achieve ‘steady state’ exercise.  In other words, 
SV may have been steadily increasing throughout acquisition, leading to inaccuracies in SV 
calculation.  Furthermore, simultaneous aorta (Ao) and main pulmonary arterial (MPA) SV has 
not been reported.  Reproducibility was also only reported for CO, and not cardiac volumes or 
SV (178). 
 
Pflugi et al compared radial vs. Cartesian acquisitions during exercise CMR perfusion studies.  
They compared radially acquired data reconstructed using several techniques to Cartesian data 
reconstructed using SENSE.  There was no statistical difference in image quality in the radially 
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acquired data compared to the Cartesian.  Temporal resolution was 93ms for the Cartesian 
acquisition and 62ms for the radial acquisition.(180) 
 
La Gerche et al compared ungated, standard real time to gated sequence during 3 levels of 
exercise, as well as comparing MRI derived CO to simultaneously invasively derived CO from 
the Fick method.  Their ungated real time sequence had a reconstructed voxel size of 2.3 x 2.3 
x 8 (though actual voxel size has not been reported) and they have reported their temporal 
resolution to be 35-38ms.  This research team, however, have given our research team a copy 
of their exam card, and their TFE duration acquisition is 47ms.  They reported that due to 
considerable ECG artifact, analyzable images from only 6 subjects out of 15 were acquired 
during the gated sequence, however, all the images were acquired during the real time 
acquisition.  They also reported considerable artifact in the gated images, in those that were 
acquired.  There was excellent correlation between CO derived by the Fick method to that from 
real time exercise CMR calculated CO, and excellent inter and intra observer reproducibility.  
However inter-study reproducibility was not reported and similar to Lurz et al, simultaneous 
Ao and MPA flow was not reported.(37) 
 
Exercise CMR has now been used by several research groups in healthy volunteers (18, 26-30, 
37, 177, 178, 181-183) and a number of different pathologies including chronic obstructive 
pulmonary disease (42), PAH(40), BMPR2 gene positive subjects (184), heart failure (37), 
CTEPH (161, 162), congenital heart disease (38, 179), pulmonary regurgitation (39), coronary 
artery disease (180), bicuspid aortic valve disease (185) and athlete’s cardiomyopathy (102).  
However, there are a number of issues.  Firstly, each research group has used different MRI 
acquisition protocols with differing temporal resolutions and spatial resolutions.  Secondly, 
while most report consistent inter and intra observer reproducibility, none have reported inter-
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test or inter-study reproducibility, and the majority have acquired volume or flow, rather than 
acquiring both.  This is an important consideration when discussing the accuracy of the test.  
Furthermore, exercise protocols have varied greatly, with some groups acquiring images after 
during exercise, during intermittent breaks or immediately after exercise.  This will be 
discussed in further detail in Chapter 3.  Fourthly, some groups have not taken in to account 
respiratory variation on exercise, which is an important consideration, which will also be 
discussed further in Chapter 3.  While change in dynamic biventricular function and RV reserve 
is clearly demonstrable with exercise CMR, a consistent, accurate and reproducible 
methodology needs to be developed.  Otherwise, it will threaten to become ‘just a research 
tool’, utilized in inconsistent, heterogeneous ways so that data becomes difficult to interpret. 
 
1.7 Summary, Hypotheses and Specific Aims 
 
The gold standard of measuring RV function has traditionally thought to be best done with 
invasive haemodynamics, however, developments in non-invasive imaging techniques are 
potentially safer and more clinically and prognostically relevant.  Conventional indices of 
resting RV function have prognostic significance in PAH but do not take in to account exercise 
capacity, and conventional cardio-pulmonary exercise tests do not directly assess RV 
dysfunction at increasing workload.  Imaging cardiac function at rest, has also been shown 
consistently not to correlate with exercise capacity. RV reserve has been gaining interest 
recently, as a way to detect subclinical ventricular-vascular uncoupling.  While exercise 
echocardiography is feasible and available, it cannot directly measure RV volumes and EF 
accurately, so surrogate methods of RV function have been developed with mixed results in 
terms of reproducibility. CMR is a highly reproducible and accurate method of evaluating 
biventricular function at rest and during exercise, and can be used to assess RV remodeling 
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after interventions.  However, there is already a high heterogeneity of approaches developing 
to this technique, with no reports of inter-study and inter-test reproducibility, nor has there been 
any model tested to demonstrate the sensitivity of CMR to detect subtle changes in RV and LV 
function, say as in the setting of acute pulmonary hypertension in the healthy heart. 
 
Specific Aims 
1. Develop and demonstrate an exercise CMR protocol which is feasible, accurate and 
reproducible 
2. Study the ability of CMR to detect physiological LV and RV changes at rest and on 
exercise in normal subjects in a model of acute pulmonary hypertension, induced by 
hypoxia 
3. Study the ability of CMR to detect changes in right ventricular reserve on exercise in 
patients with pulmonary arterial hypertension, and the impact on LV preload 
4. Describe the spectrum of ventricular volume and flow in normal hearts, normal hearts 
in acute pulmonary hypertension and in patients with chronic pulmonary arterial 
hypertension 
5. Study the pathophysiology of exercise cardiac function in patients with PAH and 
correlate with cardiopulmonary exercise testing and 6MWD 
6. Study the impact of RV obstruction from acute pulmonary vasoconstriction and chronic 
pulmonary remodeling on LV geometry and filling 
7. Study the ability of the RV to remodel post pulmonary thromboarterectomy, the 
relationship with the left ventricle and MRI correlations with functional capacity, in 
particular, improvements in exercise capacity 
 
Specific Hypotheses: 
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1. During exercise in healthy volunteers, LV and RV SV will increase driven by a 
decrease in ESV and an increase in EDV 
2. In acute pulmonary hypertension, RV-PA coupling will be maintained in healthy 
subjects demonstrated by a preservation in right ventricular reserve on exercise 
3. In patients with PAH and normal resting RV function, RV-PA uncoupling will occur, 
with deterioration of RVEF only apparent on exercise 
4. Left ventricular size will decrease during acute hypoxia, will be smaller in patients with 
chronic pulmonary hypertension and will become more apparent on exercise, due to 
under filling. 
5. On relief of RV obstruction, LV size will increase due to improvements in filling 
6. Resting parameters of cardiac function on MRI will not correlate with exercise capacity 
in patients  
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Chapter 2 – General Methodology 
 
2.1 Ethics Approval 
 
For the studies described in Chapters 5-7, informed written consent was obtained from all 
subjects and each study was approved by the Health Research Authority, Research Ethics 
Committee South East Coast, Surrey, Research Ethics Committee reference number 
13/LO/1398, the Joint Research Compliance Office (13HH0838) and sponsored by Imperial 
College London.  The study was included on the National Institute for Health Research Clinical 
Research Network Portfolio.  Chapter 4 was a retrospective analysis with the knowledge of 
The Prince Charles Hospital Ethics Committee in Queensland, Australia. 
 
2.2 Funding 
 
The studies described in Chapters 5-7 were funded by the British Heart Foundation, Project 
Grant number PG/13/44/30321 for the sum of £232,551 and peer reviewed by three 
independent reviewers. 
 
2.3 Study population and Recruitment for the Exercise CMR study 
 
Two groups were recruited:  
1) Healthy volunteers 
2) Patients with Class 1 PAH 
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2.3.1 Healthy Volunteers 
 
Healthy volunteers were screened initially via email using a simple health questionnaire.  On 
the day of attendance, a more detailed screening questionnaire was carried out, with height, 
weight, heart rate, blood pressure, electrocardiogram (ECG) and cardiovascular examination.   
 
Inclusion criteria 
 
1 Male or female 
2 Age ≥18  
3 Able and willing to give consent 
4 Able to participate for the planned duration of the study 
5 No clinically important abnormal clinical findings at the screening examination 
6 Normal ECG 
7 Normal blood pressure 
8 Able to perform all the test procedures in the study 
 
Exclusion criteria 
 
1 Known to be pregnant 
2 Have medical conditions that precludes his or her ability to participate 
3 Have history of high-altitude pulmonary oedema or mountain sickness  
4 Inability to perform or have contraindications to the test procedures 
5 Currently enrolled in other interventional study 
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6 Have impairment in communication (learning disability or impaired cerebral 
function) 
7 History of recent drug dependence and alcohol abuse (<2 years) 
8 Have BMI >35kg/m2 or weigh >120kg 
 
2.3.2 Pulmonary Arterial Hypertension Subjects 
 
Inclusion criteria 
 
1 Male or female 
2 Age ≥18  years old 
3 Have pulmonary arterial hypertension: idiopathic, hereditary, anorexigen-induced or 
connective tissue related pulmonary hypertension. 
4 Resting RVEF ≥ 45% 
 
Exclusion criteria 
 
1 Known to be pregnant 
2 Have lung disease-related and left heart disease related pulmonary hypertension  
3 FEV1 <50% predicted 
4 Have medical conditions that precludes his or her ability to participate 
5 Inability to perform or have contraindications to the test procedures 
6 Currently enrolled in other interventional study 
7 Have impairment in communication (learning disability or impaired cerebral 
function) 
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8 History of recent drug dependence and alcohol abuse (<2 years) 
 
2.4 Recruitment 
2.4.1 Healthy volunteers 
The healthy volunteers were recruited via advertisement to the general public. 
 
2.4.2 Participants with Pulmonary Arterial Hypertension 
The participants were recruited from referrals from the staff in the Pulmonary Hypertension 
service and then directly approached and invited to participate. 
 
2.5 Follow up 
 
10 Healthy volunteers were asked to return within three months to repeat the above procedure 
for validation during normoxia.  Exercise CMR was separated from other routine tests, such 
as CPET and 6MWD, by at least 4 hours. 
 
2.6 Our Services 
 
The Pulmonary Hypertension service at Hammersmith hospital is part of the designated 
national pulmonary hypertension service for England. We have a programme of clinical and 
basic science research in pulmonary hypertension and exercise physiology.  Diagnosis is made 
according to current European guidelines. (186).  In 2012 the service saw 1162 patients; 361 
were new referrals of whom 95 had PAH. 
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2.7 Statistical Analysis: 
 
Data was analysed using IBM SPSS statistics Version 22.  Descriptive data for continuous 
variables was expressed as medians and the interquartile range, or as mean ± standard 
deviation where appropriate. Comparisons between groups for continuous variables were 
performed where normally distributed using unpaired two sample t tests or the Mann-Whitney 
U test as appropriate.  Comparisons within groups for continuous variables were performed 
where normally distributed using the paired samples t test or the Wilcoxon signed rank test.  
A two way repeated measures analysis of variance (ANOVA) was used to compare cardiac 
response from rest, exercise to immediately post exercise in healthy volunteers during 
normoxia and hypoxia.  A mixed ANOVA was used to compare biventricular response from 
rest, exercise to immediately post exercise in healthy volunteers and patients.  Pearsons 
correlation coefficients were used to evaluate the bivariate relationship between resting and 
exercise measures of biventricular function and relevant demographic and clinical factors. The 
Bland Altman test was used to compare between tests and alpha coefficient to compare intra 
and inter-observer reproducibility and inter-study reproducibility.  A Bonferroni correction 
was applied to adjust for multiple comparisons where appropriate.  A two tailed p-value <0.05 
was considered statistically significant with a bonferroni correction used where appropriate. 
 
2.8 Clinical Data 
 
2.8.1 6MWD 
 
The 6MWD was carried out as part of the patient’s usual clinical work up.  It was carried out 
by the Pulmonary Hypertension Specialist Nurse according to the American Thoracic Society 
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Guidelines (187).  The following data was captured 1) Distance walked 2) O2 saturations at the 
beginning 3) O2 saturations at the end 
 
2.8.2 Cardiopulmonary Exercise Testing 
 
CPET comprised a ramp-protocol cycle test on an electronically braked bicycle ergometer 
(Bike, VIASprint 200; Equipment, Jaeger Masterscreen CPX; Software, JLAB LABManager 
5.3.0.4) (188).  The value for the bicycle ergometer increase (watts/min) was estimated so that 
the subject’s peak workload would be achieved in around 10 minutes, and was based on the 
subject’s reported level of fitness.  Subjects were encouraged to exercise until exhaustion and 
3 minutes of rest and recovery data were also recorded.  Each participant breathed through a 
calibrated mass flow sensor with expired gas sampled on a breath by breath basis enabling 
measurement of VO2, VCO2, minute ventilation (VE), and respiratory rate.  Oxygen saturation 
was monitored with a finger probe attached to a pulse oximeter.  Subjects were monitored 
throughout testing with a 12 lead ECG. 
 
The CPET operator recorded the peak VO2 as the highest peak VO2 over a 30 second period.  
VE/VCO2 was calculated by fitting a first order polynomial to the VE/VCO2 data where the 
relationship becomes linear, near the start of incremental exercise until the respiratory 
compensation point using the metabolic cart software. The following data were captured 1) 
Peak VO2 2) Peak work rate and 3) VE/VCO2 slope 
 
2.8.3 Lung Function Testing 
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Spirometry was carried out according to American Thoracic Society/European Respiratory 
Society standards.  The following data was captured: 1) Forced expiratory value in 1 second 
(FEV1) and 2) Forced vital capacity (FVC) 
 
2.8.4 Echocardiogram 
 
The following data was captured where possible from the patient’s most recent 
echocardiogram. 
 
Parasternal Long Axis View 
LV end diastolic diameters (cm) Posterior wall (cm) 
LV end systolic diameter (cm) Aortic root diameter (cm) 
Interventricular septum (cm)  
 
Parasternal Short Axis view of Right ventricular outflow tract (ROVT) 
Doppler 
RVOT acceleration time (m/sec) 
Pulmonary regurgitant velocity (PRV), beginning of diastole (m/sec) 
PRV end diastole (m/sec) 
 
Short Axis View at the Level of the Papillary Muscles 
LV eccentricity index systole LV eccentricity index diastole 
 
Apical Four Chamber View 
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2D Doppler Tissue Doppler Imaging 
Basal diameter of RV (cm) TRV (m/sec) LV septal E’ 
RAA (end systole) (cm2) Mitral inflow (m/sec) (E and A 
waves) 
LV septal A’ 
RA volume index (ml/m2) DT (mitral inflow, m/sec) LV lateral wall E’ 
RV FAC (%) LVOT tract velocity (m/sec) LV lateral wall A’ 
LVEF (Simpsons) Aortic flow (m/sec) RV free wall E’ 
 AR velocity (cm/sec) RV free wall A’ 
 Tricuspid inflow (m/sec) (E and 
A waves) 
RV free wall S wave 
 DT (tricuspid inflow, m/sec) RV MPI 
 TAPSE (mm) RV IVRT 
RV: Right ventricle, ED: End diastolic, ES: End systolic, RAA: right atrial area, FAC: 
fractional area change, TRV: tricuspid regurgitant velocity, DT: deceleration time, LVOT: left 
ventricular outflow tract, MPI: myocardial performance index, IVRT: isovolumic relaxation 
time 
 
Subcostal view 
• Inferior vena cava size 
• RA pressure estimation from % collapsing  
 
2.8.5 Ventilation Perfusion scan 
 
The results of the patient’s ventilation perfusion (V/Q) scan were documented. 
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2.8.6 Computed Tomography Pulmonary Angiogram 
 
The results of the patient’s computed tomography pulmonary angiogram (CTPA) scan were 
documented. 
 
2.8.7 Cardiac catheterisation 
 
Right heart catheterisation at was carried out as a routine clinical test for the patients at 
diagnosis.  The following data was collected from patient files: 1) Blood pressure and heart 
rate 2) Right atrial pressure 3) Pulmonary artery systolic pressure 4) Pulmonary artery diastolic 
pressure 5) Mean pulmonary arterial pressure 6) Pulmonary capillary wedge pressure 7) 
Cardiac output 8) Pulmonary vascular resistance 
 
2.8.8 Plasma Assays 
 
Data from the following blood test was captured. 
• Full blood count 
• Electrolytes, urea and creatinine 
• Liver function tests 
•        B-type natriuretic peptide (BNP) 
 
2.9 Subject Preparation 
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All subjects were instructed to avoid alcohol in the preceding 24 hours, and to avoid caffeine 
intake 6-8 hours before attending for the research tests.  They were also instructed, depending 
on the time of day of the test, to keep meals light.  Patients were instructed to continue their 
regular medications as usual. 
 
2.10 Imaging Protocol 
 
2.10.1 Cardiac Magnetic Resonance Imaging 
 
CMR was performed on a 1.5T Philips Achieva system (Best, Netherlands).  A 32-element 
cardiac phased-array coil was used for signal reception.  Continuous heart rate and oxygen 
saturations were monitored (Nonin 7500FO MRI Compatible Pulse Oximeter).   
 
The subject’s height was used to determine the optimal positioning on the MRI couch.  Care 
was taken to ensure that the subject was positioned such that they could pedal within the 
scanner with no restriction, and that their heart was no more than 10cm from isocentre.  Once 
the subject was optimally positioned, the feet were taken out of the pedals to rest on the couch 
during rest scanning and placed in to the pedals just prior to the commencement of exercise. 
 
A resting and exercise protocol was used to acquire the data.  20 minutes of rest or the period 
of time it took for heart rate returned to baseline was given to healthy volunteers before the 
administration of the 12% oxygen.  Participants breathed 12% oxygen for 10 minutes before 
resting acquisitions commenced and the same exercise protocol was used in the hypoxic study. 
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After all the images were acquired, participants were taken out of the CMR bore, the hypoxic 
gas removed and they were monitored supine until saturations and heart rate returned to 
normal. 
 
2.10.2 Breath hold Ventricular Volumes and Function 
 
In accordance with the international guidelines on tomographic imaging, the standardized 
approach to MRI image acquisition and display was used (189).  The heart is orientated and 
displayed using the long axis of the left ventricle.  Other selected planes are orientated at 90o 
angles relative to this long axis, and are described as short axis, vertical long axis and horizontal 
axis. 
 
Scout images were obtained and used to plan standard, retrospectively gated, breath hold, 2D 
cine balanced steady-state free precession (B-SSFP) images in the left ventricular short axis 
(LVSA) plane from base to apex using the following parameters: Field-of-view=370mm x 
370mm; Repetition time/Echo time = 3.0/1.5msec; Flip angle 60˚; Bandwidth = 1250Mz/pixel; 
Acquired pixel size = 2.0 x 2.2mm; Section thickness = 8mm with a 2mm gap; Reconstructed 
voxel size = 1.2 x 1.2 x 8mm; Number of sections = 10-12; Cardiac phases = 30 
 
2.10.3 Breath hold Aortic and Main Pulmonary Arterial Flow Quantification 
 
MPA and aortic flow data were acquired using a retrospectively gated flow sensitive gradient-
echo sequence acquired during a breath hold.  Image planes were located at the midpoint of the 
main pulmonary artery and ascending aorta (sino-tubular junction).  The parameters were: 
Field-of-view = 350 x 302; Repetition time/Echo time = 4.2/2.6 msec; Flip angle 20 ˚; 
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Bandwidth = 1724Hz; Acquired pixel size = 3.0 x 3.0 x 10mm; Section thickness = 10mm; 
Reconstructed voxel size = 1.37 x 1.37 x 10mm; 
 
2.10.4 Real time, Free Breathing Ventricular Volumes and Function at Rest and Exercise 
 
Free breathing, real time LVSA images were acquired using the following parameters: Field-
of-view = 305mm x 305mm; Repetition time/echo time = 2.5/1.26msec; Flip angle 50˚; 
Bandwidth = 87.9 Hz; Acquired voxel size 2.73 x 2.73 x 10mm; Section thickness = 10mm 
with no gap; Reconstructed voxel size = 1.19 x 1.19 x 10; Number of sections = 14; Slice scan 
order = base to apex; Dynamic scan time = 66 seconds, with 50 dynamics per slice; Temporal 
resolution 74ms; 
 
Real time images were acquired using LVSA stack geometry by specifying a number of frames 
acquired at each section before moving the imaging plane to the next contiguous slice position.  
Furthermore, the number of slices was adjusted according to the individual’s cardiac size and 
also anticipating downward cardiac translation, in order not to inadvertently miss acquisition 
of the apex. 
 
2.10.5 Real time, Free Breathing Aortic and Main Pulmonary Arterial Flow 
Quantification at Rest and Exercise 
 
Free breathing, real time MPA and aortic phase contrast images were acquired using the 
following parameters: Field-of-view = 300 x 300; Repetition time/Echo time = 11/3.7 msec; 
Flip angle 20 ˚; Bandwidth = ; Acquired pixel size = 3.0 x 3.0 x 10mm; Section thickness = 
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10mm; Reconstructed voxel size = 1.17 x 1.17 x 10mm; Dynamic scan time = 4.5 seconds with 
100 dynamics; Temporal resolution = 44ms 
 
Phase contrast velocity was set at 200cm/s for the aorta and 150cm/s for the MPA at rest, and 
at 200cm/s for both the aorta and MPA during exercise and immediately post exercise 
acquisition. 
 
During exercise, the slice locator was re-positioned in the expiratory phase on the exercise 
RVOT and LVOT images to acquire optimal MPA and aortic flow data respectively.  Prior to 
cessation of exercise, the position of the aortic and MPA acquisitions was checked for accurate 
placement and aliasing.  It was repeated if these were considered to be less than ideal.  This 
was repeated immediately post exercise. 
 
2.11 Ventricular Volumes and Mass Analysis 
 
Volume and mass analysis was carried out on Osirix (available at The Royal Prince Alfred 
Hospital, Sydney) and CVI cmr42 (available at Imperial College, London).  To carry out 
volumetric analysis of the heart from a cine image, two frames must be identified: end systole 
and end diastole.  The end-diastolic frame is usually acquired immediately after the R wave 
and the end systolic frame is identified visually as that with the smallest left and right 
ventricular cavity.  
 
Segmentation of the breath hold and real time short axis cine stacks was performed by semi-
automated left ventricular and right ventricular endocardial and epicardial surface contour 
detection, with manual adjustment, at end diastole and endocardial surfaces only in end systole 
	 72	
(cvi42) (Figure 2.1a and b).  Semi automated techniques have been demonstrated to have better 
inter-observer agreement, and detailed contouring shown to have less variability that simplified 
contouring (190).  For the real-time, free breathing cines, care was taken to choose a heart beat 
that occurred during end expiration, by visually tracking the position of the diaphragm. 
 
In both the breath hold and real time, rest and exercise cines, the papillary muscles and 
trabeculae were included as part of the blood pool to maintain consistency and reduce the 
chance of bias (191).  The mitral and tricuspid valve planes were tracked manually using the 
breath hold LVOT, RVOT and right ventricular long axis (RVLA) images for the rest cine 
analysis, and were tracked using exercise LVOT and RVOT images for the exercise cines. Care 
needs to be taken in identifying the basal slice, as this is a potential source of error (192). 
 
End diastolic and end-systolic volumes were calculated using measurements from each slice 
and were summed using the method of the disks.  Stroke volume was calculated as EDV – 
ESV.  Cardiac output was calculated as SV x HR and ejection fraction was calculated as (EDV 
– ESV) / ESV (193).  Left and right ventricular mass was calculated from the total myocardial 
volume multiplied by the specific gravity of myocardium (1.05 g/mL). Values were indexed to 
body surface area e.g. LVEDV index = LVEDV / BSA.  Right ventricular reserve was 
calculated as Exercise RVEF – Rest RVEF.  Septal curvature was measured in the short axis 
plane at the level of the LV papillary muscles.  Segmentation was carried out by drawing 3 
point arcs on the epicardial surface of the LV septal and lateral walls.  The curvature was 
calculated as the ratio of the septal and lateral wall curvatures. 
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A 
 
B 
Figure 2.1:  Segmentation of real time LVSA cines at rest and exercise A)  Rest end diastole 
and end systole, B) Exercise end diastole and end systole.  Papillary muscles and trabeulcations 
were included as part of the bloodpool and measurements were made during expiration 
 
2.12 Aortic and MPA Flow Analysis 
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Assessment of the breath hold aortic and MPA flow images was performed by semi automated 
vessel edge detection with manual operator correction (ArtFun, Paris) 
 
Assessment of the breath hold and real time, free breathing aortic and MPA flow images were 
performed by semi-automated vessel edge detection with manual operator correction (ArtFun, 
Paris).  ROIs were created around the aorta and MPA using a semi automated method with 
manual correction (Figure 2.2.)  This created time-volume and time-velocity curves from which 
SV and mean and average velocity could be calculated.   
 
Figure 2.2. :  Real time aortic flow with region of interest.  This was created using ArtFun. 
 
SV was calculated as the area under the curve of the time-volume curve, and calculated as the 
total forward flow minus any backward flow, for both the aorta and MPA (Figure 2.3).  Peak 
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velocity was taken as the peak velocity occurring during systole (Figure 2.4), and mean velocity 
as the mean of the velocities through systole (Figure 2.5).   For the real time analysis, an average 
of the first 5 consecutive heartbeats was taken.  Pulsatility was calculated as Maximum area – 
Minimum area/Minimum area x 100.  Cardiac output was calculated as SV x HR and indexed 
to body surface area. 
 
Flow data was checked for aliasing and phase offsets >0.6cm/second prior to analysis and 
unwrapped or adjusted prior to analysis using software developed in-house by our physicist, 
Pawel Tokarczuk. 
 
Figure 2.3:  Time-flow curve:  Stroke volume was calculated as the area under time-flow curve, 
and then averaged over 5 heartbeats 
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Figure 2.4:  Time-velocity curve and peak velocity:  Peak velocity was taken as the peak 
velocity per beat, and then averaged over 5 heartbeats. 
 
Figure 2.5:  Time-velocity curve and mean velocity:  Mean velocity was taken as the mean 
velocity throughout systole 
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2.13 Exercise protocol 
 
Exercise was performed supine, inside the scanner, using an MRI compatible circular 
ergometer (Lode MRI Circular Ergometer, Netherlands).  An exercise protocol was tailored 
for each subject according to his or her CPET result. 
 
Subjects performed 3 minutes of warm up which included 1 minute of cycling while the load 
was gradually increased to the pre-determined power set at 40% of the watts achieved during 
CPET.  Subjects then exercised at this load for 2 minutes, until steady state was achieved which 
was confirmed by stabilisation of heart rate.  Images were acquired during continuous exercise.   
 
Once the exercise images were acquired, subjects were instructed to stop cycling, at which 
time, the imaging protocol for immediately after exercise imaging commenced.  Imaging 
commenced within 2 seconds of the subject ceasing exercise.  MPA and then aortic flow were 
acquired first, taking 9 seconds, and then the LVSA stack commenced.  Hence the LVSA cine 
commenced around 10 seconds after the subject ceased exercise and took 66 seconds to acquire. 
 
Subjects were encouraged during the exercise protocol, and were able to listen to the music of 
their choice.  The exercise was terminated at the end of the protocol, or if any concerns were 
raised by the staff or subject. 
 
2.14 Acute Hypoxia Protocol 
 
Hypoxia was induced by using 12% oxygen, with continuous oxygen saturation and heart rate 
monitoring.  Each subject was fitted with an extra small, small, medium or large mask, as 
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appropriate, to ensure the correct fit and reduce the chance of gas leakage.  The inspirate was 
supplied from a medical gas mixture containing 12% oxygen in nitrogen administered from a 
commercially prepared cylinder (British Oxygen Company) and was kept in the outside MRI 
room.  A 1000L Douglas bag was filled from the cylinder that could be taken inside the MRI 
room.  A 35mm breathing tube connected to a 3 way T shaped stopcock, ran from the Douglas 
bag, and connected to a mask adaptor 7400/7450 which in turn was connected to a T shaped, 
non-rebreather valve on the 7450 V2 Blue Silicone Rubber Mask, which is airtight, fitted on 
the subject’s face.  All the equipment was supplied from Cranlea Human Performance Ltd, 
Birmingham and manufactured by Carefusion Corporation, USA.  Subjects were instructed to 
breath the 12% oxygen at rest, for 10 minutes, until saturations dropped and had plateaued.  
Images were then acquired at rest, with alteration to breath hold duration according to the 
subject’s perception of breathlessness.  Exercise and immediately post exercise imaging was 
then performed as per protocol.  The total duration of hypoxia was around 35 minutes. 
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Chapter 3 – Exercise CMR Methodology Development 
 
3.1 Introduction 
 
Exercise CMR is a new, innovative method that is being developed by several research groups 
to assess dynamic biventricular function.  However, there are several important methodological 
considerations that may significantly alter the quality and accuracy of the results, and research 
groups have varied in their approaches thus far.  These include the exercise protocol and the 
timing of imaging, respiratory variation, how aliasing and phase offset errors are accounted 
for, and the correct balance between spatial and temporal resolution.  We aimed to develop a 
methodological approach that was feasible for both healthy volunteers and patients, gathered 
data during steady state exercise, contained accurate and analyzable data, and could 
demonstrate accuracy and inter-test, intra-observer, inter-observer and inter-study 
reproducibility. 
  
3.2 Exercise protocol 
 
Exercise protocols have varied widely amongst groups using exercise CMR as well as exercise 
haemodynamic studies.  Incremental increases in watts to exhaustion (177-179), exercise fixed 
at 2 levels of 0.5 and 1 watt per kilogram (194), fixed heart rate aims (181, 185, 195), the Bruce 
protocol (196, 197), fixed levels of exercise (182) and static exercises including handgrip (27), 
bicep curls (28) and one legged raises (30) have been used.  Other groups have performed 
CPET in subjects prior to the exercise CMR and then tailored an exercise protocol according 
to these parameters.  These protocols have also been mixed.  Medium intensity exercise defined 
as 40% of maximal watts (42, 198), a graded protocol of low, medium and high intensity 
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exercise defined as 25%, 50% and 66% watts(193) and a fixed level of exercise at 60% 
maximal VO2 uptake have been used (38, 39, 199).   
 
Most groups have utilized supine, cycle ergometers (38, 39, 42, 193, 198, 199).  This form of 
exercise has been able to achieve a higher levels of watts, reaching 218 +/- 52W in an athlete, 
contrasting with a straight leg, kicking motion which was able to achieve a maximum of only 
22.5W in a healthy volunteer (178), limited by small muscle exhaustion.  However, the group 
who used this form of exercise felt that this helps reduce motion artifact.  Upright exercise has 
been used within the scanner, however, this is not widely available (195).  Exercise on an 
external bike or treadmill has also been utilised, with scanning occurring during recovery (196, 
197).  Scanning during continuous exercise (37, 40, 102), intermittent breaks during exercise 
(18) and immediately after exercise (182, 183) has also been carried out, with and without 
breath holds. 
 
When developing the exercise protocol, there were several considerations: 1) Data is collected 
during continuous steady state exercise when heart rate and stroke volume are stable and hence 
reproducible 2) Patients who are likely to have symptoms such as shortness of breath, are able 
to complete the exercise protocol and all the relevant data collected 3) The exercise level is set 
high enough to achieve clinically significant physiological changes 4) Image quality is 
preserved.   
 
We aimed to determine: 
1. The optimal timing at which to collect exercise data 
2. Examine the rate of change in physiology immediately post exercise on CPET in order 
to justify imaging during continuous exercise 
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3. The optimal positioning for the subject within the scanner, to ensure that exercise and 
imaging could be carried out simultaneously 
 
3.2.1 Methods 
 
In order to ensure that the exercise level would be aerobic as opposed to static and achieve high 
enough levels of wattage in order to demonstrate clinically relevant physiological changes, a 
MRI compatible supine cycle ergometer (Lode, Netherlands) was purchased. (Figure 3.1)  
Modifications to the tabletop were made, to ensure that the cycle ergometer was able to sit low 
as low as possible on the tabletop. 
 
 
Figure 3.1:  Set up of cycle ergometer with a subject inside the scanner. 
 
Two healthy volunteers underwent upright CPET with a ramp protocol, and then supine CPET 
at a fixed level of exercise, set at 40% of the watts achieved on the upright CPET. 
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These healthy volunteers were then positioned inside the scanner.  Height was measured, and 
once the subject was in the optimal position for cycling and scanning, the distance from the 
sole of the foot extended, to the centre of the posterior coil was measured.  
 
They were exercise at multiple levels of exercise, including 20%, 40% and 66% of the watts 
achieved on CPET. 
 
3.2.2 Observations 
 
During the progressive ramp protocol, VO2, VCO2 and HR steadily increased throughout 
exercise.  Oxygen pulse, which is used as a surrogate for SV, increased steadily and plateaued 
after approximately 7 minutes of exercise (Figure 3.2a and b).  However, as HR continued to 
rise, CO would also continue to rise as, given it is a product of SV and HR.  Also of note, CPET 
clearly demonstrated that immediately after cessation of exercise, VO2, VCO2, HR, SV and 
hence CO (Figure 3.2a and b), immediately begins to decrease hence as the CMR protocol 
takes 66 seconds to acquire, post exercise imaging would not accurately image the cardiac 
responses that had occurred during exercise. 
 
During supine CPET at 40% of the watts achieved, wattage was increased to the target load 
over the first minute of exercise.  As demonstrated in Figures 3.3 a and b, VO2 and VCO2 
plateaued after 3 minutes of warm up, and similarly, so did HR.  SV plateaued slightly earlier.  
This showed that in order to acquire images at steady state exercise, a warm up of 3 minutes – 
1 minute to increase the load to target and 2 minutes at that load, is required to ensure steady 
SV, HR and CO calculations.  Also of note, the VO2 at 40% of the watts achieved on upright 
exercise did not correspond to the same VO2 on supine exercise.  While peak cardiac output 
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may be marginally higher during upright exercise, cardiac output, blood volume distribution 
and efficacy of the muscle pump and oxygen supply differ during upright and supine cycle 
exercise due to differeing kinetics.  Cardiac output is higher during supine exercise at mild to 
moderate exercise intensities.  Hence using the watts at a certain VO2 on upright exercise as 
your target for supine exercise cannot be used interchangeably (200). 
 
…….. VCO2 ……. VO2 
 
……. HR ……. Oxygen pulse 
a	
b	
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Figure 3.2 CPET results from a healthy volunteers on a ramp protocol.  The vertical red lines 
indicate the beginning and end of exercise: a) VO2 in blue and VCO2 in red increase 
consistently throughout exercise with the ramp protocol, with immediate fall after cessation of 
exercise. b) Heart rate in pink and oxygen pulse in blue also steadily increase, and immediately 
fall after exercise.  Oxygen pulse reaches a plateau after around 7 minutes 
 
a	
b	
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Figure 3.3: CPET at 40% of the watts on upright exercise a) VO2 in blue and VCO2 in red, b) 
Heart rate in pink and oxygen pulse in blue; all parameters plateau at 3 minutes of warm up. 
 
3.2.3 Outcomes 
 
It was noted that the ideal point to place the centre of the posterior coil was at 0.7 x subject’s 
height (cm), with the subject lying on the MRI couch with their feet fully extended in to the 
pedals.  This simple calculation avoided taking the subject on and off the couch to make 
adjustments and streamlined the set up.  All subjects were able to be positioned such that they 
were able to perform continuous exercise during image acquisition, however, due to space 
restriction, some subjects had to be scanned off isocentre to enable this.  This did not cause any 
significant issues with data acquisition or analysis 
 
We demonstrated that it takes 3 minutes to achieve steady state and approximately 2-3 minutes 
to acquire images.  Hence we decided that imaging at two levels of exercise would not be 
feasible for patients, as that would entail at least 12 minutes of exercise, and due to subject 
exhaustion, may end up with immediately post exercise imaging as opposed to imaging during 
continuous exercise.  In addition, as 66% of the watts achieved on upright exercise corresponds 
with high intensity supine exercise (37), 40% of the watts achieved, to correspond with 
moderate intensity exercise was set as our pre-determined load.  Furthermore, it was noted 
when we exercised healthy volunteers at 3 levels of supine exercise during protocol 
development, image quality deteriorated significantly at high intensity exercise due to sideways 
movements of the subject. 
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Hence we decided that exercising at one fixed level of moderate intensity exercise, set at the 
level of watts achieved on upright CPET, would achieve satisfactory physiological changes, 
but ensure that all subjects, particularly patients, could sustain exercise and complete the 
protocol.  In particular, data collection would occur during steady state exercise, which was of 
utmost importance.  The comparison between continuous steady state exercise and immediately 
post exercise imaging in both health and disease will be discussed in detail, in Chapters 5, 6 
and 7. 
 
3.3 Respiratory Variation 
 
Inspiratory fluctuations of LV and RV SV have been well documented over many years, with 
an increase in RV SV and a decrease in LV SV on inspiration (201-205).  Claessen et al 
documented with real time CMR LVSA cines a fluctuation of 21 mL ± 10% between 
inspiratory and expiratory RVSV, but no difference for LVSV fluctuations (4mL ± 10%) at 
rest, with a significant decline in both RVSV and LVSV during the Valsalva manoeuver, 36 
mL ±14% and -22 mL ± 17% respectively.  On exercise, variations in RVSV were  maintained, 
but variations in LVSV became significant, with larger LVSV during expiration, in exercise.  
Van de Hout et al demonstrated with real time Ao flow acquisitions with CMR that aortic 
stroke volume ranged around 13.1 ± 2.7mL for normal breathing and 35.3 ± 8.3 with deep 
breathing, with large drops in SV with the Valsalva Manoeuvre (206). 
 
Some groups have attempted to mitigate this during exercise CMR, by attempting to acquire 
images during breath holds, either immediately post exercise or during intermittent breaks 
during exercise, while others have not taken respiratory variation in to account as previously 
discussed.   
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We aimed to: 
1. Demonstrate that LV and RVSV fluctuates during rest and exercise with respiration 
2. Determine the ideal point at which to analyse LV and RV volumes on the real-time cine 
stacks, as to correlate with conventional analysis at rest 
 
A subject’s left and right ventricular volumes were analysed for a slice using the methods 
outlined in Chapter 2.  The results were plotted on a graph for rest and exercise and compared 
to the volume from the equivalent slice obtained from conventional breath hold cine stacks. 
 
3.3.1 Observations 
 
Fluctuation of RV (Figure 3.4a) and LV (Figure 3.4b) volume at rest, and on exercise (Figure 
3.4c) was demonstrated.  In this subject, respiratory variation appeared to be more prominent 
for the RV than for the LV at rest, but then it became apparent for the LV on exercise. Also of 
note in this subject, the volume for the RV correlated with the volume calculated from the 
breath hold slice during the expiratory phase.  It was approximately 2mL lower for the breath 
hold acquisitions than the real time, for the end-diastolic volume for the LV.   
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a 
b 
c 
Figure 3.4 Fluctuations in RV and LV volume with respiration: a) Fluctuation in RV volume 
during inspiration and expiration b) No fluctuation in LV volume during inspiration and 
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expiration c) Fluctuation in LV and RV volume during exercise.  For the LV, it became 
apparent: EDV, End diastolic volume; ESV, End systolic volume, The black arrow represents 
inspiration and the purple arrow represents expiration 
 
3.3.2 Outcomes 
 
This demonstrated that respiratory fluctuations in SV need to be accounted for particularly for 
the RV, to ensure accuracy and reproducibility, but furthermore, if we wanted to show that 
conventional breath hold imaging correlated with real time free breathing imaging, volumetric 
analysis should be carried out during the expiratory phase. 
 
The respiratory bellows was applied to subjects during scanning, at rest and during exercise.  
Unfortunately, the trace was occasionally lost due to unknown reasons and not necessarily due 
to interference from exercise.  This was raised with Philips, the MRI manufacturer, but a 
resolution could not be found.  However, respiratory traces for all subjects were collected and 
filed where possible.   
 
Ideally, the ability to input this data in to the software to assist in analyses would have been 
desirable.  Unfortunately, the software did not allow for this, and the technology to develop 
our own software was not available, as it had been to the Leuven group.  Funding for software 
development or collaboration with software developers will be a consideration for our next 
grant application. 
 
When analysing the cines, the phase of respiration was evident from tracking the diaphragm.  
For each slice, end diastole and systole were identified at the point or near the point of end 
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expiration.  As there were multiple heartbeats and respiratory cycles for each slice, the best 
heart beat that, for example, that had less movement artifact, could be chosen and analysed.  
 
As respiratory bellows data could not be used for flow analysis, aortic and MPA flow was 
calculated as the mean of the first 5 consecutive heartbeats.  This decision was made for two 
main reasons 1)  It has been previously demonstrated that mean aortic flow correlates with 
breath hold Ao flow (207) when averaged over multiple heart beats, and does not correlate if 
just one free breathing heart beat is compared to one heart beat acquired during a breath hold 
(208).  2) 5 heartbeats would cover one phase of respiration at rest and during exercise. 
 
In terms of cardiac displacement along the long axis, Hori et al also demonstrated that during 
free breathing, mean displacement of the heart on the long axis was 2.2mm to 3.7mm (209), 
which did not cause significant variations in volumetric analysis in CMR, as slices are set at 
10mm.  We noticed that during exercise, this displacement increased, particularly at high 
intensity exercise.  This was rectified by installing handlebars that the subjects could hold on 
to during exercise.  Subjects were instructed to hold them during exercise, and to keep their 
upper body still, which was simple but very effective.  Furthermore, we used moderate level 
intensity exercise so that upper body effort was not required to maintain effort. 
 
3.4 Aliasing 
 
Aliasing results when the velocity encoded value (VENC) is set below the peak velocity in the 
vessel of interest.  If the velocity phase shift exceeds ±180˚, it cannot be distinguished from 
one within the ±180˚ range, and velocity information is ‘wrapped’ within a voxel, known as 
velocity aliasing (wraparound).  In other words, a physical phase of 190˚ is interpreted in the 
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image as -170˚.  Aliasing causes errors in flow measurements, however, it is easy to detect this 
during imaging as inaccuracies in the VENC amount and direction, leads to distorted field 
gradients and inverted signal intensity of the peak velocities, as compared with that of 
surrounding voxels (Figure 3.5).  VENC, is available as an adjustable sequence parameters.  
Once the images are acquired, VENC cannot be changed, hence during imaging if aliasing 
occurs and is excessive, imaging should be repeated with a larger VENC (172, 173, 210). 
 
During exercise, it was noted that the velocity in the aorta and MPA increased and necessary 
adjustments of the VENC were made, pre-imaging.  For the aorta, the VENC was set to 
220cm/s, and for the MPA, it was set to 200cm/s.   
 
However, these increases in VENC were inadequate in certain subjects, in particular, in 
individuals with large CO such as tall men or very physically fit individuals, or patients with 
significantly turbulent flow in the MPA.  While it was noticed during imaging, in the setting 
of exercise and a limited period of time to acquire the images, repeat imaging was occasionally 
not carried out, particularly in the early, development stages of the protocol.  
 
Figure 3.5:  Aliased phase contrast image of the aorta, AA = Ascending aorta, DA = 
Descending aorta:  Black represents wraparound flow, while white represents no wraparound.  
This diagram shows significant wraparound in the ascending aorta due to high velocity flow 
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from LV ejection. (From: Gatehouse et al, Applications of phase-contrast flow and velocity 
imaging in cardiovascular MRI, Eur Radiol, 2005) 
 
In house software was developed by our physicist, Pawel Tokarczuk, to spatially and 
temporally phase unwrap these datasets. The correction in aliasing was carried out in two 
stages.  Firstly, the phase in each region of interest (ROI), at each epoch, was spatially 
unwrapped.  This was usually enough to lead to a correct result, but occasionally, the choice 
of the initial seed point within an ROI, introduced an overall shift in the unwrapped phase of 
2Mπ, where M is some random integer.  Since each epoch is unwrapped separately, the effect 
was to introduce uncontrolled jumps in the mean phase between one epoch and the next, 
leading to an incorrect flow curve even though the spatially unwrapped flow profile within 
each ROI is smooth.  However, it was possible to correct for this by looking at the mean phase 
in each ROI across the epochs and assuming that this does not step by more than π from one 
epoch to the next.  Once this mean regional phase has been temporally unwrapped, the 
difference between the two means can be used to correct the phase in each region.  An example 
of this is demonstrated in Figure 3.6. 
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Figure 3.6 Volume-time curves demonstrating aliasing and unwrapping spatially and 
temporally a) aliased dataset (b) not interpretable after spatial unwrapping (b), but was c) 
successfully unwrapped after temporal unwrapping 
 
Untenberger et al also developed software to unwrap aliased, real time flow data, both spatially 
and temporally.  They tested the software using phantom, aliased human flow data which was 
unwrapped and un-aliased flow data and demonstrated that unwrapped flow data allowed for 
accurate analysis of real-time, aliased flow data, acquired with a reduced velocity encoding 
(211).  Our software similarly, allowed us to analyse aliased flow data, when the VENC settings 
were not adequately set. 
 
3.5 Phase shift 
 
Cine phase contrast velocity images may contain an artificial, positive or negative, spatially 
varying velocity offset, which may significantly distort flow volumes.  Phase offset error 
occurs when stationery tissues erroneously show a small velocity.  After the subtraction of one 
gradient velocity from the other to form the phase difference image, residual errors may remain 
including gradient eddy currents, concomitant field terms and gradient field distortions (212).  
Whether phase offset causes a significant clinical issue varies in the literature, with some 
authors concluding that without hardware or software to reduce phase offset errors, significant 
flow errors occur (213, 214), but other authors concluding that background phase correction 
makes no difference to flow analysis  (215).  A phase offset of 0.6cm/second has been 
published as the limit of acceptability (213).  Furthermore, the occurrence of phase offset errors 
have been reported as similar for both breath hold and non breath hold ascending aorta 
acquisitions (208) . 
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Velocity offsets can be reduced by decreasing the distance between the flow of interest and the 
magnetic isocentre and most current CMR systems have automatic couch positioning for flow 
imaging, which brings the vessel of interest for flow measurement in to the isocentre plane.  
However, the degree of phase offset can also vary unpredictably with slice orientation and slice 
shift so does not occur predictably (212).  Several post-processing techniques have been 
developed to correct phase offset errors.  One method is to acquire a stationary phantom phase 
contrast image after the clinical scan, with the identical imaging parameters.  Then the phantom 
phase offsets are subtracted from the patient phase contrast images to produce background 
phase correct images.  This however, is time consuming and hence clinically limited.  
Alternatively, some post processing software may allow for the user to place a ROI in 
stationary tissue near the vessel being measured, and the correction ROI value is subtracted 
from the vessel velocity.  However, with free breathing, exercise imaging, it is difficult to find 
any stationary tissue. 
   
So far in the exercise CMR literature, Steeden et al reported using Maxwell correction to 
remove the effects of concomitant gradients originating from the low encoding gradients.  This 
was done automatically by fitting a quadratic surface through the stationary tissue (177).  They 
however, could not see the images during scanning, in order to assess accurate placement, as 
the images took 5 minutes to reconstruct.  Roberts et al stated they accounted for phase shift 
using static tissue (18), however, we found that there was not any stationary tissue due to free 
breathing and movement of respiratory and muscle tissue.  In order to scan quickly, we did not 
correct for background phase effects during imaging as with the short echo time and the 
adequate shimming (a shim is a device in the magnet used to reduce inhomogeneties), the 
background effects were considered to be small.  During analysis, if the phase offset was 
considered to be >0.6cm/second, the unwrapping software that was developed in house, had 
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the function of adjusting the x axis (Figure 3.7).  However, as small adjustments can cause 
large changes in flow calculations, these adjustments were kept to a minimum and only 3% of 
all flow acquisitions including aorta, MPA, rest and exercise in healthy volunteers and patients 
were adjusted. 
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Figure 3.7 Phase offset and correction a)  Flow-time curve demonstrating a significant phase 
offset, with the zero point well below the zero point of the x-axis b) Adjusted baseline, 
demonstrating a correction of 4.1 cm/s. 
3.6 Imaging Protocol Development and Assessment of Accuracy and Reproducibility 
 
3.6.1 Introduction 
 
It has been demonstrated that real time CMR cine and phase contrast imaging of the aorta and 
MPA is feasible and accurate at rest, and potentially already clinically applicable in the setting 
of arrhythmias and shortness of breath (207, 216-219).  A wide variety of acceleration 
techniques have been used, including Cartesian and non-Cartesian, and gated and non-gated 
methods.  Furthermore, respiratory variation has been managed by employing short breath 
holds, shallow breathing, free breathing with respiratory navigation, or with no compensation 
for respiratory variations in volume.   
 
Systole is known to be shorter than diastole, isovolumic relaxation (or end-systole) time is 
actually longer, ranging between 85-106ms, with isovolumic contraction (or end diastole) 
around 36ms. (220-222).   While it is recommended that in order to reliably capture end diastole 
and end systole in conventional LVSA imaging, the temporal resolution of retrospectively 
gated cine images should be 50ms (171), temporal resolutions of 180ms (218), 164ms (209) 
and 87ms (219) have been shown to be accurate and reproducible for the LV and RV when 
compared to a conventional breath hold, retrospectively gated sequence at rest. 
 
It is important to keep in mind the definition of temporal resolution, and how a low temporal 
resolution is maintained in conventional imaging versus real time imaging.  In conventional 
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imaging, images are constructed over several heartbeats, resulting in an image, which appears 
to be one heartbeat, but is actually a reconstruction of the average of several heartbeats.  So 
while the increment of time by which a change in the imaged dynamic process can be seen may 
be in the range of 40-50ms, the actual period of time for data acquisition is actually longer.  
However, real time imaging, like echocardiography, is capturing true dynamic data, and true 
temporal resolution is defined as the actual period of time that data is acquired. 
 
In more recent exercise CMR reports, the group from Amsterdam reported a temporal 
resolution of 100ms for their real time, LVSA in their initial report (223).  In subsequent 
reports, temporal resolution improved to 56ms for LVSA and 43.6ms for flow acquisitions 
with a spatial resolution of 2.2 x 1.5mm.  The sequence was not ‘true’ real time, in that they 
were gated, and there were breaks in exercise between cine acquisitions and flow acquisitions, 
but the images were taken during exercise (40, 42, 162).  Parallel SENSE imaging was used.  
Inter-test and inter-study reproducibility has not been reported, nor how respiratory variation 
and how valvular plane discrimination was assessed. 
 
The group from Leuven has published several reports using exercise CMR(37, 102, 161, 184, 
224).  Reported temporal resolution is 35-38ms and the reconstructed but not acquired spatial 
resolution has been reported as 2.3 x 2.3 x 8mm.  They used true real time, un-gated 
acquisitions using parallel sensitivity encoding (SENSE) imaging, with an acceleration factor 
of 2.  While they demonstrate excellent correlation between Fick derived CO and CMR derived 
CO, again inter-test and inter-study reproducibility has not been reported, and flow and cine 
images have not been acquired in each subject.  They describe in detail how respiratory 
variation was carefully taken in to account, and they developed their own software that 
integrated ECG and respiratory bellow information.  Furthermore, they acquired LVSA and 
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horizontal long axis (HLA) stacks, and the software was able to assist with mitral and tricuspid 
plane delineation, using both stacks.  This was demonstrated to me personally and it was an 
elegant approach to ensuring accurate basal analysis. 
 
Great Ormond Street Hospital (GOSH) in London has also published several reports (28, 177-
179).  They use a radial k-t SENSE, a non-Cartesian, sequence which is gated and only captures 
2 heart beats per slice, with a temporal resolution of 35.5ms and a voxel size of 3.0 x 3.0 and 
10.  They also compare this to a standard real time, parallel GRAPPA sequence that has a 
temporal resolution of 80ms and a spatial resolution of 3.1 x 3.9 x 10.  They concluded that 
their non-Cartesian acquisition is more accurate and reproducible with accuracy defined as 
LVSV = RVSV, and reproducibility defined as CO, and that this is due to the improved 
temporal resolution of the non-Cartesian approach.  However, the spatial resolution is poor and 
they only acquire 2 heartbeats per slice, rather than 8-10 heart beats.  Furthermore, they have 
not acquired LVSA and flow sequences simultaneously so there is no inter-test reproducibility 
reported, and they do not report volumes or ejection fraction reproducibility for their non-
Cartesian sequence.   They also do not take respiratory variation in to account. 
 
3.6.2 Aims 
 
We aimed to  
 
1. Develop a LVSA cine sequence and imaging protocol that balance spatial and temporal 
resolution, so that valvular plane delineation was accurate 
2. Demonstrate inter-test reproducibility 
3. Demonstrate intra and inter-observer and inter-study reproducibility 
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4. Demonstrate inter-study reproducibility 
 
3.6.3 Methods 
3.6.3.1 Sequence Development 
Three subjects carried out several sessions of real time LVSA optimisations within the scanner 
at rest and exercise.  Several sequences were trialed, and the approach included 1) Starting with 
the protocol used by Leuven (37), with attempts to optimize contrast by altering the flip angle 
2) Testing k-t blast sequences 3) Acquiring triggered conventional LVSA, while free breathing 
during exercise. 4) Testing real time sequences with improved spatial resolution.  All sequences 
were Cartesian. 
 
Real time LVSA 1: Flip angle 50, SENSE with an acceleration factor of 2 
Field-of-view = 320 x 334mm; Repetition time/echo time = 1.86/0.93msec; Flip angle 50˚; 
Acquired voxel size 3.64 x 4.78 x 8mm; Reconstructed voxel size: 2.58 x 2.61 x 8mm; Section 
thickness = 8mm with no gap; Number of sections = 18; Dynamic scan time = 59 seconds with 
50 dynamics per slice and 12 slices, Temporal resolution 44.6ms; 
 
Real time LVSA 2- Flip angle 60, SENSE with an acceleration factor of 2 
Field-of-view = 320 x 334mm; Repetition time/echo time = 1.86/0.93msec; Flip angle 60˚; 
Acquired voxel size 3.64 x 4.78 x 8mm; Reconstructed voxel size: 2.58 x 2.61 x 8mm; Section 
thickness = 8mm with no gap; Dynamic scan time = 90 seconds with 50 dynamics per slice 
and 12 slices; Temporal resolution 44.6ms; 
 
Real time LVSA 3 – Flip angle 80, SENSE with an acceleration factor of 2 
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Field-of-view = 320 x 334mm; Repetition time/echo time = 1.86/0.93msec; Flip angle 80˚; 
Acquired voxel size 3.65 x 4.87 x 8mm; Reconstructed voxel size: 2.61 x 2.61 x 8mm; Section 
thickness = 8mm with no gap; Dynamic scan time = 2 minutes with 50 dynamics per slice and 
12 slices; Temporal resolution 45.5ms; 
 
Real time LVSA 4 – k-t blast 
Field-of-view = 320 x 308mm; Repetition time/echo time = 2.6/1.29msec; Flip angle 80˚; 
Acquired voxel size 2.96 x 3.21 x 10mm; Reconstructed voxel size: 2.5 x 2.49 x 10mm; Section 
thickness = 10mm with no gap; Dynamic scan time = 60 seconds with 50 dynamics per slice 
and 12 slices; Temporal resolution 56.5; 
 
Conventional gated sequence, free breathing LVSA 5 –  
Field-of-view=370mm x 370mm; Repetition time/Echo time = 3.0/1.5msec; Flip angle 60˚; 
Acquired pixel size = 2.0 x 2.2mm; Section thickness = 8mm with a 2mm gap; Reconstructed 
voxel size = 1.2 x 1.2 x 8mm; Number of sections = 10-12; Cardiac phases = 30 
 
Real time LVSA 6 – Improved spatial resolution 
Field-of-view = 305mm x 305mm; Repetition time/echo time = 2.5/1.26msec; Flip angle 50˚; 
Acquired voxel size 2.73 x 2.73 x 10mm; Section thickness = 10mm with no gap; 
Reconstructed voxel size = 1.19 x 1.19 x 10; Number of sections = 14; Slice scan order = base 
to apex; Dynamic scan time = 66 seconds, with 50 dynamics per slice as 12 slices; Temporal 
resolution 74ms; 
 
Real time phase contrast sequence 
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The real time phase contrast sequence provided by Philips was trialed for both the aorta and 
MPA during rest and exercise.  The parameters were: Field-of-view = 300 x 300; Repetition 
time/Echo time = 11/3.7 msec; Flip angle 20 ˚ ; Acquired pixel size = 3.0 x 3.0 x 10mm; Section 
thickness = 10mm; Reconstructed voxel size = 1.17 x 1.17 x 10mm; Dynamic scan time = 4.5 
seconds with 100 dynamics; Temporal resolution = 44ms 
 
3.6.3.2 Accuracy and Reproducibility study 
 
Subjects 
The methodology is described in Chapter 2 and will be briefly described here.  Healthy 
volunteers were recruited to the study via advertisement with pre-screening via email with a 
simple questionnaire.  Inclusion and Exclusion criteria are discussed in Chapter 2.  More 
detailed screening was carried out on the day of attendance with height, weight, heart rate, 
blood pressure and a cardiovascular examination.   Cardiopulmonary exercise testing was 
carried out to pre-determine the load that the subject would exercise at in the scanner. 
 
Rest Imaging 
Imaging was carried out on a 1.5 Tesla Philips Achieva with a 32 cardiac channel coil.  
Conventional retrospectively gated cine and phase contrast imaging was carried out.  Resting 
free breathing, high temporal resolution, real time LVSA cine and Ao and MPA phase contrast 
images were taken. 
 
The parameters for the real time, free breathing, rest and exercise LVSA cines were as follows:  
Field-of-view = 305mm x 305mm; Repetition time/echo time = 2.5/1.26msec; Flip angle 50˚; 
Acquired voxel size 2.73 x 2.73 x 10mm; Section thickness = 10mm with no gap; 
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Reconstructed voxel size = 1.19 x 1.19 x 10; Number of sections = 14; Slice scan order = base 
to apex; Dynamic scan time = 66 seconds, with 50 dynamics per slice and 12-14 slices; 
Temporal resolution 74ms; 
 
The parameters for the real time, free breathing, rest and exercise phase contrast images were 
as follows: Field-of-view = 300 x 300; Repetition time/Echo time = 11/3.7 msec; Flip angle 20 
˚; Bandwidth = ; Acquired pixel size = 3.0 x 3.0 x 10mm; Section thickness = 10mm; 
Reconstructed voxel size = 1.17 x 1.17 x 10mm; Dynamic scan time = 4.5 seconds with 100 
dynamics; Temporal resolution = 44ms 
 
Exercise and immediately post Exercise Imaging 
During exercise and immediately after exercise, LVOT, RVOT, LVSA and 4 chamber cines, 
as well as Ao and MPA phase contrast images were acquired.  The slice locator was re-
positioned in the expiratory phase on the RVOT and LVOT to determine optimal placement 
for MPA and Ao flow acquisitions respectively.  Prior to cessation of exercise, the position of 
the Ao and MPA acquisitions was checked for accurate placement and aliasing and repeated if 
required. 
 
Exercise Protocol 
Exercise was carried out on an MRI compatible ergometer (Lode, Netherlands).  Each subject’s 
predetermined load was set at 40% of the watts achieved during upright CPET.  Warm up 
consisted of increasing the load to target over one minute, and then maintaining that for 2 
minutes.  At 3 minutes, heart rate was monitored for stability, and then imaging commenced.  
Subjects were spoken to continuously during the exercise protocol.  Once exercise imaging 
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was complete, the subject was instructed to cease exercise and remain with their feet in the 
pedals, while immediately post exercise imaging commenced. 
 
Inter-study reproducibility 
10 subjects were asked to return for repeat exercise CMR imaging within three months of the 
initial scan. 
 
Inter-observer reproducibility 
Data from 15 subjects was chosen randomly.  One observer with 4 years of CMR experience 
(A.D.M) analysed the real time LVSA cine acquisitions and an observer with 5 years CMR 
experience (B.S.) analysed the real time aortic and MPA flow acquisitions. 
 
Image Analysis: 
Breath hold and real time LVSA cines were analysed using cvi42.  Breath hold and real time 
phase contrast images were analysed on ArtFun (Paris).   
 
Volume, Stroke volume and Ejection Fraction analysis from LVSA 
Endocardial surfaces were traced at end systole and end diastole for each slice using a semi 
automated method with manual correction (cvi42) and volumes were calculated by the 
Simpsons summation rule.  LV and RVSV were calculated as EDV – ESV and EF was 
calculated as EDV-ESV/EDV x 100 and expressed as a percentage.  Care was taken in the real 
time images to analyse heartbeats that occurred during or near to the expiratory phase of 
respiration.  All volumes were indexed to body surface area. 
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Stroke Volume analysis from Phase Contrast Images 
ROIs were created around the aorta and MPA using a semi automated method with manual 
correction.  This created time-volume curves from which could be calculated.  SV was 
calculated as the area under the curve of the time-volume curve.  For the real time analysis, an 
average of the first 5 consecutive heartbeats was taken. Cardiac output was calculated as SV x 
HR and indexed to body surface area. 
 
Unwrapping and Phase offset adjustments 
Flow data was checked for aliasing and phase offsets >0.6cm/second prior to analysis and 
unwrapped or adjusted prior to analysis developed by in house software. 
 
Statistical Analysis: 
IBS SPSS Version 22 and Sigma Plot Version 13 were used for data analysis.  Continuous data 
is expressed as mean +/- standard deviation. The Bland-Altman test was used to demonstrate 
inter-test reproducibility.  Intra-class correlations were used for intra and inter observer 
reproducibility, and inter-study reproducibility.  Accuracy was defined as LVSV = RVSV, 
LVSV = AoSV and RVSV = MPASV 
 
3.6.4 Results 
 
3.6.4.1. Sequence Development 
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Real time sequence 1 
This sequence was the same published by the Leuven group (Figure 3.8)(37).  We found that 
when used in our scanners, significant SENSE artifact obscured the lateral wall.  
Furthermore, the spatial resolution did not lend itself to accurate basal analysis, particularly 
as we did not have an integrated system that could track the mitral and tricuspid planes using 
the HLA. 
 
Figure 3.8:  Real time LVSA sequence 1:  Significant SENSE artifact obscuring the lateral wall 
and inadequate spatial resolution indicated by blue arrow 
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Real time sequence 2 
In order to improve the blood-pool contrast and reduce artifact, the flip angle was increased to 
60 degrees (Figure 3.9).  While this did reduce artifact, the spatial resolution was still deemed 
inadequate for accurate analysis. 
 
Figure 3.9: Real time LVSA sequence 2:  Reduction in SENSE artifact but ongoing inadequate 
blood-pool contrast 
 
Real time sequence 3 
The flip angle was increased to 80 degrees to further improve blood-pool contrast, however, 
this increased the acquisition time to 2 minutes.  Furthermore, we still considered that the 
spatial resolution was not adequate for basal analysis (Figure 3.10) 
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Figure 3.10:  Real time LVSA sequence 3:  Improved contrast but longer acquisition time 
 
Real time stack 4 – kt blast 
The blood-pool contrast significant improved, with excellent temporal resolution using k-t 
blast.  Unfortunately, there were significant issues with SENSE artifact obscuring the lateral 
and anterior walls (Figure 3.11) 
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Figure 3.11:  Real time LVSA sequence 4:  Improved blood pool contrast and excellent 
temporal resolution, but SENSE artifact obscuring lateral and anterior walls 
 
Triggered free breathing real time stack 5 
Conventional triggered LVSA was trialed during exercise.  Movement artifact obscured the 
lateral and inferior walls and it also appeared that end systole was not adequately captured 
during exercise (Figure 3.12 a and b).  Furthermore, as the ECG trigger was occasionally lost 
during exercise, this would interrupt the acquisitions, occasionally making it impossible to 
acquire exercise images. 
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Figure 3.12:  Gated conventional LVSA sequence during exercise a) End diastolic volume, 
significant movement artifact obscuring lateral and inferior walls b) End systolic volume, did 
not appear to be true end systole (given this was an exercise acquisition) 
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Real time LVSA – improved spatial resolution 
Temporal resolution was compromised marginally (from 47ms to 74ms), however, the spatial 
resolution improved significantly and the blood-pool contrast was excellent (Figure 3.13).  On 
testing with exercise, we felt that end diastole and end systole were captured, and this sequence 
lent itself to accurate mitral and tricuspid plane delineation. 
 
Figure 3.13:  Real time LVSA sequence 6:  Improved spatial resolution and a reduction in 
temporal resolution.  Excellent blood-pool contrast 
 
Real time MPA and Aorta phase contrast acquisitions: 
The sequence provided by Philips was suitable for analysis, and no adjustment to the sequence 
was required.  However, it was noted that during exercise, the cut-plane would shift due to 
movement of the diaphragm and downward displacement of the heart during exercise, leading 
to inaccurate flow data (Figure 3.14).  By acquiring RVOT and LVOT views at the beginning 
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of the exercise acquisition protocol, the slice locator could be adjusted. Furthermore, once the 
data was acquired, as re-construction occurred immediately, the data was reviewed for accurate 
placement and acquisition before the subject stopped exercising, and repeated if it was deemed 
inadequate. 
 
 
a      b  
 
c      d 
Figure 3.14:  RVOT and LVOT exercise acquisitions demonstrating movement of the 
diaphragm during expiration and inspiration and cut-plane location a) RVOT during expiration 
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b) RVOT during inspiration c) LVOT during expiration d) LVOT during inspiration.  Blue 
arrow indicates cut-plane location and red arrow indicates diaphragm 
 
Furthermore, a real-time rest and exercise 4 chamber (Figure 3.15) was acquired for several 
reasons 1) To assist with mitral and tricuspid plane delineation 2) Assess for the occurrence of 
tricuspid regurgitation during exercise, particularly during patients.  A phase contrast 4 
chamber was also acquired to assist with this. 
 
Figure 3.15:  Real time, exercise 4 chamber cine 
 
3.6.4.2 Accuracy and Reproducibility study 
 
Subjects 
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38 subjects participated and completed rest and exercise breathing room air.  All resting breath 
hold and real time data was analyzable.  From the exercise data, all phase contrast imaging was 
well located and analyzable.  From the exercise cine acquisitions, the base of the RV was not 
captured in one subject due to cardiac displacement downwards during exercise, but all LV 
data was available.  Subject demographics will be outlined in detail in Chapter 5. 
 
Intra-observer reproducibility 
The inter-observer intra-class correlation coefficients for real time rest and exercise aortic and 
MPA phase contrast and LVSA cines are summarized in table 3.1. 
 
Table 3.1: Intra-observer reproducibility: Intra-class correlation 
 Alpha coefficient 95% confidence interval 
Lower Bound Upper Bound 
Resting Ao SV 1.000 1.000 1.000 
Resting MPA SV 0.999 0.997 1.000 
Resting LVEDV 0.978 0.935 0.992 
Resting LVESV 0.925 0.793 0.974 
Resting LVSV 0.960 0.884 0.986 
Resting LVEF 0.587 0.127 0.840 
Resting RVEDV 0.976 0.931 0.992 
Resting RVESV 0.910 0.755 0.969 
Resting RVSV 0.955 0.871 0.985 
Resting RVEF 0.707 0.323 0.891 
Exercise Ao SV 0.999 0.997 1.000 
Exercise MPA SV 0.998 0.994 0.999 
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Exercise LVEDV 0.972 0.919 0.991 
Exercise LVESV 0.928 0.8 0.975 
Exercise LVSV 0.951 0.862 0.983 
Exercise LVEF 0.824 0.554 0.937 
Exercise RVEDV 0.972 0.919 0.991 
Exercise RVESV 0.871 0.660 0.955 
Exercise RVSV 0.966 0.903 0.989 
Exercise RVEF 0.625 0.185 0.856 
 
Intra-observer reproducibility was excellent for rest and exercise aortic and MPA phase 
contrast acquisitions, and excellent for rest and exercise LV and R volumes.  It was moderate 
for rest and exercise LV and RVEF. 
 
Inter-observer reproducibility 
Inter-observer intra-class coefficients for real time, rest and exercise, aortic and MPA phase 
contrast and LVSA cine acquisitions are summarized in Table 3.2. 
 
Table 3.2:  Inter-observer reproducibility: Intra class correlation 
 Alpha coefficient 95% confidence interval 
Lower Bound Upper Bound 
Resting Ao SV 0.999 0.998 1.0 
Resting MPA SV 0.999 0.996 1.0 
Resting LVEDV 0.986 0.958 0.996 
Resting LVESV 0.893 0.666 0.966 
Resting LVSV 0.971 0.909 0.991 
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Resting LVEF 0.599 -0.248 0.871 
Resting RVEDV 0.975 0.921 0.992 
Resting RVESV 0.923 0.76 0.975 
Resting RVSV 0.957 0.865 0.986 
Resting RVEF 0.854 0.546 0.953 
Exercise Ao SV 0.998 0.993 0.999 
Exercise MPA SV 0.983 0.951 0.994 
Exercise LVEDV 0.980 0.937 0.994 
Exercise LVESV 0.950 0.844 0.984 
Exercise LVSV 0.976 0.924 0.992 
Exercise LVEF 0.880 0.626 0.961 
Exercise RVEDV 0.984 0.951 0.995 
Exercise RVESV 0.939 0.811 0.980 
Exercise RVSV 0.975 0.922 0.992 
Exercise RVEF 0.744 0.202 0.918 
 
Inter-observer reproducibility was excellent for rest and exercise aortic and MPA phase 
contrast acquisitions.  It was excellent for rest and exercise LV and RV volumes, and resting 
RVEF and exercise LVEF.  It was moderate for resting LVEF and exercise RVEF. 
 
Inter-test correlation 
Table 3.3 summarises the Bland Altman Results for the comparisons between resting real time 
to breath hold LVSA and phase contrast acquisitions.  Table 3.4 summarises the Bland-Altman 
results for the comparisons between resting real time flow and LVSA derived stroke volumes.  
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Table 3.5 summarises the Bland-Altman results for comparisons between real time exercise 
flow and LVSA stroke volumes, and left and right stroke volumes. 
 
Table 3.3: Bland Altman comparisons of resting real time to breath hold LVSA and phase 
contrast acquisitions 
Parameter Bias Standard 
Deviation 
Limits of 
Agreement 
95% 
confidence 
interval 
Bias 
Present 
LVEDV -0.80 9.39 -19.20, 17.59 -3.88 to 2.28 No 
LVESV 1.45 7.55 -13.35, 16.25 -1.02 to 3.92 No 
LVSV -2.23 7.10 -16.14, 11.68 -4.56 to 0.09 No 
LVEF -0.96 4.06 -8.92, 6.99 -2.29 to 0.37 No 
RVEDV -1.19 9.13 -19.10, 16.71 -4.19 to 1.80 No 
RVESV -1.11 8.66 -18.90, 15.97 -3.95 to 1.72 No 
RVSV -0.27 7.74 -15.21, 15.15 -0.599 to 2.05 No 
RVEF 0.73 10.7 -20.26, 21.73 -2.78 to 4.25 No 
MPA SV 7.4 9.2 -10.68, 25.51 4.39 to 10.44 Yes 
Ao SV 0.73 10.7 -20.26, 21.73 -2.78 to 4.25 No 
 
Table 3.4: Bland Altman Comparison of Resting Real time Flow and LVSA Stroke Volumes 
Parameter Bias Standard 
Deviation 
Limits of 
Agreement 
95% 
confidence 
interval 
Bias Present 
Ao to LVSV 5.0 11.5 -17.6, 27.6 1.24 to 8.8 Yes 
Ao to MPA SV -0.59 10.5 -21.2, 20.04 -4.04 to 2.86 No 
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MPA to RVSV 1.22 11.23 -20.81, 23.24 -2.47 to 4.90 No 
LV to RVSV -4.40 4.62 -13.45, 4.66 -5.91 to -
2.88 
Yes 
 
Table 3.5: Bland Altman comparison of Real time Exercise Flow and Cine stroke volumes, and 
Left and Right Stroke Volumes. 
 Bias Standard 
Deviation 
Limits of 
agreement 
95% 
confidence 
interval 
Bias present 
Ao to MPA -3.43 9.49 -22.04, 15.18 -6.54 to -
0.32 
Yes 
Ao to LVSV 5.78 10.62 -15.05, 26.6 2.29 to 9.26 Yes 
MPA to 
RVSV 
2.73 8.61 -14.14, 19.61 -0.13 to 5.6 No 
LVSV to 
RVSV 
-6.25 8.07 -22.06, 9.56 -8.94 to -
3.56 
Yes 
 
There was a bias between real time and breath hold MPA phase contrast acquisitions, with a 
bias of 7.4mL.  Otherwise, there no other bias between resting breath hold and real time 
acquisitions.  There was a consistent bias demonstrating that real time LVSA derived stroke 
volumes were higher than Ao phase contrast derived stroke volumes at rest and exercise, with 
the bias at rest being 5.0mL and 5.78mL on exercise.  There was a consistent bias 
demonstrating that real time LVSA derived LVSV was higher than RVSV at rest and exercise.  
At rest the bias was 4.4mL and on exercise, it was 6.25mL.  There was a bias between Ao and 
MPA stroke volumes on exercise, with Ao higher with a bias of 3.4mL. 
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Inter-study reproducibility 
Table 3.6 summarises the exercise inter-study reproducibility. 
Table 3.6:  Inter-study reproducibility on exercise: Intra-class Correlation 
 Alpha coefficient 95% confidence interval 
Lower Bound Upper Bound 
Ao SV 0.874 0.493 0.969 
MPA SV 0.919 0.674 0.980 
LVEDV 0.939 0.776 0.985 
LVESV 0.920 0.712 0.979 
LVSV 0.900 0.651 0.974 
LVEF 0.819 0.428 0.952 
RVEDV 0.923 0.723 0.980 
RVESV 0.750 0.269 0.931 
RVSV 0.945 0.795 0.986 
RVEF 0.603 0.002 0.884 
 
There was excellent correlation between exercise aortic and MPA phase contrast SV, as well 
as LV volumes, LVEF and RV volumes and stroke volumes.  There was a moderate correlation 
between exercise RVEF. 
3.6.5 Discussion 
3.6.5.1 Sequence Development 
 
We found that the spatial resolution of the Leuven protocol (2.3 x 2.3 x 8mm) did not lend 
itself to accurate delineation of the mitral and tricuspid valve planes, with significant SENSE 
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artifact with a flip angle of 50° that resolved with an increase in flip angle, but led to an increase 
in acquisition time.  The Leuven had developed their own software to integrate the HLA stack 
to assist analysis in the setting of poorer spatial resolution, however, we did not have this ability 
with cvi42.  Furthermore, as we were planning on acquiring LVSA, MPA and Ao flow 
sequences, acquiring a HLA stack would add at least another minute and a half to the protocol, 
which I felt was not possible in the setting of a patient exercising.  As to using gating, we also 
found similarly to Leuven, that often images could not be acquired due to loss of the ECG trace 
during exercise, and then the images that were captured were often not of suitable quality to 
analyse due to artifact.  Furthermore, it appeared to us that end systole was not captured during 
exercise. 
 
While the GOSH group had reported that their standard real time with a temporal resolution of 
80ms was not accurate, they only acquired 2 heart beats per slice and their sequence was gated 
to specifically such that the first R-R interval was used to reach steady state, and the next R-R 
interval for data acquisition.  Hence there was only one heart-beat per slice.  Gating was 
probably possible in their setting, as subjects were not exercising at medium to high workloads, 
so perhaps there was little ECG interference.  Our sequence acquired between 6-8 heartbeats, 
to allow for at least 2 respiratory cycles and hence respiratory variation to be taken in to 
account.  If several heartbeats are acquired, then instead of just one chance, in one heartbeat, 
to acquire end diastole and end systole, there are multiple opportunities.  Furthermore, our 
spatial resolution was much better than GOSH reported standard real time sequence, and better 
than any other research groups thus far.   
 
Hence to improve the spatial resolution, we compromised marginally on temporal resolution.  
We found that this allowed for accurate mitral and tricuspid plane delineation, but also captured 
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end diastole and end systole.  Furthermore, our exercise protocol was during submaximal 
exercise, hence the heart rates would not be reaching maximal levels, as compared to the 
Leuven exercise protocol. 
 
To assist with mitral and tricuspid plane delineation, we acquired exercise LVOT and RVOT 
views at start of the exercise protocol.  This not only helped with repositioning of the slice 
locater, but it also assisted with tracking the location of the valvular planes during downward 
cardiac translation through respiration, and for endocardial surface tracing in analysis.  
Furthermore, we acquired a 4 chamber cine and a 4 chamber phase contrast cine, to assist with 
analysis and to document qualitatively when tricuspid regurgitation occurred during exercise. 
 
For the real time flow sequence an echo planar imaging sequence was used with a temporal 
resolution of 44ms and a reconstructed voxel size of 1.17 x 1.17 x 10mm.  This was comparable 
to the other groups previously mentioned.  The Amsterdam group has a temporal resolution of 
47ms and the GOSH group’s was 40.4ms.  The Leuven group have not yet reported exercise 
flow data. 100 dynamics were acquired and this took a total of 4.5 seconds. 
 
 
Acquiring the flow data in the correct location was of utmost importance, particularly during 
exercise.  The imaging plane for both the MPA and Aorta must be prescribed perpendicular to 
the course of the vessel.  For the pulmonary artery, the cutplane is defined in a systolic phase, 
as to ensure optimal image angulation during the majority of blood flow.  For the MPA Hori 
et al have demonstrated that up and down displacement is 4.6 – 6mm during free breathing at 
rest (209).  Thus far, only one group has reported that MPA flow acquisition was compromised 
by motion artifact and shifted acquisition plane due to downward cardiac translation during 
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exercise (183).  The sequence used by Steeden et al required 5 minutes to reconstruct(177).  
However, I felt that to ensure accuracy, a sequence was required that could reconstruct in real 
time. 
 
Overall, our emphasis was on a balance between an adequate temporal resolution that captured 
end systole and end diastole, but also to have adequate spatial resolution to delineate the 
tricuspid and mitral valve planes.  We also developed a sequence that allowed for flow and 
cine acquisitions during exercise, and acquired RVOT, LVOT and 4 chamber  and phase 
contrast cines to assist with analysis and account for the development of tricuspid regurgitation.  
 
3.6.5.2 Accuracy and Reproducibility study 
 
We have shown that at rest, there is a bias between real time aortic SV and LVSV with LVSV 
a mean of 5mL higher, and real time MPA SV and breath hold MPA SV acquisitions with 
breath hold acquisitions a mean of 7mL higher.  There was no bias at rest between real time 
and breath hold LVSA acquisitions. 
 
On exercise, there was a bias between real time aortic SV and MPA SV, with MPA SV a mean 
of 3mL lower, aortic SV and LVSV with LVSV a mean of 5.8mL higher and LVSV and RVSV 
with RVSV a mean of 6mL lower.  Taken together, these suggest that left sided SV calculations 
on exercise are higher than right sided, but that also LVSV calculations tend to be higher than 
aortic and RVSV. 
 
There are several explanations for this.  Aortic and MPA stroke volumes were calculated as an 
average over 5 consecutive heartbeats, while LVSA cines were analysed during expiration.  
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Hence, it may be expected that the flow acquisitions may be lower than the LVSA generated 
stroke volumes.  Additionally, we were conservative with our approach to the correction of 
phase offsets, hence real time flow acquisitions with phase offsets, could contribute to this bias.  
Furthermore, we know that there is an increase in left side flow during expiration, which could 
explain the bias between left and right-sided stroke volumes, as well as aortic and MPA stroke 
volumes. 
 
Furthermore, it has been shown that there are differences between stroke volume analyses 
between the aorta and MPA. Using phase contrast measurement, Evans et al found a 5% 
difference between flow in the ascending aorta and flow in the pulmonary artery in health 
volunteers.  A deviation from the true flow of 3.5% - 4.5% was estimated as the inborn 
technical error of phase contrast measurement when a non-breath hold cine gradient-echo 
sequence with prospective gating is used (225).  Kondo et al (226) found similar deviations 
between flow in the aorta and flow in the pulmonary trunk. 
 
However, the difference found between breath hold and real time MPA stroke volume 
acquisitions could also be because real time acquisitions are actually more physiologically 
representative than inspiratory or expiratory acquisitions (227). Johansson et al demonstrated 
that expiratory held acquisitions reduced the pulmonary regurgitant fraction compared to help 
inspiratory and non-breath hold, and was different to volumetric derived stroke volumes.  The 
non breath hold calculation was the same as the stroke volume difference calculation, so 
potentially more accurate (228). 
 
The difference between left and right-sided stroke volumes on exercise could also have a 
physiological explanation.  Pulmonary vascular distensibility  and shunting through 
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intrapulmonary arteriovenous anastomoses, and not intra-cardiac shunts, has been 
hypothesized and demonstrated to occur in humans, as well as be present anatomically (229).  
It is thought to occur, as a mechanism to decrease afterload on the right ventricle, during 
episodes of elevated pulmonary pressures, such as during exercise or hypoxia, and occur in 
more than 95% of healthy humans on exercise, starting during submaximal exercise and 
increasing with exercise intensity (229-231) and has been shown to be proportional to increases 
in pulmonary capillary pressure and capillary blood volume (232).  Mechanisms and causes of 
intra-pulmonary shunting are shown in Figure 3.16. 
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Figure 3. Intrapulmonary arteriovenous anastomoses: Summary of the model of how active 
and passive regulation of the pulmonary circulation could determine the recruitment and 
perfusion of intrapulmonary arteriovenous anastomoses (IPAVA) under various conditions.  
Small/thin vessels with a pink background with no erythrocytes or microspheres represent no 
pulmonary perfusion but the potential for recruitment.  Yellow spheres represent intravenously 
injected microspheres.  A)  At rest, breathing room air – there is only recruitment of a small 
portion of the pulmonary vasculature with no shunting, and no appearance of microspheres in 
the left ventricle.  B) Increased blood flow during exercise or due to an intravenous inotropic 
drug and breathing room air – this causes passive recruitment of a larger proportion of the 
pulmonary vasculature which contains IPAVA.  Hence microspheres appear in the left 
ventricle.  The volume of flow through the IPAVA increases as the intensity of exercise 
increases.  C)  At rest breathing hypoxic gas – Flow is increased slightly.  Hypoxia causes an 
active redistribution of pulmonary blood flow towards those areas of the lung with IPAVA and 
consequently, IPAVA are passively recruited.  Hence microspheres appear in the left ventricle.  
D)  Increased flow during exercise or during inotropic infusion breathing 100% oxygen.  
Hyperoxia causes an active redistribution of pulmonary blood flow through hyperoxic 
vasoconstriction of IPAVA or hyperoxic vasodilation of areas without IPAVA>  Hence 
IPAVA are not recruited and no microspheres appear in the left ventricle.  (Adapted from 
Lovering et al, Intrapulmonary arteriovenous anastomoses in humans – response to exercise 
and the environment, J Physiol) 
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Hence these biases could represent a true bias, or could be due to intra-pulmonary 
arteriovenous anastomoses.  However, it was important to ensure that the LVSA cines were 
analysed at the same point in the respiratory cycle, so that rest and exercise comparisons could 
be made, given the known fluctuations in stroke volume and these differences are small and 
unlikely to have clinical impact.  Furthermore, the fact that LVSA derived SV were consistently 
higher, demonstrates that temporal resolution was infact adequate to capture end diastole and 
end systole – the concern with a lower temporal resolution would be that EDV would be 
underestimated and ESV overestimated, hence a lower stroke volume, however, we did not 
have that problem.  Future work could include developing software that can integrate 
respiratory bellow tracing with time-volume curves, so that stroke volume from phase contrast 
acquisitions can be analysed only during expiration.  Designing a study to see if these 
differences are reduced with hyperoxia may clarify whether shunting is present. 
 
Our intra and inter-observer reproducibility is also excellent for all parameters, and moderate 
for RVEF.  We feel that the acquisition of RVOT, LVOT and 4 chamber cines were 
instrumental, to allow for accurate analysis between observers for the LVSA cines. 
 
We have demonstrated that there is excellent inter-study reproducibility of exercise CMR for 
aortic and MPA stroke volumes, LV volumes and ejection fraction and RV volumes, and 
moderate reproducibility for RVEF.  This has not been published by other groups, and 
demonstrates the reproducibility of steady state, continuous exercise acquisitions on follow up.  
 
3.6.6. Summary: 
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1. On exercise, left sided stroke volumes from aortic phase contrast and LVSA cines to 
be higher than right-sided MPA and RV stroke volumes.   
 
2. Stroke volume calculated from LV volumes is consistently 5mL higher than stroke 
volumes calculated from aortic phase contrast images.  This is likely a result of analysis 
of the LVSA during expiration 
 
3. There is excellent intra-observer reproducibility for real time resting and exercise aortic 
and MPA stroke volumes, resting and exercise LV volumes and ejection fraction and 
resting and exercise RV volumes.  There is moderate reproducibility for resting and 
exercise RVEF 
 
4. There is excellent inter-observer reproducibility for real time resting and exercise aortic 
and MPA stroke volumes, resting and exercise LV and RV volumes and RVEF and 
moderate reproducibility for resting LVEF and exercise RVEF. 
 
5. There is excellent inter-study reproducibility for exercise aortic and MPA stroke 
volumes, LV volumes and ejection fraction and RV volumes, and moderate 
reproducibility for RVEF 
 
3.7 Overall Conclusions 
 
We developed a methodology that accounted for several important factors: 
1. The exercise protocol allowed for: 
a. An adequate warm up 
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b. Data acquisition during continuous steady state exercise 
c. Patients could realistically complete the exercise protocol and all data could be 
collected 
2. The LVSA and flow sequences had adequate temporal resolution 
3. Mitral and tricuspid valve planes could be adequately delineated in analysis through 
adequate spatial resolution and tracking from exercise LVOT and RVOT planes 
4. That aortic and MPA exercise data was collected accurately 
5. That respiratory variation, which has a significant impact on volumes, stroke volume 
and hence cardiac output calculation was taken in to account 
6. That aliasing and phase offset errors were accounted for 
 
Overall, we believe we have developed a protocol that allows for accurate data acquisition and 
analysis, and that we have robustly assessed reproducibility.  From this, we felt that we could 
set out to use it to demonstrate pathophysiological changes in biventricular function in acute 
and chronic pulmonary hypertension. 
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Chapter 5 – Exercise and Immediately Post Exercise CMR in healthy volunteers 
 
5.1 Introduction 
Exercise CMR is a novel, innovative approach to assessing dynamic biventricular function.  
Several research groups have used it so far, to assess biventricular function in healthy adults, 
as well as in a number of pathologies.  However, approaches have varied, particularly the 
timing of imaging that may affect the interpretation of exercise physiology, in health and 
disease. 
5.2 Aims and Hypotheses 
 
We aimed to demonstrate that our approach to carrying out and analyzing exercise CMR was 
feasible, accurate and reproducible as well as demonstrate and describe normal biventricular 
function and flow during steady state exercise and immediately post exercise, generate normal 
values in healthy adults, and correlate resting and exercise biventricular function with VO2 
peak.  We hypothesized that a moderate level of exercise in healthy volunteers would produce 
a decrease in LVESV and RVESV, an increase in LVEDV, an increase in LVSV and RVSV 
and an increase in LVEF and RVEF.  Immediately post exercise, we hypothesized that there 
would be an immediate decrease in CO and a decrease in LV and RVEF. 
 
5.3 Methodology 
 
The methodology is described in Chapter 2 and will be briefly described here.  Healthy 
volunteers were recruited to the study via advertisement with pre-screening via email with a 
simple questionnaire.  Inclusion and Exclusion criteria are discussed in Chapter 2.  More 
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detailed screening was carried out on the day of attendance with height, weight, heart rate, 
blood pressure and a cardiovascular examination.   Cardiopulmonary exercise testing was 
carried out to pre-determine the load that the subject would exercise at in the scanner. 
 
5.3.1 Preparation 
 
Care was taken to ensure that the subject was positioned such that they could pedal within the 
scanner with no restriction, and that the heart was no more than 10cm from isocentre.  
Continuous heart rate and oxygen saturation monitoring was carried out throughout the study. 
 
5.3.2 Imaging 
 
5.3.2.1 Rest Imaging 
Imaging was carried out on a 1.5 Tesla Philips Achieva with a 32 cardiac channel coil.  
Conventional retrospectively gated cine and phase contrast imaging was carried out.  Resting 
free breathing, high temporal resolution, real time LVSA cine and aortic and MPA phase 
contrast images were taken. 
 
5.3.2.2 Exercise and Immediately Post Exercise Imaging 
During exercise and immediately after exercise, free breathing, high temporal resolution, real 
time LVOT, RVOT, LVSA and 4 chamber cines, and Ao and MPA phase contrast images were 
acquired.   
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5.3.3 Exercise Protocol 
 
Exercise was carried out on an MRI compatible ergometer (Lode, Netherlands).  Each subject’s 
predetermined load was set at 40% of the watts achieved during upright CPET.  Warm up 
consisted of increasing the load to target over one minute, and then maintaining that for 2 
minutes.  At 3 minutes, heart rate was monitored for stability, and then imaging commenced.  
Subjects were spoken to continuously during the exercise protocol.  Once exercise imaging 
was complete, the subject was instructed to cease exercise and remain with their feet in the 
pedals, while immediately post exercise imaging commenced.  Immediately post exercise 
imaging commenced within 1 second of the subject ceasing exercise and the full protocol took 
a minimum of 86 seconds to acquire. 
 
5.3.4 Image Analysis: 
 
Breath hold and real time LVSA cines were analysed using cvi42 (Circle, Cardiovascular 
Imaging, Canada).  Breath hold and real time phase contrast images were analysed on ArtFun 
(UPMC, Paris).   
 
5.3.4.1 Volume, Stroke volume and Ejection Fraction analysis from LVSA 
 
Endocardial surfaces were traced at end systole and end diastole in the expiratory phase of 
respiration, for each slice using a semi automated method with manual correction and volumes 
were calculated by the Simpsons summation rule.  LV and RVSV were calculated as EDV – 
ESV and EF was calculated as EDV-ESV/EDV x 100 and expressed as a percentage.  All 
volumes were indexed to body surface area. 
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5.3.4.2 Stroke Volume, Mean and Average Velocity and Pulsatility analysis from Phase 
Contrast Images 
 
ROIs were created around the aorta and MPA using a semi automated method with manual 
correction.  This created time-volume and time-velocity curves from which SV and mean and 
average velocity could be calculated.  SV was calculated as the area under the curve of the 
time-volume curve.  Peak velocity was taken as the peak velocity occurring during systole, and 
mean velocity as the mean of the velocities through systole (Figure).   For the real time analysis, 
an average of the first 5 consecutive heartbeats was taken.  Pulsatility was calculated as 
Maximum area – Minimum area/Minimum area x 100.  Cardiac output was calculated as SV x 
HR and indexed to body surface area. 
 
5.3.4.3 Unwrapping and Phase offset adjustments 
 
Flow data was checked for aliasing and phase offsets >0.6cm/second prior to analysis and 
unwrapped or adjusted prior to analysis using software developed in-house by our physicist, 
Pawel Tokarczuk. 
 
5.3.5 Statistical Analysis 
 
IBM SPSS Version 22 was used for data analysis.  Data was checked for normality.  
Continuous data is expressed as mean ± standard deviation.  Paired t-tests were used to compare 
differences between measurements.  Pearson’s correlation was used to test the associations 
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between CPET parameters and biventricular function.  A Bonferroni correction was applied to 
adjust for multiple comparisons. 
 
5.4 Results 
 
38 subjects participated and completed rest and exercise breathing room air.  All resting breath 
hold and real time data was analyzable.   
 
From the exercise data, all phase contrast imaging was well located and analyzable.  From the 
exercise cine acquisitions, the base of the right ventricle was not captured in one subject due 
to cardiac displacement downwards during exercise, but all left ventricular data was available. 
 
From the immediately post exercise data, 37 aortic and MPA phase contrast data was available.  
1 subject’s immediately post exercise flow data was too aliased and could not be unwrapped 
by the software.  Out of the cine acquisitions, 31 real time LVSA were analyzable.   6 cine 
stacks could not be analysed as due to deep breathing immediately post exercise, the base of 
the left and right ventricle were not captured during expiration, and in one case, the table moved 
spontaneously during acquisition. 
 
Reproducibility and accuracy data have been presented and discussed in Chapter 3. 
 
5.4.1 Subject characteristics: 
 
The gender distribution was equal with 19 men and 19 women.  Relevant characteristics are 
summarized in Table 5.1. 
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Table 5.1:  Subject characteristics 
 Mean Standard Deviation Minimum Maximum 
Age 35.6 9.3 24 66 
BMI 24.5 3.2 20.2 35.3 
BSA 1.9 0.2 1.6 2.3 
Peak VO2 (mL/min) 2690.6 841.2 964 4814 
Max Load (W) 240.8 81.1 93 452 
Set load in scanner (W) 93.2 30.5 37 180 
Values are expressed as Mean +/- SD 
 
Subjects were also asked to classify the amount of exercise they carried out per week, as either 
less than 1 hour, between 1-3 hours, between 3-5 hours and above 5 hours a week.  6 subjects 
said less than 1 hour, 10 between 1-3 hours, 7 between 3-5 hours and 14 above 5 hours a week. 
 
5.4.2 Rest, Exercise and Immediately After Exercise Physiology 
 
Rest, exercise and immediately post exercise heart rate, stroke volume index, cardiac index and 
LV and RV volumes, stroke volumes and ejection fraction are summarized in Table 5.2. 
 
From rest to exercise and from rest to immediately post exercise, heart rate, CI, LVSV, RVSV, 
Aortic SVI and MPA SVI increased.  An increase in LVSV was driven by an increase in 
LVEDVI and decrease in LVESV.  Increase in RVSV was driven by a decrease in RVESV.  
Both LV and RVEF increased.  All changes were significant to p <0.0001.  There was no 
significant difference between rest and exercise RVEDVI, p=0.245.  Figure 5.1 demonstrates 
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change in RVEF from rest to exercise in all subjects.  One subject had a slight decrease in 
RVEF on exercise.  There was no issue with scan quality. 
 
Table 5.2:  Heart rate, Cardiac Index and Biventricular Parameters at Rest, Exercise and 
Immediately post Exercise 
 Rest Exercise Immediately post 
Exercise 
HR 61 ± 11 122 ± 12 91±16 
Ao SVI 51.4 ± 11.0 61.7 ± 10.3 64.7 ± 12.3 
MPA SVI 51.4 ± 9.9 60.0 ± 9.3 62.1 ± 11.2 
CI 3.1 ± 0.6 7.6 ± 1.5 5.9 ± 1.6 
LVEDVI 84.3 ± 14.7 90.1 ± 15.5 91.2 ± 16.4 
LVESVI 30.4 ± 5.3 25.5 ± 7.0 26.2 ± 5.3 
LVSVI 53.8 ± 10.7 64.6 ± 10.7 65.1 ± 13.2 
LVEF 63.7 ± 3.6 71.9 ± 4.5 71.1 ± 4.2 
RVEDVI 90.4 ± 17.5 88.1 ± 14.5 89.2 ± 18.3 
RVESVI 38.9 ± 8.8 27.1 ± 8.4 25.8 ± 8.1 
RVSVI 51.5 ± 10.8 60.9 ± 9.5 63.4 ± 12.4 
RVEF 57.0 ± 5.1 69.6 ± 6.1 71.4 ± 5.0 
All results expressed as mean ± standard deviation.  All comparisons from rest to exercise, and 
rest to immediately post exercise are highly significant, p < 0.0001, except for RVEDVI that 
is not significant for both settings.   
 
Figure 5.1:  Change in RVEF from Rest to Exercise 
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5.4.3 Exercise to Immediately Post Exercise – Comparison of Right Ventricular 
Parameters and Cardiac Index 
 
When comparing right and left ventricular parameters from exercise to immediately post 
exercise, there is a significant increase in RVEF (p=0.022) with an increase in LVEDVI 
(p=0.036) and an increase in Ao SVI (p=0.001).  Cardiac Index is significantly lower 
immediately post exercise, compared to exercise p < 0.0001 driven by a decrease in heart rate 
(p < 0.0001).  Change in cardiac index from rest, to exercise to immediately post exercise is 
shown in Figure 5.2 
 
Table 5.3: Comparison of Cardiac Index and Right Ventricular Parameters from Exercise to 
Immediately Post Exercise 
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 Exercise Immediately post Exercise P value 
CI 7.6 ± 1.5 5.9 ± 1.6 <0.0001 
HR 122.4 ± 12.3 91.6 ± 16.1 <0.0001 
Ao SVI 61.4 ± 10.4 64.7 ± 12.3 0.001 
MPA SVI 60.0 ± 9.3 62.1 ± 11.2 <0.0001 
RVEDVI 88.6 ± 14.9 91.2 ± 16.4 0.036 
RVEF 69.6 ± 6.1 71.4 ± 5.0 0.022 
 
Figure 5.2:  Change in Cardiac Index from Rest to Exercise to Immediately post Exercise 
 
 
 
5.4.4 Range of Change of Biventricular Parameters on Sub-Maximal Exercise 
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The mean, standard deviation and minimum and maximum values for the change in 
biventricular parameters and cardiac index are summarized in Table 5.3.  There was no 
difference in the change in cardiac index and biventricular parameters between genders, from 
rest to exercise, summarized in Table 5.4 
 
Table 5.4:  Mean, standard deviation and range of the change of Biventricular Parameters and 
Cardiac Index in the Healthy Volunteers 
 Mean Standard 
Deviation 
Minimum Maximum 
LVEDVI 5.8 7.0 -7.2 22.6 
LVESVI -4.9 5.2 -17.41 8.94 
LVSVI 10.8 4.9 0.57 18.8 
LVEF 8.1 4.6 -2.7 20.7 
RVEDVI -1.6 8.0 -21.47 14.76 
RVESVI -11.3 7.4 -29.3 6.1 
RVSVI 9.7 5.7 -4.6 25.19 
RVEF 12.4 6.5 -2.71 24.4 
CI 4.5 1.3 2.3 8.0 
 
 
Table 5.5:  Comparison of Change of Biventricular Parameters between Males and Females 
Change on Exercise Female Male P value 
LVEDVI 4.1 ± 7.2 7.6 ± 6.5 1.0 
LVESVI -4.5 ± 4.5 -5.3 ± 5.8 1.0 
LVSVI 8.8 ± 5.1 12.8 ± 3.9 0.09 
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LVEF 7.2 ± 3.9 9.0 ± 5.2 1.0 
RVEDVI -2.1 ± 7.8 -1.0 ± 8.4 1.0 
RVESVI -10.8 ± 7.0 -11.9 ± 8.0 1.0 
RVSVI 8.7 ± 5.3 10.9 ± 6.0 1.0 
RVEF 11.5 ± 5.2 13.5 ± 7.6 1.0 
CI 4.0 ± 1.3 5.0 ± 1.0 0.18 
 
 
5.4.5 MPA Area, Pulsatility and Velocity 
 
MPA area, pulsatility and velocity data are summarised in Table 5.6.  Maximum and minimum 
MPA area increased significantly during exercise.  Peak and average velocity increased.  There 
was no significant difference in the change in pulsatility from rest to exercise, however, the 
trend was for pulsatility to decrease on exercise. 
 
Table 5.6: MPA Velocity, Area and Pulsatility from Rest to Exercise 
 Rest Exercise P value 
Maximum Area 8.2 ± 1.5 9.1 ± 1.9 0.005 
Minimum Area 5.0 ± 1.0 6.0 ± 1.3 <0.0001 
Pulsatility (%) 65.7 ± 27.9 53.2 ± 25.0 0.22 
Peak Velocity 58.4 ± 14.4 91.3 ± 24.2 <0.0001 
Average Velocity 12.6 ± 2.8 14.6 ± 3.4 <0.0001 
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5.4.6 Resting and Exercise Correlations with VO2 peak and Amount of Exercise/week 
 
The correlations of subject characteristics and biventricular parameters are summarized in 
Table 5.7.  Peak VO2 correlated moderately with LV and RVEDVI, LV and RVESVI and LV 
and RVSVI at rest and exercise, as well as change in LVEDVI on exercise. It also correlated 
moderately with male gender, higher BSA and with the amount of exercise carried out during 
the week.  There was no correlation with age, resting cardiac index or with resting or exercise 
LV or RV ejection fraction. 
 
Table 5.7: Peak VO2 Correlations with subject characteristics and Biventricular Parameters 
 Pearson’s correlation P value 
Male gender 0.533 0.001 
BSA 0.570 <0.0005 
Amount of exercise/week 0.522 0.001 
LVEDVI 0.543 <0.0001 
LVESVI 0.407 0.011 
LVSVI 0.543 <0.0001 
RVEDV 0.593 <0.0001 
RVESVI 0.530 0.001 
RVSVI 0.523 0.001 
Exercise CI 0.666 <0.0001 
Ex LVEDV 0.671 <0.0001 
Ex LVESVI 0.433 0.007 
Ex LVSVI 0.668 <0.0001 
Ex RVEDVI 0.522 0.001 
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Ex RVSVI 0.602 <0.0001 
Change in LVEDVI 0.350 0.031 
 
 
Furthermore, the more exercise carried out per week correlated with resting LV and RVEDVI, 
resting LV and RVESVI and resting LV and RVSVI.  However, it correlated with exercise LV 
and RVEDVI and exercise LV and RVSVI but not exercise LV or RVESVI..  This is 
summarized in Table 5.8. 
 
Table 5.8:  Correlation of amount of exercise/week with Biventricular Resting and Exercise 
Parameters 
 Pearson’s Correlation P value 
LVEDVI 0.509 0.001 
LVESVI 0.415 0.010 
LVSVI 0.494 0.002 
RVEDVI 0.551 <0.0001 
RVESVI 0.530 0.001 
RVSVI 0.455 0.004 
Ex LVEDVI 0.531 0.001 
Ex LVSVI 0.577 <0.0001 
Ex RVEDVI 0.496 0.002 
Ex RVSVI 0.556 <0.0001 
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5.5 Discussion 
 
We have demonstrated that moderate supine exercise is characterized by an increase in LV and 
RVSVi, an increase in LV and RVEF, a decrease in LV and RVESVi, an increase in LVEDVi 
and no change in RVEDVi.  The exercise LV dynamics is consistent with a large body of 
evidence over many years, carried out using radionuclide angiography, invasive 
haemodynamics and exercise echocardiography (17, 20, 21, 23, 31, 34, 102, 233-237) and 
confirms that LVSV is augmented by Frank Starling mechanisms, as well as an augmentation 
of contractility. 
 
The mechanisms of augmenting RVSVi on exercise appear to be different to that of the LV.  
Our results demonstrated that augmentation of RVSVi on exercise was due to an increase in 
contractility, shown by the decrease in RVESVi with no increase in RVEDVi.  Mols et al 
demonstrated using radionuclide ventriculography that on exercise, RVEDVi remains 
unchanged, with a decrease in RVESV, concluding that increased contractility and not Frank-
Starling mechanisms contribute to an increase in RVSVi on supine exercise (36).  Conversely, 
Mahler et al showed an increase in RVEDVi and LVEDVi on upright exercise, however, did 
not show a decrease in RV or LVESVi, which is contrary to most of aerobic exercise literature 
(238).  Using exercise CMR, Holverda et al have demonstrated that RVSVi increases due to a 
decrease in RVESVi with no change in RVEDVi, however, they did not demonstrate an 
increase in LVEDVi on exercise as we have (42).  Lurz et al showed an increase in LV and 
RVSVi, driven by a decrease in LV and RVESVi.  However, they showed a trend for a decrease 
in LV and RVEDVi (178). La Gerche et al reported no increase in LV or RVEDVi at peak 
exercise, but a decrease in LV and RVESVi(37).  Roest et al also showed no increase in LV or 
RVEDVi, and a decrease in RV and LV ESVi (26).  Hence while these studies agree that 
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RVEDVI does not increase on exercise, the majority of the more recent exercise CMR studies 
are contrary to previous research and our findings, in terms of change of LVEDVI on exercise.   
 
It is important to note that both Lurz and La Gerche did not allow a 3 minute warm up and did 
not scan during steady state exercise, and Lurz et al used a resistive type exercise rather than 
aerobic.  Holverda and Roest scanned during breaks in exercise.  Furthermore, these differences 
may be due to posture, as it is documented that change in LVEDVi is more dramatic on upright, 
compared to supine exercise, particularly if the subject’s legs are left in the pedals during rest 
scanning (25).  We were particular about taking the subject’s legs out of the pedals during rest 
scanning, to ensure the legs were not elevated relative to the chest. This also demonstrates the 
importance of the type of exercise, exercise protocol and the timing of imaging, and how it can 
influence exercise physiology and results.   
 
Furthermore, we have demonstrated that healthy subjects who have a higher VO2 peak, have a 
larger resting and exercise biventricular size.  This is perhaps of little surprise, as we know that 
athletes have larger cardiac chamber size (20), and it has been demonstrated that in sedentary 
healthy subjects and patients, exercise training leads to an increase in resting and exercise 
LVEDVi (233-236, 239) and RVEDVi (240).  However, we have also noted that change in 
LVEDVi correlates with peak VO2, suggesting that higher VO2 relies on enhancement of 
Frank-Starling mechanisms, rather than improvements in contractility.  We have also shown 
that the more exercise the subject does per week correlates with higher resting and exercise LV 
and RVEDVI, and resting and exercise LV and RVSVI, but not with that exercise LV and 
RVESVI suggesting that exercise training increases exercise stroke volume by augmenting 
biventricular preload, rather than changes in the contractile states of both ventricles.  This is 
supported by a study carried out by Wolfe et al, demonstrating that exercise training in 
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sedentary subjects led to a higher SVi on exercise due to a larger LVEDVi rather than changes 
in contractile state from studying invasive haemodynamics on exercise (235).  Kitzman et al 
showed that in patients with heart failure with preserved ejection fraction and healthy 
volunteers, that change in LVEDVi on exercise correlated with LVSVi and CI.  In the patient 
group, abnormalities in diastolic function limiting the patient’s ability to augment SV by means 
of the Frank-Starling mechanism, limited exercise physiology (22).  Higginbotham et al have 
also reported that increases in LVSVi on exercise is augmented by increases in LVEDVi rather 
than changes in LVESVi, supporting the hypothesis that Frank-Starling mechanisms are key 
in LVSVi augmentation during exercise (32). Furthermore, Boutcher et al studied 10 trained, 
10 active and 10 sedentary men and showed that trained men had greater LV filling and 
contractility and active men had greater filling, than sedentary men (33).  This supports this 
notion that due to greater LV compliance or increased LV filling from exercise training, Frank 
Starling mechanisms augment a higher LVSVi and hence CI and higher VO2 peak, rather than 
due to improvements in contractility. 
 
However, we showed no correlation of change of cardiac chamber size or VO2 peak with age.  
Rodheffer et al demonstrated an age related increase in LVEDVi on exercise, with no blunting 
of CO response, and concluded that with age, there is a shift from catecholamine mediated 
increase in heart rate and reduction in ESV, to a greater reliance on the Frank Starling 
mechanisms (16).  However, the fitness of the subjects was not documented, and we have 
shown that the more exercise subjects carried out in the week, the larger the cardiac chamber 
size.  Conversely, Stratton et al studied 13 older and 11 younger men, before and after exercise 
training.  Both groups increased resting LVEDVi, but also increased exercise LVEDVi further, 
and hence CO and EF increased as a result of improved Frank-Starling mechanisms, in both 
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the young and elderly (19), and other studies have also demonstrated no association between 
change in LVEDVI, SVI or EF and age (32). 
 
Higginbotham et al have demonstrated that exercise EF is lower in women than in men, and 
women have a higher exercise LVEDV(24).  Hanley et al similarly showed that men had a 
greater increase in LVEF and women had a greater increase in LVEDVI(35).  Aksut et al 
showed no gender differences (21).  In our study, while male gender was associated with a 
higher VO2 peak, there was no association with change in LVEDVi or change in LVEF.  Once 
again, it is important to document the amount of exercise that individual subjects do a week, 
as this may influence the results. 
 
Another important finding of our study, is that there are significant differences in heart rate, 
cardiac index, stroke volume, RVEF and LVEDVI between exercise and immediately post 
exercise.  Immediately post exercise, there is a drop in heart rate leading to a large decrease in 
CI.  However, there is an increase in SVI, with an increase in RVEF and LVEDVI.  Horwitz 
et al noted that in dogs, LVEDVi increased during exercise and remained elevated during 
recovery, with a prompt recession of contractility, concluding that Frank-Starling mechanisms 
play an important role after exercise (241).  Stein et al demonstrated no increase in LVEDV 
during exercise, but then an increase in LVEDV during recovery, hence concluded that during 
recovery, there is a measurable effect of Frank-Starling mechanisms (242).  More recently, 
Takahashi et al demonstrated that on supine exercise, stroke volume increased markedly during 
recovery, with a decrease in cardiac output due to an immediate, rapid decrease in heart rate 
(243) which is similarly supported by a number of other studies (244, 245).  Together, these 
studies support our findings, however, no study to date has documented changes in RVEF from 
continuous exercise to immediately after exercise, and we have shown a significant increase.  
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This potentially explains the increase in LVEDVI found during recovery, as it can be 
hypothesized that there is an increase in RV contractility due to a reduction in pulmonary 
pressures, and a subsequent increase in LV filling. Furthermore, LaFountain et al carried out 
exercise CMR in 10 fit subjects, but scanned their subjects immediately after exercise to 
maximum exhaustion.  While there was a correlation between SV and VO2 peak, there was no 
correlation between CO and VO2 peak.  This could be explained by out data, as we have shown 
that exercise CI correlates with peak VO2 and then also clearly demonstrated that CI 
immediately decreases after exercise, hence carrying out imaging after exercise would not 
reflect peak exercise physiology. 
 
Identifying these differences in exercise versus immediately post exercise is crucial, as this 
may have implications when studying patients and how results are interpreted. Plotnick et al 
have demonstrated using radionuclide angiography, comparing health volunteers and patients 
with myocardial ischaemia, that at peak exercise, those with ischaemia had a lower LVEF and 
higher LVESV, however, immediately post exercise, there was no significant difference 
between these parameters.  In the patients, ejection fraction recovery was characterized by a 
decrease in LVESV, concluding that enhanced contractility played a major role in recovery in 
the patient group (246).  Despite this, several groups who have started using exercise CMR 
have carried out imaging immediately after exercise or during short breaks in exercise (18, 26, 
162, 180-183).  Demonstrating these differences in a patient group using exercise CMR, would 
be vital to highlight methodology flaws that could affect the interpretation of results. 
 
Also of note, is that in all 38 subjects, we were able to gather analyzable data at rest and 
exercise, which contrasts with exercise echocardiography where analyzable exercise data 
varies.  La Gerche et al have reported that when comparing exercise CMR to exercise 
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echocardiography, high quality images were available in all subjects using exercise CMR, but 
only 71% using exercise echocardiography (102).  We have also been able to propose a range 
of normal parameters for change in biventricular function during sub-maximal exercise, which 
is currently not available in the literature. 
 
A number of studies have been carried out to explore the use of CMR indices to quantify 
pulmonary pressures including (247) as well as PVR (248) and relative area change or 
pulsatility has been shown to be a predictor of RV function (84) and predict mortality in 
patients with PAH (249).  Furthermore, stroke volume index, relative area change and PA 
average blood flow velocity have been shown to be associated with functional class in 
pulmonary hypertension (82). Garcia-Alvarez et al demonstrated that pulmonary artery 
velocity was the parameter that had the strongest univariate correlation with PVR (250).  On 
exercise, it is known that in healthy subjects, pulmonary arterial pressure increases while PVR 
decreases.  The distensibility of the pulmonary circulation has been demonstrated by Argiento 
et al who showed on exercise echocardiography that pulmonary arteries distend by 2% of their 
initial diameters for each mmHg increase in transmural pressure (43).  It is important to note 
that pulsatility measured on CMR is looking at changes in vessel size, while studies using 
echocardiography measuring distensibility are linked to pressure. 
 
We have demonstrated on exercise that PA pulsatility does not change on exercise, and that 
peak and average velocity increase.  Farouzan et al demonstrated changes in MPA pulse wave 
velocity, but similarly no change in pulsatility on exercise in healthy volunteers, concluding 
that exercise CMR can identify a decrease in proximal pulmonary artery compliance (183).  
Hence no change or the trend of PA pulsatility to decrease on exercise could be a reflection of 
increased pulmonary pressures on exercise, while the increase in average blood velocity, given 
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its association with PVR, could reflect the distensible pulmonary circulation on exercise, and 
a decrease in PVR.  If this is the case, we would expect on hypoxic exercise, that PA pulsatility 
would decrease, and that average blood velocity on exercise would not rise due to hypoxic 
pulmonary vasoconstriction.  
 
5.5.1 Limitations 
 
There are several limitations to our study.  The analysis of the real time LVSA cines, is manual 
and can be time consuming.  Furthermore, there is reliance on the operator of identifying the 
correct phase of respiration, as well as end diastole and end systole.  The temporal resolution 
of our LVSA cines is 74ms, and could be improved.  However, we have demonstrated excellent 
intra and inter-observer reproducibility, inter-study reproducibility and inter-test 
reproducibility, as discussed in Chapter 3. 
 
We have shown an increase in LVEDVI on exercise, and while our findings are consistent with 
older studies, they are not consistent with the more recent exercise CMR studies.  This could 
be explained by the position of the subject’s legs during exercise, the type of exercise, the 
intensity of exercise, but also the phase in the respiratory cycle that the images are analysed.  
We have analysed our images during end expiration, which could explain why we have 
demonstrated an increase in LVEDVI, as we know there is an increase in LV filling on 
expiration.  However, this further highlights the importance of the methodology, and how the 
exercise protocol, respiration and method of analysis, may affect the interpretation of results.  
While not necessarily a limitation, these results also have to be interpreted in the knowledge 
that the subjects are supine and not erect.  These physiological differences are described in 
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Chapter 1.2.  Also, we are comparing peak VO2 recorded on erect CPET to cardiac parameters 
acquired during supine steady state exercise. 
 
There is also a relatively small sample size, which limits the ability to set normal ranges, 
particularly when comparing gender, age or ethnicity groups.  Furthermore, our group was a 
relatively active and fit group, which may introduce bias, as there was no difference in resting 
LV and RV size between genders, which has otherwise been shown in the literature (251).  
 
5.6 Conclusions 
 
We have demonstrated several key points: 
 
1. Supine moderate level intensity exercise is characterized by an increase in LVSV, 
RVSV, LVEF and RVEF, a decrease in LVESV and RVESV, an increase in LVEDV 
and no change in RVEDV.  We have proposed a range of normal values for 
biventricular volumes and function, in men and women, between 25-65 years old, 
during sub-maximal exercise. 
 
2. Immediately post exercise, there is a decrease in CO, a decrease in HR, an increase in 
SV, an increase in LVEDVI and an increase in RVEF.  This could have implications in 
the assessment of patient pathophysiology. 
 
3. On exercise, there is no change in MPA pulsatility on exercise, but an increase in MPA 
average blood flow velocity, which could reflect pulmonary vascular distensibility.  
Whether this can detect subtle changes in the pulmonary vasculature, such as in a model 
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of acute pulmonary hypertension driven by hypoxic pulmonary vasoconstriction, would 
be interesting to study. 
 
4. Peak VO2 correlates with male gender, larger BSA, amount of exercise you do in a 
week, larger resting and exercise LV and RV volumes, larger exercise MPA area, 
exercise CI and an increase in LVEDVI on exercise.  The amount of exercise carried 
out per week correlates with biventricular size, but not biventricular end systolic 
volume, suggesting that exercise training augments preload rather than contractility 
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Chapter 6 – Cardiovascular Changes at Rest and Exercise in Healthy Volunteers During 
Acute Normobaric Hypoxia 
 
6.1 Introduction 
 
The effects of hypoxia on RV and LV volumes and function have not been well characterized 
in humans during exercise stress.  It is known that acute hypoxic exercise is characterized by 
an attenuation of VO2 peak, pulmonary vasoconstriction, and signs of RV strain.  The 
attenuation of VO2 peak is thought to be secondary to reduced RV forward flow, however, no 
imaging studies thus far have been able to definitively document changes in RVSV or RVEF.  
Hence real-time, free breathing MRI afford the opportunity to study the consequences of these 
changes in detail. 
 
6.2 Aims and Hypotheses 
 
We hypothesized that acute hypoxia would have adverse effects on the RV, particularly during 
exercise – and that reduced forward flow from the RV during acute hypoxic exercise might 
lead to reduced LV volumes, from reduced pre-load. In this MRI study, therefore, we examined 
detailed parameters of RV and LV volumes and function, as well as flows in the PA and aorta, 
to examine this hypothesis.  
 
6.3 Methodology 
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The methodology is described in Chapter 2, 3 and 5 and will be briefly described here.  Healthy 
volunteers were recruited to the study via advertisement with pre-screening via email with a 
simple questionnaire.  More detailed screening was carried out on the day of attendance with 
height, weight, heart rate, blood pressure and a cardiovascular examination.   Cardiopulmonary 
exercise testing was carried out to pre-determine the load that the subject would exercise at in 
the scanner. 
 
6.3.1 Preparation 
 
Care was taken to ensure that the subject was positioned such that they could pedal within the 
scanner with no restriction, and that there heart was no more than 10cm from isocentre.  
Continuous heart rate and oxygen saturation monitoring was carried out throughout the study. 
 
6.3.2 Imaging 
Rest Imaging 
Imaging was carried out on a 1.5 Tesla Philips Achieva with a 32 cardiac channel coil.  
Conventional retrospectively gated cine and phase contrast imaging was carried out.  Resting 
free breathing, high temporal resolution, real time LVSA cine and Ao and MPA phase contrast 
images were taken. 
 
Exercise and immediately post Exercise Imaging 
During exercise and immediately after exercise, free breathing, high temporal resolution, real 
time LVOT, RVOT, LVSA and 4 chamber cines, and Ao and MPA phase contrast images were 
acquired.   
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6.3.3 Exercise Protocol 
Exercise was carried out on an MRI compatible ergometer (Lode, Netherlands).  Each subject’s 
predetermined load was set at 40% of the watts achieved during upright CPET.  Warm up 
consisted of increasing the load to target over one minute, and then maintaining that for 2 
minutes.  At 3 minutes, heart rate was monitored for stability, and then imaging commenced.  
Subjects were spoken to continuously during the exercise protocol.  Once exercise imaging 
was complete, the subject was instructed to cease exercise and remain with their feet in the 
pedals, while immediately post exercise imaging commenced. 
 
6.3.4 Hypoxic Protocol 
Hypoxia was induced by using 12% oxygen with continuous oxygen saturation and heart rate 
monitoring (Nonin MRI Compatible Oximeter, 7500).  Each subject was fitted with an extra 
small, small, medium or large mask, as appropriate, to ensure the correct fit and reduce the 
chance of gas leakage.  The inspirate was supplied from a medical gas mixture containing 12% 
oxygen in nitrogen administered from a commercially prepared cylinder (British Oxygen 
Company) and was kept in the outside MRI room.  A 1000L Douglas bag was filled from the 
cylinder that could be taken inside the MRI room.  A 35mm breathing tube connected to a 3 
way T shaped stopcock, ran from the Douglas bag, and connected to a mask adaptor 7400/7450 
which in turn was connected to a T shaped, non-rebreather valve on the 7450 V2 Blue Silicone 
Rubber Mask fitted on the subject’s face.  All the equipment was supplied from Cranlea Human 
Performance Ltd, Birmingham.  Subjects were instructed to breath the 12% oxygen at rest, for 
10 minutes, until saturations dropped and had plateaued.  Images were then acquired at rest, 
with alteration to breath hold duration according to the subject’s perception of breathlessness.  
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Exercise and immediately post exercise imaging was then performed as per protocol.  The total 
duration of hypoxia was around 35 minutes.  This is summarized in figure 6.a. 
 
Figure 6.a:  Flow diagram showing steps of image acquisition, during rest, exercise and 
immediately after exercise, during normoxia, rest after normoxia and hypoxia. 
6.3.5 Image Analysis: 
 
Breath hold and real time LVSA cines were analysed using cvi42 (Circle, Cardiovascular 
Imaging, Canada).  Breath hold and real time phase contrast images were analysed on ArtFun 
(UPMC, Paris).   
 
6.3.5.1 Volume, Stroke volume and Ejection Fraction analysis from LVSA 
 
Normoxia •Images	acquired	during	rest,	exercise	and	immediately	after	exercise
Rest	for	20	minutes,	Normoxia •Images	acquired	at	rest	at	the	end	of	this	20	minutes,	during	normoxia
Hypoxia	applied	for	10	minutes	until	saturations	plateued •Rest	images	acquired	during	hypoxia
Exercise	during	hypoxia	commenced
•Images	acquiring	during	exercise	and	immediately	after	exercise
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Endocardial surfaces were traced at end systole and end diastole in the expiratory phase of 
respiration for each slice, using a semi-automated method with manual correction and volumes 
were calculated by the Simpsons summation rule.  LV and RVSV were calculated as EDV – 
ESV and EF was calculated as EDV-ESV/EDV x 100.  All volumes were indexed to body 
surface area. 
 
6.3.5.2 Stroke Volume, Mean and Average Velocity and Pulsatility analysis from Phase 
Contrast Images 
 
ROIs were created around the aorta and MPA using a semi-automated method with manual 
correction.  This created time-volume and time-velocity curves from which SV and mean and 
average velocity could be calculated.  SV was calculated as the area under the curve of the 
time-volume curve.  Peak velocity was taken as the peak velocity occurring during systole, and 
mean velocity as the mean of the velocities through systole.   For the real time analysis, an 
average of the first 5 consecutive heartbeats was taken.  Pulsatility was calculated as Maximum 
area – Minimum area/Minimum area x 100 and expressed as a percentage.  Cardiac output was 
calculated as SV x HR and indexed to BSA. 
 
6.3.5.3 Unwrapping and Phase offset adjustments 
 
Flow data was checked for aliasing and phase offsets >0.6cm/second prior to analysis and 
unwrapped or adjusted prior to analysis (Omnibus Velocity Unwrapping With Phase Offset 
Correction, MATLAB wrapper, Pawel Tokarczuk). 
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6.3.6 Statistical Analysis: 
 
IBM SPSS Version 22 was used for data analysis.  Data was checked for normality.  
Continuous data is expressed as mean ± standard deviation.  Paired t-tests were used to compare 
differences between measurements.  A two way repeated measures ANOVA was used to test 
the interaction between the effect of oxygen level and exercise on right and left ventricular 
cardiovascular parameters with main and simple main effects analysis.  A Bonferroni 
correction was applied to adjust for multiple comparisons for all simple main effects and 
pairwise comparisons. 
 
6.4 Results 
 
38 subjects were recruited.  37 subjects completed resting hypoxia and 34 subjects completed 
exercise hypoxia.  Saturations fell to 84±4% at rest and 77±5% during exercise. 
 
From the data, all images acquired at rest could be analysed.  From the exercise images, all 34 
phase contrast and LV volumes could be analysed.  2 exercise LVSA cines missed the RV 
base. 
 
Immediately after exercise, 32 from 34 phase contrast images were analyzable.  2 were not 
correctly positioned.  24 LVSA cines could be analysed.  The 10 cines that could not be 
analysed was due to an increase in the depth of subject respiration immediately after exercise, 
causing incomplete acquisition of the base of the RV and LV and hence were excluded from 
the analysis. 
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17 subjects had LVSA cines acquired at the start of the study and then after the period of rest, 
before commencing the hypoxia protocol. 
 
6.4.1 Biventricular volumes at the start of the study vs. after the period of rest 
 
Table 6.1 summarises the results of biventricular volumes at the start of the study and the 
normoxia protocol, and then after the period of rest before commencing the hypoxia protocol.  
There was no significant difference in LV volumes, SV or LVEF.  There was no difference in 
RVEDVI, RVSVI or RVEF.  However, RVESVI was significantly smaller, p=0.032, which 
could be as a result of the exercise carried out prior to the hypoxia study. 
 
Table 6.1:  Comparison of biventricular volumes pre-normoxia and pre-hypoxia, n = 17 
LV = Left ventricular; RV = Right ventricular; EDVi = Indexed end diastolic volume; ESVi = 
Indexed end systolic volume; SVi = Indexed stroke volume; EF = Ejection fraction; 
 
 Pre Normoxia Protocol Pre Hypoxia Protocol p value 
LVEDVI 83.7 ± 14.6 79.0 ± 14.6 1.0 
LVESVI 30.2 ± 5.2 28.2 ± 7.7 0.32 
LVSVI 53.5 ± 10.7 51.0 ± 8.3 1.0 
LVEF 63.8 ± 3.6 65 ± 4.5 0.488 
RVEDVI 90.0 ± 17.8 81.8 ± 15.2 0.136 
RVESVI 38.6 ± 8.9 32.1 ± 8.0 0.032 
RVSVI 51.3 ± 11.1 49.7 ± 8.3 1.0 
RVEF 57.1 ± 5.2 60 ± 5 0.352 
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6.4.2 Effects of Hypoxia at Rest 
The comparisons of heart rate, cardiac index and biventricular volumes between normoxia and 
hypoxia are summarized in Table 6.2. 
 
Table 6.2:  Rest Normoxia vs. Rest Hypoxia Biventricular Volumes, n = 37 
Ao = Aortic, MPA = Main Pulmonary Artery, CI = Cardiac Index, LV = Left ventricular; RV 
= Right ventricular; EDVi = Indexed end diastolic volume; ESVi = Indexed end systolic 
volume; SVi = Indexed stroke volume; EF = Ejection fraction; 
 
Cardiac Index, heart rate and SVI 
 
Cardiac index was higher at rest during hypoxia, driven by a higher heart rate, with no change 
in Ao, MPA, LV or RV SVI. 
 Rest Normoxia Rest Hypoxia p value 
HR 61.6 ± 10.6 74.5 ± 12.2 <0.001 
Ao SVI 51.3 ± 10.9 50.4 ± 12.3 1.0 
MPA SVI 51.3 ± 9.9 51.6 ± 9.8 1.0 
CI 3.1 ± 0.6 3.6 ± 0.7 <0.001 
LVEDVI 83.7 ± 14.6 79.9±13.8 <0.001 
LVESVI 30.2 ± 5.2 26.7 ± 5.6 <0.001 
LVSVI 53.5 ± 10.7 53.0 ± 10.1 1.0 
LVEF 63.8 ± 3.6 66.6 ± 4.7 0.036 
RVEDVI 90.0 ± 17.8 87.6 ± 16.7 0.828 
RVESVI 38.6 ± 8.9 26.9 ± 8.7 0.024 
RVSVI 51.3 ± 11.1 51.7 ± 9.4 1.0 
RVEF 57.1 ± 5.2 59.4 ± 5.1 0.12 
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Right Ventricle 
 
There was no difference in RVEDVI or RVEF during hypoxia at rest compared to normoxia.  
RVESVI was significantly smaller (p <0.024), however, there was a significant difference in 
RVESVI post exercise but pre hypoxia that may influence this result. 
 
Left Ventricle 
 
LVEDVI and LVESVI were significantly smaller at rest during hypoxia, compared to 
normoxia (p <0.001 for both comparisons).  LVEF was significantly higher at rest during 
hypoxia (p = 0.036) 
 
6.4.3 Effects of Hypoxia on Atrial size 
 
Table 6.3:  Comparison of Left and Right Atrial size from Normoxia to Hypoxia 
 Normoxia Hypoxia P value 
Left Atrial Area 24.1 ± 5.4 21.0 ± 9.3 0.032 
Right Atrial Area 24.8 ± 5.9 25.0 ± 5.4 0.621 
 
There was a significant decrease in left atrial size at rest, p=0.032 
 
6.4.4 Effects of Hypoxia on Interventricular septum 
Table 6.4:  Effect of Hypoxia on the Interventricular Septum 
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 Normoxia Hypoxia P value 
Rest 0.91 ± 0.2 0.81 ± 0.2 <0.0001 
 
There was a significant flattening of the interventricular septum, p <0.0001 
 
6.5.5 Biventricular Response from Rest to Exercise during Hypoxia 
 
The response of heart rate, cardiac index and biventricular function is summarized in Table 
6.5. 
 
Table 6.5: Comparison of Heart rate, Cardiac Index and Biventricular Parameters from Rest to 
Exercise, during Hypoxia 
Outcome Variable Hypoxia Rest Hypoxia Exercise P value 
HR (bpm) 74.5 ± 12.2 142.8± 12.2 <0.0001 
Ao SVi (ml/m2) 50.4 ± 12.3 58.3 ± 11.4 <0.0001 
MPA SVi (ml/m2) 51.6 ± 9.8 56.2 ± 10.9 0.05 
CI (l/min/m2) 3.6 ± 0.7 8.3 ± 1.8 <0.0001 
LV EDVi (ml/m2) 79.9±13.8 81.5±13.6 1.0 
LV ESVi (ml/m2) 26.7 ± 5.6 20.6 ± 5.2 <0.0001 
LV SVi (ml/m2) 53.0 ± 10.1 60.7 ± 10.3 <0.0001 
LV EF (%) 66.6 ± 4.7 74.7 ± 4.3 0<0.0001 
RV EDVi (ml/m2) 87.6 ± 16.7 82.5 ± 15.4 0.132 
RV ESVi (ml/m2) 35.8 ± 9.4 25.6 ± 8.9 <0.0001 
RV SVi (ml/m2) 51.7 ± 9.4 56.7 ± 10.0 <0.0001 
RVEF (%) 59.4 ± 5.1 69.9 ± 6.3 <0.0001 
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6.5.5.1 Cardiac Index, Heart Rate and Stroke Volume Index 
There is a significant increase in heart rate (p<0.0001), cardiac index (p < 0.0001), Ao stroke 
volume (p < 0.0001) and MPA stroke volume (p = 0.05) during hypoxic exercise. 
 
6.5.5.2 Right Ventricular Volumes and Ejection Fraction 
There is an increase in RVSVI on exercise (p < 0.0001) that is driven by a decrease in RVESVI 
(p < 0.0001), with no change in RVEDVI (p=0.132). 
 
6.5.5.3 Left Ventricular Volumes and Ejection Fraction 
There is an increase in LVSVI on exercise (p < 0.0001) that is driven by a decrease in LVESVi 
(p < 0.0001) with no change in LVEDVI (p = 1.0). 
 
6.5.6 Biventricular Response from Rest to Exercise: Comparison of Normoxia to Hypoxia 
 
The interaction of exercise and oxygen level, on the change of heart rate, cardiac index and 
biventricular function is summarized in Table 6.6.  Simple main effects analysis comparing 
exercise parameters during normoxia to hypoxia is summarized in Table 6.7. 
 
Table 6.6:  Interaction between Oxygen level and the effect on Exercise: Comparison of Heart 
rate, Cardiac Index and Biventricular Function from Rest to Exercise, during Normoxia and 
Hypoxia 
Outcome Variable Normoxia Hypoxia Interaction of 
effect of oxygen Rest Exercise Rest Exercise 
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Ao = Aortic, MPA = Main Pulmonary Artery, CI = Cardiac Index, LV = Left ventricular; RV 
= Right ventricular; EDVi = Indexed end diastolic volume; ESVi = Indexed end systolic 
volume; SVi = Indexed stroke volume; EF = Ejection fraction; 
 
Table 6.7: Simple main effects analysis:  Comparison of Heart rate, Cardiac Index and 
Biventricular Parameters on Exercise, during Normoxia vs. Hypoxia 
Outcome Variable Normoxia Exercise Hypoxia Exercise P value 
HR (bpm) 123.0± 10.5 142.8± 12.2 <0.0001 
level on 
exercise: p value 
HR (bpm) 61.6 ± 10.6 123.0± 10.5 74.5 ± 12.2 142.8± 12.2 0.004 
Ao SVi (ml/m2) 51.3 ± 10.9 62.0 ± 10.3 50.4 ± 12.3 58.3 ± 11.4 0.048 
MPA SVi (ml/m2) 51.3 ± 9.9 60.2 ± 9.3 51.6 ± 9.8 56.2 ± 10.9 0.014 
CI (l/min/m2) 3.1 ± 0.6 7.6 ± 1.5 3.6 ± 0.7 8.3 ± 1.8 0.328 
LV EDVi (ml/m2) 83.7 ± 14.6 89.6 ± 15.1 79.9±13.8 81.5±13.6 <0.0001 
LV ESVi 30.2 ± 5.2 25.0 ± 6.7 26.7 ± 5.6 20.6 ± 5.2 0.375 
LV SVi (ml/m2) 53.5 ± 10.7 64.6 ± 10.7 53.0 ± 10.1 60.7 ± 10.3 0.001 
LV EF (%) 63.8 ± 3.6 72.2 ± 4.5 66.6 ± 4.7 74.7 ± 4.3 0.958 
RV EDVi (ml/m2) 90.0 ± 17.8 88.3 ± 15.2 87.6 ± 16.7 82.5 ± 15.4 0.036 
RV ESVi 38.6 ± 8.9 26.9 ± 8.7 35.8 ± 9.4 25.6 ± 8.9 0.322 
RV SVi (ml/m2) 51.3 ± 11.1 61.3 ± 10.0 51.7 ± 9.4 56.7 ± 10.0 <0.0001 
RVEF (%) 57.1 ± 5.2 69.9 ± 6.3 59.4 ± 5.1 69.1 ± 6.6 0.017 
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Ao SVi (ml/m2) 62.0 ± 10.3 58.3 ± 11.4 0.012 
MPA SVi (ml/m2) 60.2 ± 9.3 56.2 ± 10.9 0.012 
CI (l/min/m2) 7.6 ± 1.5 8.3 ± 1.8 <0.0001 
LV EDVi (ml/m2) 89.6 ± 15.1 81.5±13.6 <0.0001 
LV ESVi (ml/m2) 25.0 ± 6.7 20.6 ± 5.2 <0.0001 
LV SVi (ml/m2) 64.6 ± 10.7 60.7 ± 10.3 <0.0001 
LV EF (%) 72.2 ± 4.5 74.7 ± 4.3 0.036 
RV EDVi (ml/m2) 88.3 ± 15.2 82.5 ± 15.4 <0.0001 
RV ESVi (ml/m2) 26.9 ± 8.9 25.6 ± 8.9 1.0 
RV SVi (ml/m2) 61.3 ± 10.0 56.7 ± 10.0 <0.0001 
RVEF (%) 69.9 ± 6.3 69.9 ± 6.3 1.0 
 
 
6.5.6.1 Heart Rate 
There was significant interaction between the effects of oxygen level and exercise on heart rate 
(p=0.004) with a more pronounced increase of heart rate during hypoxia. (Figure 6.1).  Simple 
main effects analysis showed that heart rate was higher at rest and also on exercise, p < 0.0001 
 
Figure 6.1 – Change in Heart Rate from Rest to Exercise, during Normoxia and Hypoxia 
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6.5.6.2 Cardiac Index 
There was no significant interaction between the effects of hypoxia on the change of CI on 
exercise (p=0.328).  Simple main effects analysis showed that CI was significantly higher at 
rest (p<0.001) and exercise (p<0.0001) 
 
6.5.6.3 Aortic and MPA Stroke Volume 
There was a significant interaction between the effects of hypoxia on the change of aortic and 
MPA SVI on exercise (Ao SVI, p=0.048, Figure 6.2 and MPA SVI, p=0.014, Figure 6.3). 
Simple main effects analysis showed that this was driven by a significant difference between 
aortic and MPA SVI during hypoxic exercise (p=0.012 for both comparisons), and that there 
was no difference at rest (p = 1.0 for both comparisons). 
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Figure 6.2 – Change in Ao SVI from Rest to Exercise during Normoxia and Hypoxia 
 
Figure 6.3 – Change in MPA SVI from Rest to Exercise during Normoxia and Hypoxia 
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6.5.6.4 Left and Right Ventricular Stroke Volume 
There was a significant interaction of hypoxia on the change of LVSVI (p=0.001) and RVSVI 
(p<0.0001) on exercise (Figure 6.4 and 6.5 respectively). Simple main effects analysis showed 
that was driven by a lower RVSVI and LVSVI during hypoxic exercise compared to normoxic 
exercise on simple main effects analysis (p<0.0001 for both comparisons).  There was no 
difference at rest (p = 1.0 for both comparisons). 
 
Figure 6.4:  Change in LVSVI from Rest to Exercise, during Normoxia and Hypoxia 
 
Figure 6.5:  Change in RVSVI from Rest to Exercise, during Normoxia and Hypoxia 
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6.5.6.5 Left Ventricular Volumes and Ejection Fraction 
There was a significant interaction between the effects hypoxia on change of LVEDVI on 
exercise (p <0.0001, Figure 6.6).  Simple main effects showed that LVEDVI increased during 
normoxic exercise (p <0.0001), but did not increase during hypoxic exercise (p=0.112) and 
that LVEDVI was lower at rest and exercise, during normoxia and hypoxia (p<0.0001).   
 
There was no interaction with the change in LVESVI, p = 0.375 or LVEF p=0.958.  Simple 
main effects analysis showed that LVESVi was smaller and LVEF higher at rest and exercise 
during hypoxia, compared to normoxia (p<0.0001 for all comparisons except LVEF at 
exercise, p=0.036) 
 
Figure 6.6:  Change in LVEDVI from Rest to Exercise, during Normoxia and Hypoxia 
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6.5.6.6 Right Ventricular Volumes and Ejection Fraction 
There was a significant interaction between hypoxia and change of RVEDVI on exercise 
(p=0.036, Figure 6.7).  This was driven by a significantly smaller RVEDVI was during hypoxic 
exercise than normoxic exercise (p < 0.0002), with no significant difference at rest (p = 0.828) 
 
There was no interaction between the effects of oxygen level and exercise on RVESVi, p = 
0.322.  However, while RVESVI was significant lower at rest (p = 0.024), RVESVi was not 
significantly different on hypoxic exercise (p=0.294).   
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There was a significant interaction of hypoxia on the change RVEF on exercise (p=0.017, 
Figure 6.8). There was no difference between rest and exercise RVEF during normoxia or 
hypoxia (p=0.12 and 1.0 respectively), hence the rise in RVEF on exercise during hypoxia was 
less than during normoxic exercise. 
 
Figure 6.7: Change in RVEDVI from Rest to Exercise, during Normoxia and Hypoxia 
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Figure 6.8:  Change in RVEF from Rest to Exercise, during Normoxia and Hypoxia 
 
Figure 6.8a – Change in RVEF from Rest to Exercise during Hypoxia for each Individual 
 
 
6.5.7 Biventricular Response from Rest to Immediately after Exercise 
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The response of heart rate, cardiac index and biventricular parameters as assessed from 
immediately after exercise during hypoxia are summarized in Table 6.8. 
 
Table 6.8: Comparison of Heart rate, Cardiac Index and Biventricular Parameters from Rest to 
Immediately after Exercise, during Hypoxia 
Outcome Variable Hypoxia Rest Hypoxia IAE P value 
HR (bpm) 73.9 ± 11.9 110.0 ± 25.1 <0.0001 
Ao SVi (ml/m2) 50.5 ± 12.4 61.7 ± 13.1 <0.0001 
MPA SVi (ml/m2) 51.2 ± 9.6 57.5 ± 11.6 <0.0001 
CI (l/min/m2) 3.6 ± 0.7 6.7 ± 2.0 <0.0001 
LV EDVi (ml/m2) 78.5 ± 13.0 84.9 ± 13.7 <0.0001 
LV ESVi (ml/m2) 25.8 ± 4.9 20.0 ± 3.9 <0.0001 
LV SVi (ml/m2) 52.5 ± 9.9 65.0 ± 11.3 <0.0001 
LV EF (%) 67.0 ± 4.5 76.4 ± 3.1 <0.0001 
RV EDVi (ml/m2) 85.8 ± 15.8 87.4 ± 15.0 0.369 
RV ESVi (ml/m2) 35.0 ± 8.4 23.4 ± 7.3 <0.0001 
RV SVi (ml/m2) 50.8 ± 9.4 64.1 ± 10.3 <0.0001 
RVEF (%) 59.3 ± 4.8 73.6 ± 5.1 <0.0001 
 
Heart Rate, Cardiac Index and Stroke Volume 
There is a significant increase in heart rate, cardiac index and aortic and MPA stroke volume, 
p <0.0001 for all comparisons. 
 
Right Ventricular Volumes and Function 
There is an increase of RVSVI, which is driven by a decrease in RVESVI (p < 0.0001 for both 
comparisons.)  There is no change in RVEDVI. 
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Left Ventricular Volumes and Function 
There is an increase in LVSVI, which is driven by an increase in LVEDVI and a decrease in 
LVESVI (p < 0.0001). 
 
6.5.8:  Biventricular Response from Rest to Immediately after Exercise: Comparison of 
Normoxia and Hypoxia 
 
The interaction between normoxia and hypoxia and changes in biventricular parameters from 
rest to immediately after exercise is summarized in Table 6.9.  The simple main effects 
comparing normoxia to hypoxia biventricular parameters immediately after exercise are 
summarized in Table 6.10. 
 
Table 6.9: Comparison of the interaction between Normoxia and Hypoxia on Heart rate, 
Cardiac Index and Biventricular Function from Rest to Immediately After Exercise, during 
Normoxia and Hypoxia 
Outcome Variable Normoxia Hypoxia Exercise*Oxygen 
Rest IAE Rest IAE 
HR (bpm) 61.6 ± 10.8 92.1 ± 15.9 74.1 ± 12.1 110.0 ± 25.1 0.127 
Ao SVi (ml/m2) 51.3 ± 11.2 65.1 ± 12.8 50.3 ± 12.6 61.7 ± 13.1 0.08 
MPA SVi (ml/m2) 50.9 ± 10.2 62.1 ± 11.6 51.1 ± 9.7 57.5 ± 11.6 0.014 
CI (l/min/m2) 3.1 ± 0.6 6.0 ± 1.5 3.6 ± 0.7 6.7 ± 2.0 0.198 
LV EDVi (ml/m2) 82.3 ± 13.8 90.9 ± 16.0 78.5 ± 13.0 84.9 ± 13.7 0.025 
LV ESVi 29.9 ± 5.3 26.0 ± 4.7 25.8 ± 4.9 20.0 ± 3.9 0.023 
LV SVi (ml/m2) 52.3 ± 9.7 64.9 ± 13.7 52.5 ± 9.9 65.0 ± 11.3 0.905 
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LV EF (%) 63.8 ± 3.6 71.1 ± 4.2 66.6 ± 4.7 76.4 ± 3.1 0.047 
RV EDVi (ml/m2) 90.0 ± 17.8 89.2 ± 18.3 87.6 ± 16.7 87.4 ± 15.0 0.955 
RV ESVi 38.9 ± 8.8 25.8 ± 8.1 35.0 ± 8.4 23.4 ± 7.3 0.766 
RV SVi (ml/m2) 51.3 ± 11.1 63.4 ± 12.4 51.7 ± 9.4 64.1 ± 10.3 0.810 
RVEF (%) 57.1 ± 5.2 71.4 ± 5.0 59.4 ± 5.1 73.6 ± 5.1 0.714 
 
Table 6.10: Simple main effects analysis: Heart Rate, Cardiac Index and Biventricular 
Parameters Immediately After Exercise during Normoxia and Hypoxia 
Outcome Variable Normoxia Immediately 
After Exercise 
Hypoxia Immediately 
After Exercise 
P value 
HR (bpm) 91±16 110.0 ± 25.1 <0.0001 
Ao SVi (ml/m2) 64.7 ± 12.3 61.7 ± 13.1 0.048 
MPA SVi (ml/m2) 62.1 ± 11.2 57.5 ± 11.6 0.012 
CI (l/min/m2) 5.9 ± 1.6 6.7 ± 2.0 0.012 
LV EDVi (ml/m2) 91.2 ± 16.4 84.9 ± 13.7 <0.0001 
LV ESVi (ml/m2) 26.2 ± 5.3 20.0 ± 3.9 <0.0001 
LV SVi (ml/m2) 65.1 ± 13.2 65.0 ± 11.3 1.0 
LV EF (%) 71.1 ± 4.2 76.4 ± 3.1 <0.0001 
RV EDVi (ml/m2) 89.2 ± 18.3 87.4 ± 15.0 1.0 
RV ESVi (ml/m2) 25.8 ± 8.1 23.4 ± 7.3 0.564 
RV SVi (ml/m2) 63.4 ± 12.4 64.1 ± 10.3 1.0 
RVEF (%) 71.4 ± 5.0 73.6 ± 5.1 0.228 
 
Heart Rate 
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There is no significant interaction between hypoxia and normoxia and the change of heart rate 
when comparing rest to immediately after exercise.  (p = 0.127).  However, heart rate is higher 
during hypoxia than normoxia immediately aft exercise (p < 0.0001) 
 
Cardiac Index 
There is no significant interaction between hypoxia and the change of cardiac index.  Cardiac 
index is significantly higher immediately after exercise during hypoxia, than normoxia, p = 
0.012. 
 
Aortic and MPA Stroke Volume Index 
There is no significant interaction between hypoxia and the change of aortic SVI (p = 0.08) 
although on simple main effects analysis, aortic SVI is slightly lower immediately after 
hypoxic exercise, than normoxic exercise, p = 0.048.  There is a significant interaction between 
hypoxia and the change of MPA SVI (p = 0.014).  Simple main effects shows that MPA SVI 
is significantly lower immediately after hypoxic exercise, than normoxic exercise, p = 0.012. 
 
Left Ventricular Volumes and Function 
There is a significant interaction between normoxia and hypoxia, and change in LVEDVI from 
rest to immediately after exercise in both conditions, normoxia and hypoxia (Figure 6.9).  
However, simple main effects analysis shows there is a significant increase in LVEDVI from 
rest to immediately after exercise, p < 0.0001, which contrasts to no increase in LVEDVI 
during continuous exercise, suggesting an improvement in LV filling immediately after. 
 
There was a significant interaction between changes in LVESVI from rest to immediately after 
exercise, p = 0.025 (Figure 6.10), with a bigger decrease in LVESVI during hypoxia 
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immediately after exercise compared to normoxia, p <0.0001.  There was no interaction and 
no significant difference between resting or exercise values of LVSVI. 
 
Figure 6.9: Change in LVEDVI from Rest to Immediately after Exercise 
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Right Ventricular Volumes and Function 
There was no significant interaction of change in RVEDVI, RVESVI, RVSVI or RVEF 
between hypoxia and normoxia, rest to immediately after exercise, with no significant 
difference between these parameters immediately after exercise on simple main effects 
analysis. 
 
6.5.9 MPA Area, Pulsatility and Velocities 
 
Table 6.11: Comparison of MPA Area, Pulsatility and Velocities from Rest to Exercise during 
Hypoxia 
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MPA Parameter Hypoxia Rest Hypoxia Exercise P value 
Maximum Area 8.4 ± 1.3 9.1 ± 1.6 0.01 
Minimum Area 5.8 ± 1.1 6.3 ± 1.1 0.06 
Pulsatility 48.3 ± 23.5 45.2 ± 14.6 1.0 
Peak Velocity 62.4 ± 14.1 91.6 ± 26.1 <0.0001 
Average Velocity 12.1 ± 2.5 13.1 ± 3.3 0.065 
 
MPA Area 
Maximum MPA area increased in size on hypoxic exercise, p=0.01, however, there was no 
significant increase in MPA minimum area p = 0.06.  There was no significant change in MPA 
pulsatility, p=1.0.  
 
MPA Velocities 
There was a significant increase in MPA Peak velocity, p < 0.0001, however, the increase in 
MPA average velocity was not significant, p=0.065. 
 
When analyzing the interaction between hypoxia and normoxia on the change of MPA size, 
pulsatility and velocities, there were no significant interactions.  However, the change of 
average MPA velocity on hypoxic exercise trended towards significance, p = 0.059, with a 
trend for the rise of MPA average velocity during hypoxic exercise to be lower, than that of 
normoxic exercise (Figure 6.9) 
 
Figure 6.11:  Change of MPA Average Velocity from Rest to Exercise, during Normoxia and 
Hypoxia 
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6.6 Discussion 
 
6.6.1 Changes at Rest with Hypoxia 
 
We have shown that during acute hypoxia at rest, there is a decrease in LV volumes, an increase 
in LV contractility reflected in a marginally higher LVEF, with no change in RV volumes or 
RVEF.  There was no change in right or left sided stroke volume, but an increase in cardiac 
index driven by a higher heart rate.  This is likely to be the consequence of sympathetic nervous 
system activation.  Furthermore, we have shown a shift in the interventricular septum, as well 
as a decrease in left atrial area. 
 
p = 0.065 
n=34 	
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It is well accepted acute hypoxia leads to an increase in heart rate and cardiac output, with no 
change in resting stroke volume at rest and our results are consistent with that(114-116). At 
rest, acute hypoxia increases heart rate and cardiac output, with no change in SV.  During 
submaximal exercise during acute hypoxia, it is recognized that initially CO at any workload 
is higher, but VO2 peak is blunted by a decrease in maximum heart rate.  It is believed that SV 
is also blunted, but never demonstrated on an imaging study.  We also showed that LVEDVI 
and LVESVI were smaller at rest with a higher LVEF.  A resting LVSA was performed, after 
the a period of rest and before inducing hypoxia, to ensure that exercise was not a confounder, 
and it was shown that LV volumes and ejection fraction had returned to baseline.  Hence we 
can conclude that these findings are a true consequence of acute hypoxia.   
 
A reduction in LV volumes has also been demonstrated, on echocardiography, in other studies, 
however most have allowed a degree of acclimatization.  Stembridge et al demonstrated that 
after 10 days of high altitude exposure in lowlanders, LVEDVI was 19% lower at rest and did 
not increase in size during exercise, despite evidence of enhanced diastolic relaxation on 
speckle tracking analysis (252).  This is supported by Boussuges et al, who demonstrated that 
aortic and LV diameters fell regularly on simulated ascent to altitude, with a change in LV 
diastolic filling parameters, and no elevation of LV end diastolic pressure(120).  Allemann et 
al similarly demonstrated an increased LVEF with changes in LV diastolic filling parameters 
in children and adolescents on rapid ascent to high altitude(253).  However, it could be argued 
that the mechanisms leading to a change in LV size after acclimatization, could be due to 
reduced plasma volume, which would not contribute during acute hypoxic exposure, and 
Reciehnberger at al reported no change in LV systolic or diastolic parameters on acute hypoxic 
exposure, using echocardiography (115).  However, we hypothesize that the cause of the 
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decrease in LVEDV at rest could be due to sympathetic nervous system activation and LV 
under-filling,  
 
Acute hypoxic exposure has been shown to markedly elevate noradrenaline levels(254-256).  
Furthermore, sympathetic nervous system activation has been shown to decrease LVEDV, 
LVESV and increase LVEF in dogs (257).  LV under-filling could also contribute given that 
other studies have demonstrated changes in diastolic filling patterns at rest, however, there is 
no demonstrable change in RV forward flow or RVSV so this may be less likely. 
 
We also showed no change in RV function at rest in acute hypoxia.  Stembridge et al showed 
no change in RVEDVI at rest in lowlanders after 10 days of acclimatization.  Oliver et al 
showed during acute hypoxic exposure, that there was no change in RV volumes, stroke 
volume or ejection fraction at rest(123), and Reichenberger et al demonstrated that while sPAP 
increases during acute hypoxia, indices of RV contractility do not change at rest (115).  
Pavelescu et al also demonstrated that while acute hypoxia increases PVR, indices of RV 
systolic function remain the same.  They noted a change in RV filling, with a decrease in the 
tricuspid E:A ratio(121).  Conversely, Netzer et al found that acute hypoxia increased RV 
dimensions as measured on echo (122), and Allemann et al found that RVEDVi area decreased 
in children and adolescents at high altitude (253).  This could be a reflection of the limitation 
of echocardiography to accurately assess RV size and dimensions, and hence, only indirect 
signs of RV function such as TAPSE or the TEI index can be reliably reported.  For both the 
LV and RV volume changes, it could be argued that as MRI is a more accurate method of 
assessing biventricular volumes and this is the first study to assess biventricular volumes at rest 
during acute hypoxia using MRI, that our findings are likely to be more sensitive and accurate 
to detecting subtle changes, than previous studies that used echocardiography or radionuclide 
	 182	
ventriculography.  Hence changes in diastolic filling pattesr would appear to be less likely 
based on our data. 
 
6.6.2 Changes on Exercise with Hypoxia 
 
During hypoxic exercise, we have demonstrated a reduction in RV forward flow with blunting 
of the rise in MPA SVI and RVSVI, with a decrease in RVEDVI and blunting of the rise in 
RVEF.  Furthermore, LVEDVI does not increase on exercise, with a blunting of the rise in 
LVSVI and Ao SVI, despite a decrease in LVESVI and a higher LVEF.  These changes are 
suggestive of increased pulmonary vascular resistance leading to a reduction in RV forward 
flow and blunting of the rise of RVEF, with the decrease in RVEDVI as an adaptive mechanism 
to cope with the increased afterload.  This leads to LV under-filling, a reduction in LV preload 
and diastolic stretch, and hence a reduction in LVSVI and Ao SVI, despite an increase in LV 
contractility from sympathetic nervous system activation. 
 
A number of studies have demonstrated evidence of RV strain on acute hypoxic exercise.  
Kjaergaard et al showed that RV contractility as measured by isovolumic acceleration on 
echocardiography is impaired during hypoxic exercise, and is restored to normal values when 
sildenafil is given (126).  Evidence of RV strain during acute hypoxia, which is restored or 
partially restored with pulmonary vasodilators, has been reported in several studies using 
echocardiography.  Reichenberger et al shown that Sildenafil administration reduced sPAP and 
the TEI index during acute hypoxia, as compared to placebo (115) .  Naeije et al showed that 
Sitaxsentan decreased PVR and restored VO2 max on CPET by 30% during acute hypoxic 
exercise, and by 10% after chronic hypoxic exposure, suggesting that by reducing hypoxic 
pulmonary vasoconstriction, RV forward flow improved (125).   Similarly, Faoro et al showed 
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that Bosentan restored VO2 max by 30% during acute hypoxic exercise (258) and Ghofrani et 
al showed that Sildenafil decreased sPAP at rest and exercise at high altitude, and improved 
exercise capacity (259).  Furthermore, Hsu et al have shown a reduction in stroke volume using 
a thoracic impedance method during acute hypoxic exercise, which was restored with sildenafil 
(260).  Together, these studies support the hypothesis that acute hypoxic pulmonary 
vasoconstriction leads to signs of RV strain on exercise and a reduction of VO2 peak, which is 
partially restored with pulmonary vasodilators.  However, ours is the first imaging study to our 
knowledge, to directly document a reduction in RVSVI and MPA SVI, with evidence of 
blunting of the rise of RVEF.  Previously studies using echocardiography have only been able 
to provide indirect evidence, and hence this demonstrates the ability of exercise MRI, to assess 
exercise RV reserve in detail. 
 
We have also shown a reduction in RVEDVI on acute hypoxic exercise.  This has never been 
shown before, however, there have been now acute hypoxic exercise MRI studies to date.  Our 
study in healthy volunteers, showed that normal exercise is characterized by no significant 
change in RVEDVI.  Exercise imposes a large increase in RV wall stress, documented to be 
up to 125% compared to a 14% increase in LV wall stress (261).  During hypoxic exercise, the 
mPAP-flow relationship is further shifted, posing higher pressures on the RV (112, 114).  The 
RV is known to adapt to chronic exposure to this higher stress, by evidence of RV remodeling 
by way of an increase in RVEDVI and mass in athletes and recreationally fit subjects (262-
264).  We have also demonstrated in our healthy volunteers, than an increase in biventricular 
volumes at rest and exercise correlate with a higher VO2 peak.  However, those exposed to 
chronic hypoxia, have demonstrated lower RV and LVSV, reduced early diastolic filling of 
both the LV and RV, and decreased RV and LV volumes, which are likely to reflect an impact 
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of chronically elevated pulmonary pressures, ventricular under-filling, as well as 
hypovolaemia(265, 266). 
 
However no study to date, has demonstrated how the healthy RV adapts to an acute increase 
in load in humans.  The reduction in RVEDVI may be a consequence of sympathetic nervous 
system activation.  It has been shown in the LV on echocardiography, that a reduction in 
LVEDVI from sympathetic nervous system activation and an increase in systemic blood 
pressure, reduces the load on the LV (257), and according to the LaPlace relationship, a 
reduction in diameter reduces wall stress.  Furthermore, changes in RV filling with a decrease 
in early diastolic filling in acute hypoxia at rest has been demonstrated, which may become 
accentuated at rest (121). 
 
In animal studies, it has been shown in an acute model of pulmonary hypertension using 
pulmonary artery balloon inflation and a respiratory distress syndrome, that the RV adapts and 
increases cardiac output, not by increasing RVEDVI, but by improving contractile performance 
through homeometric autoregulation.(267, 268).  Dobutamine stress was performed in rats, 
after 6 weeks of RV pressure overload induced by pulmonary artery banding, demonstrating 
that there was an increase in RV contractility in the banded rats in response to dobutamine 
stress, with no change in RVEDVI (269).  These studies together with ours, suggests that the 
initial adaptation of the RV to an increased load, is by homeometric augmentation and an 
increase in contractility, rather than by an increase in RVEDVI and enhancement of Frank-
Starling mechanisms, to maintain stroke volume.  Furthermore, the degree of pulmonary 
pressure elevation and time of exposure to this is an important factor.  In pigs, it has been 
shown that acute moderate levels of RV pressure overload leads to maintenance of end-
diastolic and end-systolic RV segment length, implying that there is an increase in RV 
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contractility.  With severe acute pressure overload, there was a significant increase in both end 
diastolic and end systolic lengths (270).  Furthermore, that has been shown in pigs, with a step-
by-step embolic increase in afterload, that the initial RV adjustment required pure homeometric 
regulation.  Dilatation occurred subsequently as a consequence of the limitation of contractile 
reserve, which then led to vascular-ventricular uncoupling and a decrease in pulmonary blood 
flow.  Hence RV contractile recruitment represents a compensatory mechanism, whereas RV 
enlargement heralds the onset of regulatory failure (271) 
 
We have shown in our first study in healthy volunteers, that an increase in LVEDVI is a normal 
manifestation of exercise.  However, during acute hypoxia, there is no increase in LVEDVI 
suggesting relative under-filling and a reduction in preload.  As RVEDVI decreases in size, 
there is no restriction of LV filling from RV compression.  As described earlier, there is 
evidence of LV under-filling despite enhanced diastolic indices on speckle tracking analysis, 
during acute hypoxia (127, 265), with evidence of a reduction in SV on acute hypoxic exercise 
(128).  We have demonstrated for the first time, that the reduction in Ao SVI and LVSVI, can 
be explained a blunting in LV preload on exercise shown by no rise in LVEDVI, despite an 
increase in LV contractility shown by a decrease in LVESV and an increase in LVEF.  A 
previous study by Kullmer et al using echocardiography, showed no change in LVEDV or 
LVESV on exercise (119) and Ricart et al showed no change in LVEF between hypoxic and 
normoxic exercise (272), however, this could be due to the lack of sensitivity of 
echocardiography to detect biventricular volume change.  
 
 
6.6.3 Hypoxia-related changes Immediately After Exercise 
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We have shown that if imaging is performed immediately after exercise, there are no detectable 
differences in changes RV function and stroke volume between normoxic and hypoxia.  
Furthermore, while LV volumes remain lower immediately after exercise during hypoxia 
compared to normoxia, there is an increase in LVEDVI immediately after exercise suggesting 
an improvement in LV-filling, and a larger decrease LVESVI and hence increase in LVEF, 
suggesting an increase in contractility which could be related to the improvements in filling 
and utilization of Frank-Starling mechanisms. There is also no difference in LVSVI, RVSVI 
and Ao SVI detectable when imaging is performed immediately after exercise, between 
hypoxia and normoxia, which contrasts to when imaging is performed during steady state 
exercise.  However, there is a significant reduction in MPA SVI during hypoxia as compared 
to normoxia.  While cardiac index and heart rate are higher, there is no difference in interaction 
on hypoxia on the change of these parameters.   
 
In Chapter 5, we demonstrated that immediately after exercise there is increase in stroke 
volumes, an increase in LVEDVI and an increase in RVEF, and we suggested that this may be 
important when assessing exercise pathophysiology in disease.  We have shown that there are 
subtle but highly significant differences in  biventricular function in the healthy heart during 
exercise in acute pulmonary hypertension, which are not detected if imaging is carried out 
immediately after exercise.  In fact, imaging immediately after exercise was characterized by 
improvements in LV filling and contractility. 
 
We did find that MPA SVI was significantly lower immediately after exercise during hypoxia 
compared to normoxia, and there was a significant interaction.  This is likely due to the fact 
that MPA SVI acquisition was the first image acquired in the sequence.  Ao SVI was next, with 
the LVSA cine immediately after.  As outlined in Chapter 2, the full protocol acquisition time 
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is 86 seconds.  Hence within that time frame RV recovery was able to take place, further 
emphasizing our point that continuous steady state acquisition in exercise CMR is important. 
 
MPA Area, Pulsatility and Velocities 
 
We have found that average MPA velocity does not increase significantly during hypoxic 
exercise, and that there is a trend, though non-significant, for blunting of the rise in MPA 
average velocity during hypoxic exercise versus normoxic exercise  It is difficult to know, 
however, whether this is a reflection of the increase in pulmonary vascular resistance, and a 
reduction in pulmonary vascular distensibility during hypoxia and hypoxic exercise, and could 
the subject of further research.  It also raises an interesting clinical question whether a blunting 
of a rise in average MPA blood velocity, has the potential to non-invasively detect subclinical 
pulmonary vascular disease that is otherwise not present at rest, and warrants further 
investigation. 
 
6.6.4 Limitations 
 
We have demonstrated a reduction in RV forward flow, with indirect evidence of elevated 
pulmonary pressures and pulmonary vascular resistance, with interventricular septal flattening.  
However, it could be argued that acute hypoxia as a model of pulmonary hypertension, could 
cause myocardial ischaemia, acidosis and hypocapnia, leading to myocardial impairment as a 
cause of reduced RV and LV stroke volume.   
 
Acute hypoxia leads to pulmonary vasoconstriction, systemic vasodilatation, and an increase 
in ventilator drive and sympathetic nervous system activity via peripheral chemoreceptors.  
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Blood pressure remains unchanged or slightly decreased in the first few hours of hypoxic 
exposure, as hypoxic vasodilatation tends to override sympathetic vasoconstriction, with a rise 
in blood pressure occurring after 3-4 weeks of hypoxic exposure due to increasing sympathetic 
activity (110-112, 114, 273).  It has been used in numerous studies in healthy volunteers at rest 
and exercise, to study how the respiratory and cardiovascular systems respond.  Clearly, while 
the use of balloon catheters in the pulmonary circulation has been used to induce pulmonary 
hypertension in humans in the 1960s (274), this would not be ethically acceptable in healthy 
volunteers in now. 
 
The response to acute hypoxia is rapid, with an increase in PVR within the first 5 minutes, a 
lower increase over 2 hours and a maximal response at 24 hours at which early signs of 
remodeling such as medial hypertrophy, start to occur (113).   However, one concern of using 
hypoxia as a model of acute pulmonary hypertension, would be the effect of hypoxia directly 
on the myocardium. Silverman et al demonstrated that isolated rat myocytes, when exposed to 
1% oxygen, had reduced myocyte contractility and slower relaxation and it has been long 
thought that the myocardium may self limit its pump function because of decreased oxygen 
availability thereby preventing potentially fatal hypoxia induced arrhythmia or failure. 
 
However, myocardial blood flow has been shown to be preserved at rest, with an increase 
during exercise despite a lower workload at an altitude of 4500m (275).  Furthermore, 
Malconian et al showed there is no demonstrable cardiac ischaemia on exercise in healthy 
young men at extreme altitude, up to 8,848m on exercise, despite severe hypoxaemia and 
alkalosis, suggesting that oxygen delivery to the myocardium was maintained even at oxygen 
saturations as low as 49% (276).  Dilatation of epicardial coronary arteries and an increase in 
resting myocardial blood flow, compensates for the reduced oxygen content of the blood.  
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Healthy young men subject to hypoxia at rest and during submaximal and maximal workloads 
showed that reduction in arterial content was compensated by increased oxygen extraction 
while at exercise with an increase coronary blood flow.  At a reduction of 20-25% in arterial 
oxygen content, increase in flow was sufficient to supply the heart with enough oxygen during 
submaximal exercise.  Hence normal heart has a ‘coronary flow reserve’ of above 33% (277).  
Furthermore, comparable lactate steady states at relatively the same VO2 levels in normoxia 
and hypoxia in arterial blood has been demonstrated in healthy adults(278) although alkalosis 
and a decrease in CO2 has been reported (254). 
 
Also, we hypothesized that the lack of increase of LVEDVI on exercise is due to a reduction 
in preload and under-filling.  We do not have direct evidence of that, as the temporal resolution 
on real time imaging on CMR, does not allow for diastolic evaluation.  Furthermore, preload 
is dependent on multiple factors other than filling, such as heart rate, contractility and 
ventricular compliance and we are unable to measure all of these directly.  However, we have 
shown that normoxic exercise is characterized by an increase in LVEDVI, hence the lack of 
rise in LVEDVI on hypoxic exercise, may be a consequence of the reduction in RV forward 
flow. 
 
For the immediately post exercise acquisition, we were only able to analyse 24 LVSA due to 
incomplete acquisition of the basal part of the heart.  This was due to vigorous respiration of 
the subject’s post exercise, and malpositioning of the imaging window. 
 
6.7 Conclusions 
 
	 190	
1. Acute normobaric hypoxia leads to an increase in cardiac index driven by an increase 
in heart rate, with no change in stroke volume.  LV volumes decrease and LVEF 
increases could be the result of sympathetic nervous system activation.  There is no 
change in RVEDVI or RVEF. 
 
2. Exercise during acute normobaric hypoxia leads to a reduction in RV forward flow, a 
blunting of a rise in RVEF, LV underfilling and a reduction in LV forward flow.  This 
is likely to a consequence of increased pulmonary pressures. 
 
3. These changes are not detected if imaging is performed immediately after exercise 
 
4. There is a non-significant blunting of the rise in MPA average blood velocity which 
warrants further investigation, as to its significance and potential clinical meaning. 
 
5. Exercise CMR during acute normobaric hypoxia has the ability to detect subtle changes 
in RV and LV function, in the healthy heart 
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Chapter 7 – Cardiovascular Changes at Rest and Exercise in Patients with Pulmonary 
Arterial Hypertension and Normal Resting Right Ventricular Function 
 
7.1 Introduction 
 
Deterioration of RV function is a strong predictor of mortality in patients with PAH, however, 
baseline clinical characteristics and traditional tests such as 6MWD, serial 6MWD, indirect 
determinants of RV function using echocardiography and invasive haemodynamics, cannot 
determine which RV is destined to fail despite medical therapy (148-151).  Assessing RV 
reserve as a marker of subclinical RV-PA uncoupling prior to deterioration of resting RV 
function has gained attention over recent years.  Exercise CMR is a promising new technique, 
and is potentially an accurate, reproducible and non-invasive method for measuring dynamic 
RV function, that could be an ideal modality for assessing serial differences between small 
groups. 
 
7.2 Aims and Hypotheses 
 
Aims: 
1. To assess dynamic biventricular function in patients with PAH and normal resting RV 
function 
2. To correlate RV reserve with clinical characteristics, baseline haemodynamics at 
diagnosis, 6MWD, CPET and echocardiography parameters 
 
Hypotheses 
1. We hypothesize that patients will demonstrate reduced RV reserve, despite normal 
resting RV function 
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2. That RV reserve will not correlate with traditional clinical measures used for follow 
up, nor baseline haemodynamics 
3. That there will be heterogeneity of dynamic RV response amongst patients 
 
7.3 Methodology 
 
The methodology is described in Chapter 2, 3, 5 and 6 and will be briefly described here.  
Healthy volunteers were recruited to the study via advertisement with pre-screening via email 
with a simple questionnaire.  More detailed screening was carried out on the day of attendance 
with height, weight, heart rate, blood pressure and a cardiovascular examination.   
Cardiopulmonary exercise testing was carried out to pre-determine the load that the subject 
would exercise at in the scanner. 
 
Patients were recruited from referrals from the staff in the Pulmonary Hypertension service 
and then directly approached and invited to participate.  Patients underwent 6MWD, CPET, 
lung function testing, echocardiography, plasma assays, CTPA, V/Q scanning and right heart 
catherisation as part of their routine clinical work up and their most recent relevant clinical 
data was collected.  RVEF was assessed by resting CMR.  Exercise CMR was separated from 
other routine tests, such as CPET and 6MWD, by at least 4 hours.  The inclusion criteria and 
exclusion criteria are outlined in Chapter 2.   
 
7.3.1 Preparation 
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Care was taken to ensure that the subject was positioned such that they could pedal within the 
scanner with no restriction, and that their heart was no more than 10cm from isocentre.  
Continuous heart rate and oxygen saturation monitoring was carried out throughout the study. 
 
7.3.2 Imaging 
Rest Imaging 
 
Imaging was carried out on a 1.5 Tesla Philips Achieva with a 32 cardiac channel coil.  
Conventional retrospectively gated cine and phase contrast imaging was carried out.  Resting 
free breathing, high temporal resolution, real time LVSA cine and Ao and MPA phase contrast 
images were taken. 
 
Exercise and immediately post Exercise Imaging 
 
During exercise and immediately after exercise, free breathing, high temporal resolution, real 
time LVOT, RVOT, LVSA and 4 chamber cines, and Ao and MPA phase contrast images were 
acquired.   
 
7.3.3 Exercise Protocol 
 
Exercise was carried out on an MRI compatible ergometer (Lode, Netherlands).  Each subject’s 
predetermined load was set at 40% of the watts achieved during upright CPET.  Warm up 
consisted of increasing the load to target over one minute, and then maintaining that for 2 
minutes.  At 3 minutes, heart rate was monitored for stability, and then imaging commenced.  
Subjects were spoken to continuously during the exercise protocol.  Once exercise imaging 
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was complete, the subject was instructed to cease exercise and remain with their feet in the 
pedals, while immediately post exercise imaging commenced. 
 
7.3.4 Image Analysis: 
 
Breath hold and real time LVSA cines were analysed using cvi42 (Circle, Cardiovascular 
Imaging, Canada).  Breath hold and real time phase contrast images were analysed on ArtFun 
(UPMC, Paris).   
 
7.3.4.1 Volume, Stroke volume and Ejection Fraction analysis from LVSA 
 
Endocardial surfaces were traced at end systole and end diastole in the expiratory phase of 
respiration for each slice, using a semi-automated method with manual correction and volumes 
were calculated by the Simpsons summation rule.  LV and RVSV were calculated as EDV – 
ESV and EF was calculated as EDV-ESV/EDV x 100.  All volumes were indexed to body 
surface area.  RV reserve was calculated as RVEF Exercise – RVEF Rest. 
 
7.3.4.2 Stroke Volume, Mean and Average Velocity and Pulsatility analysis from Phase 
Contrast Images 
 
ROIs were created around the aorta and MPA using a semi-automated method with manual 
correction.  This created time-volume and time-velocity curves from which SV and mean and 
average velocity could be calculated.  SV was calculated as the area under the curve of the 
time-volume curve.  Peak velocity was taken as the peak velocity occurring during systole, and 
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mean velocity as the mean of the velocities through systole.   For the real time analysis, an 
average of the first 5 consecutive heartbeats was taken.  Pulsatility was calculated as Maximum 
area – Minimum area/Minimum area x 100 and expressed as a percentage.  Cardiac output was 
calculated as SV x HR and indexed to BSA. 
 
7.3.4.3 Unwrapping and Phase offset adjustments 
 
Flow data was checked for aliasing and phase offsets >0.6cm/second prior to analysis and 
unwrapped or adjusted prior to analysis (Omnibus Velocity Unwrapping With Phase Offset 
Correction, MATLAB wrapper, Pawel Tokarczuk). 
 
7.3.5 Statistical Analysis: 
 
IBM SPSS Version 22 was used for data analysis.  Data was checked for normality.  
Continuous data is expressed as mean ± standard deviation.  Paired t-tests were used to compare 
differences between measurements.  A repeated ANOVA was used to test the interaction on 
right and left ventricular cardiovascular parameters between healthy volunteers and patients 
with main and simple main effects analysis.  Pearson’s correlation was used to test the 
associations between clinical haemodynamic and CPET parameters and resting and exercise 
biventricular function. A Bonferroni correction was applied to adjust for multiple comparisons 
for all simple main effects and pairwise comparisons. 
 
 
7.4 Results 
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7.4.1 Study Population and Baseline Characteristics 
 
14 patients with idiopathic (n=12) or hereditary PAH (n=2) were enrolled in the study.  All 
subjects completed the study and all data was analyzable at rest, exercise and immediately after 
exercise.  They were compared to the 38 controls recruited in the first study, described in 
Chapter 5. 
 
Baseline characteristics, clinical and haemodynamic data are summarised in Table 7.1.  
Baseline resting biventricular function is summarised in Table 7.2.  A summary of the 
treatments the patients were on at the time of the study are summarised in Table 7.3. 
 
Table 7.1. Demographic, clinical and haemodynamic characteristics of patients  
Age 39.1 ± 9.4 
Gender (M/F) 4/10 
BSA 1.8 ± 0.2 
BMI 25.6 ± 4.3 
NYHA  
          1 
          2 
          3 
 
2 
8 
4 
6MWD 446.9 ± 75.4 
BNP 30.1 ±1 9.6 (normal < 100) 
VO2 peak 1424.9 ± 362.0 
VE/VCO2 35.4 ± 5.2 
Max Load 118.9 ± 30.1 
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Level of watts in scanner 47.4 ± 13.1 
TAPSE 1.7 ± 0.46 
sPAP 79.8 ± 27.0 
dPAP 31.7 ± 13.6 
mPAP 50.6 ± 17.6 
PVR 10.5 ± 6.3 
Years since Diagnosis 3.9 ± 3.3 
Months between Echo and Exercise CMR 3 ± 4.2 
Months between CPET and Exercise 
CMR 
1.7 ± 2.2 
Values are expressed as mean ± standard deviation 
 
Table 7.2. Resting LV and RV CMR parameters of patients 
Parameter Value 
LVEDVI 70.3 ± 14.6 
LVESVI 25.7 ± 9.3 
LVSVI 44.6 ± 6.7 
LVEF 64.3 ± 6.2 
RVEDVI 88.1 ± 2.5 
RVESVI 40.1 ± 9.5 
RVSVI 45.3 ± 2.6 
RVEF 53.6 ± 4.3 
LV mass index 52.2±11.5 
RV mass index 26.4±7.1 
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Ventricular mass index 0.53 ± 0.19 
Values are expressed as mean ± standard deviation 
Table 7.3: Summary of treatments 
Type of therapy Number of patients Specific treatments 
Anticoagulation 6 Warfarin 
Monotherapy 2 Sildenafil 
Bosentan 
Dual therapy 8 Sildenafil and Ambrisentan 
Sildenafil and Bosentan 
Sidenafil and Macitentan 
Ambrisentan and Tadalafil 
 
Calcium channel blocker 
only 
3 Diltiazem 
Nifedipine 
Triple therapy 1 Ambrisentan, Tadalafil and 
Amlodipine 
 
 
7.4.2. Baseline Resting Biventricular Function Compared to Controls 
 
There was no difference in RV volumes or ejection fraction between patients and controls as 
summarized in Table 7.4.  There was a significant difference between LVSVI (p=0.048), MPA 
SVI (p=0.012), and LVEDVI (p=0.048). 
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Table 7.4: Heart rate, Cardiac output and Biventricular Function at Rest: Healthy Controls vs. 
Patients 
Outcome Variable Controls Patients P value 
HR 61.2 ± 10.8 63.4 ± 11.5 1.0 
CI 3.1 ± 0.6 2.9 ± 0.6 1.0 
Ao SVI 51.4 ± 11.0 45.7 ± 8.6 1.0 
MPA SVI 51.4 ± 9.9 40.0 ± 8.0 0.012 
LVEDVI 84.3 ± 14.7 70.3 ± 14.6 0.048 
LVESVI 30.4 ± 5.3 25.7 ± 9.3 0.312 
LVSVI 53.8 ± 10.7 44.6 ± 6.7 0.048 
LVEF 63.7 ± 3.6 64.3 ± 6.2 1.0 
RVEDVI 89.6 ± 2.7 85.8 ± 14 1.0 
RVESVI 38.4 ± 8.5 40.1 ± 9.5 1.0 
RVSVI 51.2 ± 1.6 45.3 ± 2.6 0.612 
RVEF 57.1 ± 5.2 53.6 ± 4.3 0.36 
 
7.4.3 Biventricular Response to Exercise in Patients 
 
The biventricular response to exercise in patients is summarized in Table 7.5. There was no 
increase in stroke volume, as measured by flow or volumes.  RVEDVI increased (p=0.048), 
with no change in RVESVI or RVEF.  LVEF increased (p <0.001), driven by a decrease in 
LVSVI (p=0.012).  There was no increase in LVEDVI which started at a significantly lower 
volume in the patient group. 
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However, if RV function is assessed from rest to immediately after exercise, there is no increase 
in RVEDVI and an increase in RVESVI, leading to an increase in mean RVEF and a rise in 
RVSVI.  Hence, the changes seen during continuous steady state exercise acquisition are lost.  
This is summarized in Table 7.6. 
 
Table 7.5: Heart rate, Cardiac Index and Biventricular Function from Rest to Exercise in 
Patients 
Outcome Variable Rest Exercise P value 
HR 63.4 ± 11.5 114 ± 15.6 <0.001 
CI 2.9 ± 0.6 5.2 ± 1.2 <0.001 
Ao SVI 45.7 ± 8.6 46.2 ± 12.1 1.0 
MPA SVI 40.0 ± 8.0 40.0 ± 13.3 1.0 
LVEDVI 70.3 ± 14.6 67.2 ± 16.3 1.0 
LVESVI 25.7 ± 9.3 18.4 ± 8.8 0.012 
LVSVI 44.6 ± 6.7 48.9 ± 9.1 0.192 
LVEF 64.3 ± 6.2 73.7 ± 6.7 <0.001 
RVEDVI 85.8 ± 14 93.2 ± 16 0.048 
RVESVI 40.1 ± 9.5 45.8± 15.9 1.0 
RVSVI 45.3 ± 6.8 47.4 ± 10.1 1.0 
RVEF 53.6 ± 4.3 51.4 ± 10.7 1.0 
 
 
Table 7.6:  Right Ventricular Function from Rest to Immediately after Exercise in Patients 
 Rest Immediately after 
Exercise 
P value 
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RVEDVI 85.8 ± 14 88.0 ± 15.5 0.317 
RVESVI 40.1 ± 9.5 36.4 ± 10.7 0.031 
RVSVI 45.3 ± 6.8 51.6 ± 10.9 0.012 
RVEF 53.6 ± 4.3 58.8 ± 7.6 0.01 
 
 
7.4.4 Biventricular Response to Exercise: Patients vs. Controls 
 
The comparison between patients and healthy volunteers is summarized in Table 7 and Table 
8. 
 
Table 7.7:  Simple main effects analysis: Heart Rate, Cardiac Index and Biventricular 
Parameters on Exercise, Healthy Controls vs Patients 
Outcome Variable Exercise in Healthy 
Controls 
Exercise in Patients p value 
HR (bpm) 122 ± 12.1 114.1 ± 15.6 0.564 
Ao SVi (ml/m2) 61.7 ± 10.3 46.2 ± 12.1 <0.0001 
MPA SVi (ml/m2) 60.0 ± 9.3 40.0 ± 13.3 <0.0001 
CI (l/min/m2) 7.6 ± 1.5 5.2 ± 1.2 <0.0001 
LV EDVi (ml/m2) 90.1 ± 15.5 67.2 ± 16.3 <0.001 
LV ESVi (ml/m2) 25.5 ± 7.0 18.4 ± 8.8 0.156 
LV SVi (ml/m2) 64.6 ± 10.7 48.9 ± 9.1 <0.0001 
LV EF (%) 71.9 ± 4.5 73.7 ± 6.7 1.0 
RV EDVi (ml/m2) 88.1 ± 14.5 93.2±4.0 1.0 
RV ESVi (ml/m2) 27.1 ± 8.4 45.8 ± 15.9 0.012 
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RV SVi (ml/m2) 60.9 ± 9.5 47.4 ± 2.6 <0.0001 
RVEF (%) 69.6 ± 6.1 51.4 ± 10.7 <0.0001 
 
Table 7.8: Heart Rate, Cardiac Index and Biventricular Function from Rest to Exercise: 
Controls vs. Patients 
Outcome 
Variable 
Controls PAH patients Effects, p value 
 Rest Exercise Rest Exercise Interaction Between-
subjects effect 
HR 61.2 ± 10.8 122.4± 12.1 63.4 ± 11.5 114.1± 15.6 0.022 0.321 
CI 3.1 ± 0.6 7.6 ± 1.5 2.9 ± 0.6 5.2 ± 1.2 <0.0001 <0.0001 
Ao SVI 51.4 ± 11.0 61.7 ± 10.4 45.7 ± 8.6 46.2 ± 12.1 <0.0001 0.001 
MPA SVI 51.4 ± 9.9 60.0 ± 9.3 40.0 ± 8.0 40.0 ± 13.3 <0.0001 <0.0001 
LVEDVI 84.3 ± 14.7 90.1 ± 15.5 70.3 ± 14.6 67.2 ± 16.3 0.001 <0.0001 
LVESVI 30.4 ± 5.3 25.5 ± 7.0 25.7 ± 9.3 18.4 ± 8.8 0.169 0.005 
LVSVI 53.8 ± 10.7 64.6 ± 10.7 44.6 ± 6.7 48.9 ± 9.1 <0.0001 <0.0001 
LVEF 63.7 ± 3.6 71.9 ± 4.5 64.3 ± 6.2 73.7 ± 6.7 0.405 0.363 
RVEDVI 89.6 ± 2.7 85.8 ± 4.4 88.1 ± 2.5 93.2±4.0 0.001 0.890 
RVESVI 38.4 ± 8.5 27.1 ± 8.4 40.1 ± 9.5 45.8 ± 15.9 <0.0001 0.001 
RVSVI 51.2 ± 1.6 60.9 ± 1.6 45.3 ± 2.6 47.4 ± 2.6 <0.0001 0.002 
RVEF 57.1 ± 5.2 69.6 ± 6.1 53.6 ± 4.3 51.4 ± 10.7 <0.0001 <0.0001 
 
7.4.4.1 Heart Rate 
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There was significant interaction between the rise in heart rate between patients and controls, 
with an attenuated rise in patients (p=0.02) (Figure 7.1).  However simple main effects did not 
show any significant difference p = 0.321 between resting or exercise values. 
 
 
Figure 7.1:  Change in heart rate from rest to exercise, in healthy controls and patients 
 
7.4.4.2 Cardiac Index 
There was a significant interaction between rise in CI between patients and controls (p 
<0.0001), with the rise in CI in patients being less than controls (Figure 7.2).  There was a 
significant between subject’s effect (p<0.0001).  Simple main effects analysis showed that this 
was driven by a lower CI in patients than in controls on exercise (p<0.0001).  There was no 
significant difference at rest (p = 1.0). 
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Figure 7.2:  Change in cardiac index from rest to exercise, in healthy controls and patients 
 
7.4.4.3 Aortic and MPA Stroke Volumes 
There was a significant interaction between rise in aortic and MPA SVI between patients and 
controls (p < 0.0001), with no rise in both aortic and MPA SVI as compared to controls (Figure 
7.3 and 7.4).  There was a significant between subject’s effect (p < 0.0001).  Simple main 
effects analysis showed that for aortic SVI, there was no difference between patients and 
controls at rest, and this only became apparent on exercise (p<0.0001).  For MPA SVI, there 
was a significant difference at rest (p=0.012) which become more apparent on exercise (p < 
0.0001). 
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Figure 7.3:  Change in aortic SVI from rest to exercise, in healthy controls and patients 
 
 
Figure 7.4:  Change in MPA SVI from rest to exercise, in healthy controls and patients 
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7.4.4.4 Right Ventricular Function 
 
RVEDVI 
There was a significant interaction of exercise on the change of RVEDVI (p=0.001).  Patients 
increased RVEDVI while controls decreased RVEDVI (Figure 7.5).  However, between 
subject’s effect was not significant (p=0.890) and simple main effects analysis showed no 
difference between resting and exercise RVEDVI (p = 1.0 for both comparisons). 
 
Figure 7.5:  Change in RVEDVI from rest to exercise, in healthy controls and patients 
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RVESVI 
There was significant interaction of exercise on the change of RVESVI (p = <0.0001).  
RVESVI decrease in controls and increased in patients (Figure 7.6).  Between subject’s effect 
analysis was significant (p = 0.001) and simple main effects analysis showed this was driven 
by a significant difference on exercise (p = 0.012) and not at rest (p = 1.0). 
 
Figure 7.6:  Change in RVESVI from rest to exercise, in healthy controls and patients 
 
RVSVI 
There was significant interaction of exercise on the change of RVSVI (p = <0.0001) (Figure 
7.7).  Between subject’s effect analysis was significant (p = 0.002) and simple main effects 
analysis showed this was driven by a significant difference on exercise (p = <0.0001) and not 
at rest (p = 0.612). 
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Figure 7.7:  Change in RVSVI from rest to exercise, in healthy controls and patients 
 
RVEF 
There was significant interaction of exercise on the change of RVEF (p = <0.0001) (Figure 
7.8).  Between subject’s effect analysis was significant (p < 0.0001) and simple main effects 
analysis showed this was driven by a significant difference on exercise (p < 0.0001) and not at 
rest (p = 0.36). 
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Figure 7.8:  Change in RVEF from rest to exercise, in healthy controls and patients 
 
 
7.4.4.5 Left Ventricular Function 
 
LVEDVI 
There was significant interaction of exercise on the change of LVEDVI (p = 0.001) (Figure 
7.9).  Between subject’s effect analysis was significant (p < 0.0001) and simple main effects 
analysis showed this was driven by largely by a significant difference on exercise (p < 0.001), 
however, there was also a significant difference in LVEDVI at rest (p=0.048). 
 
	 210	
 
Figure 7.9:  Change in LVEDVI from rest to exercise, in healthy controls and patients 
 
LVESVI 
There was no interaction of exercise on the change of LVESVI (p = 0.169) (Figure 7.10).  
Between subject’s effect analysis was significant (p < 0.005) suggesting that LVESVI was 
smaller in patients than controls at rest and exercise, however, simple main effects analysis was 
not significant for either rest or exercise (p = 0.312 and 0.156). 
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Figure 7.10:  Change in LVESVI from rest to exercise, in healthy controls and patients 
 
LVSVI 
There was significant interaction of exercise on the change of LVSVI (p = <0.0001).  Between 
subject’s effect analysis was significant (p < 0.0001) and simple main effects analysis showed 
this was driven largely by a significant difference on exercise (p < 0.0001), however, there was 
a significant difference at rest between patients and controls (p = 0.048). 
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Figure 7.11:  Change in LVSVI from rest to exercise, in healthy controls and patients 
 
LVEF 
There no significant interaction of exercise on the change of LVEF (p = 405) (Figure 7.12).  
Between subjects effect analysis was not significant (p = 0.363). 
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Figure 7.12:  Change in LVEF from rest to exercise, in healthy controls and patients 
 
7.4.5 Comparison of patients who increase RVEF to those who decrease RVEF on 
exercise 
 
Within the patient group, 7 patients increased RVEF on exercise, while 7 decreased RVEF on 
exercise (Figure 7.13).  There were no differences in resting biventricular parameters, years 
since diagnosis, 6MWD, BNP level and haemodynamic parameters at diagnosis.  These are 
summarised in Table 8. 
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Figure 7.13:  Graph of every patients’ RVEF from Rest to Exercise.  7 patients increased while 
7 patients decreased RVEF on exercise 
 
Table 7.9: Baseline clinical, haemodynamic and resting biventricular parameters 
 Increase RVEF n=7 Decrease RVEF n=7 p value 
Years since diagnosis 2.0 (6) 3.0 (5) 1.0 
BMI 27.5 (5.1) 22.8 (4) 1.0 
6MWD 456 (120) 432.0 (82) 1.0 
VO2 peak 1600 (293) 1260 (205) 0.52 
VE/VCO2 33.3 (12.4) 36.7 (5.6) 1.0 
BNP 18.1 (14) 35.5 (40.9) 1.0 
PVR 6.3 (2.9) 17.0 (12.1) 0.612 
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mPAP 42 (15) 69.0 (23) 0.612 
LVEDVI 72.8 (25.5) 61.3 (23.1) 1.0 
LVESVI 24.3 (8.8) 21.5 (13.3) 1.0 
LVSVI 48.5 (11.0) 41.2 (9.6) 1.0 
LVEF 66.2 (2.5) 63.2 (11.4) 1.0 
RVEVDI 81.1 (19.8) 80.0 (26.2) 1.0 
RVESVI 37.8 (5.3) 34.2 (18.7) 1.0 
RVSVI 45.6 (4.) 46.4 (10.5) 1.0 
RVEF 55.0 (8.2) 53.5 (9.0) 1.0 
RV mass index 20.9 (11.1) 32.0 (9.2) 1.0 
LV mass index 54.8 (25.8) 45.3 (15.2) 1.0 
CI 3.2 (0.4) 2.7 (0.7) 1.0 
Values reported as median (interquartile range) 
 
Change of RVEDVI, RVESVI and LVEDVI 
The interaction of exercise on the change on RVEDVI, RVESVI and LVEDVI between these 
two subgroups was analysed. 
 
RVEDVI   
There was no significant difference in the change in RVEDVI from rest to exercise, between 
those who increase or decrease RVEF on exercise (86.7±10.8mL/m2 to 90.5±9.1mL/m2 vs. 
85.0±18.1mL/m2 to 95.9±21.6mL/m2), interaction p = 0.095 and between subjects effect was 
also not significant p = 0.825. (Figure 7.14) 
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Change in RVEDI on Exercise 
 
Figure 7.14: Change in RVEDVI from rest to exercise, in patients who increase vs those who 
decrease RVEF on exercise 
 
 
RVESVI   
There was a significant difference in the change of RVESVI from rest to exercise, between 
those who increase and decrease RVEF on exercise (40.2±6.9mL/m2 to 36.2±5.9mL/m2 vs. 
40.1±12.2mL/m2 to 55.3±17.3mL/m2, p=0.001) (Figure 7.15).  Between subject’s effects, 
however, was not significant p = 0.124.  
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Change in RVESVI on Exercise 
 
Figure 7.15: Change in RVESVI from rest to exercise, in patients who increase vs those who 
decrease RVEF on exercise 
 
 
LVEDVI   
There was a significant difference in the change of LVEDVI from rest to exercise, between 
those who increase and decrease RVEF on exercise (74.7±13.0 to 76.9±13.9 vs. 65.9 ±15.7 to 
57.5±12.7, p=0.043), but between subject’s effect was not significant, p=0.069. (Figure 7.16) 
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Figure 7.16: Change in LVEDVI from rest to exercise, in patients who increase vs those who 
decrease RVEF on exercise 
 
7.5.6 Correlations with Exercise Capacity and Right Ventricular Reserve 
 
There was no correlation between right ventricular reserve and age, years since diagnosis, 
recent 6MWD, TAPSE or BNP and haemodynamics and pulmonary vascular resistance at 
diagnosis. 
 
There was a strong, negative correlation between right ventricular reserve and ventricular mass 
index (-0.710, p=0.004).  Right ventricular reserve correlated weakly with resting LV volume 
(LVEDVI 0.263, p=0.016, LVESVI 0.247, p=0.024) but not with resting RV function. 
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VO2 peak correlated moderately with right ventricular reserve (0.517, p <0.0001), an increase 
in LVEDVI (0.513, p<0.0001), and exercise RVEF (0.548, p<0.0001), and strongly with 
RVSVI and LVSVI (0.722, p<0.0001, 0.770 P<0.0001, respectively.  It did not correlate with 
resting LVEF or RVEF, or exercise LVEF. 
 
7.5.7 MPA Area, Pulsatility and Velocity 
 
7.5.7.1 MPA Maximum Area 
There was no significant interaction between exercise and change in MPA maximum area 
between controls and patients (Controls 8.2±1.5cm2 to 9.1±1.9, Patients 12.7 ± 3.1 to 13.9 ± 
3.6, p = 0.380).  However, there was a significant between subjects effect (p < 0.0001) 
 
7.5.7.2 MPA Minimum Area 
There was no significant interaction between exercise and change in MPA minimum area 
between controls and patients (Controls 5.0 ± 1.0 to 6.0 ± 1.3, Patients 9.2 ± 2.9 to 10.8 ± 3.1, 
p = 0.099).  However, there was a significant between subjects effect (p < 0.0001) 
 
7.5.7.3 MPA Pulsatility 
There was no significant interaction between exercise and change in MPA Pulsatility between 
controls and patients (Controls, 65.7 ± 27.9 to 40.7 ± 17.5, Patients 40.7 ± 17.5 to 32.4 to 11.0, 
p = 0.704).   
 
7.5.7.4 MPA Peak Velocity 
There was a significant interaction between exercise and change in MPA peak velocity 
(Controls 58.4 ± 14.3 to 91.3 ± 24.2, Patients 37.1 ± 10.8 to 40.3 ± 15.2, p < 0.0001) with a 
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blunting of the rise in MPA peak velocity in patients.  Between subjects effects was also highly 
significant (p < 0.0001) (Figure 7.17) 
 
Figure 7.17: Change in MPA Peak Velocity from rest to exercise, in controls and patients 
 
7.5.7.5 MPA Average Velocity 
There was a significant interaction between exercise and change in MPA average velocity 
(Controls 12.6 ± 2.8 to 14.6 ± 3.4, Patients 6.5 ± 2.2 to 6.2 ± 2.8, p < 0.0001) with no rise in 
MPA average velocity in patients compared to a significant rise in controls.  Between subjects 
effects was also highly significant (p < 0.0001) (Figure 7.18) 
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Figure 7.18: Change in MPA Average Velocity from rest to exercise, in controls and patients 
 
7.5 Discussion 
 
7.5.1 RV Reserve and Biventricular Remodeling in patients with normal resting RVEF 
 
As described in Chapter 5, normal exercise is characterized by an increase in RV contractility, 
and an increase in LVEDVI and decrease in LVESV, with a rise in RV and LV stroke volumes.  
We know that in normal subjects, exercise is characterized by a reduction or no rise in PVR, 
due to pulmonary vascular reserve, however in patients with PAH, pulmonary vascular 
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resistance does not fall, and may even rise during exercise.  This puts an even increased load 
on the RV. 
 
Furthermore, we have shown in Chapter 6, that the healthy RV compensates homeometrically 
or by increasing systolic contraction rather than heterometrically or through RV dilatation and 
Frank Starling mechanisms, to cope with an increased load in a model of acute pulmonary 
hypertension.  However, there remains a reduction in RV forward flow and a blunting of the 
rise in RVEF, leading to LV under-filling. 
 
We have then proceeded to demonstrate that in patients with preserved resting RVEF, exercise 
is characterized by an increase in mean RVEDVI, with no change in mean RVESVI or RVEF.  
Cardiac index increases due to an increase in heart rate, with no changes in stroke volume 
measured by volumes or flow.  When comparing change in biventricular parameters to healthy 
controls, while there was significant interaction, there was no between subjects’ difference in 
rest or exercise RVEVDI, but it was highly significant for RVESVI driven by a between 
subject’s difference in exercise parameters, and hence RVEF.  This suggests that in patients 
with normal resting RVEF, homeometric compensation lacks reserve that is only apparent on 
exercise, and mechanisms to cope with an increased afterload are blunted.  Hence, preload 
augmentation and RV dilatation, is a secondary consequence, but the degree of increase in 
RVEDVI is not large enough to be significantly different from healthy controls.  There was 
also a highly significant interaction of the effect of exercise on change in LVEDVI, but 
LVESVI and LVEF were not, suggesting LV underfilling and maintained LV contractility, 
supporting our observations in the hypoxia study, that reduced RV forward flow from increased 
pulmonary vascular resistance, leads to LV under-filling. 
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When comparing the subgroups that increase or decrease RVEF on exercise, exercise in those 
who increase RVEF on exercise was characterized by a decrease in RVESVI hence a 
maintenance of the ability to increase contractility.  However, RVESVI and RVEDVI both 
increased on exercise in those who dropped RVEF.  Once again, there was no significant 
interaction in change in RVEDVI between the two groups.  LV under-filling was apparent in 
those who dropped their RVEF on exercise, with a decrease in LVEDVI. 
 
Furthermore, we have shown that ventricular mass index, and no other resting indices on CMR, 
correlates with exercise RV function and right ventricular reserve.  This suggests that RV 
hypertrophy from an increase in afterload, combined with LV atrophy from underfilling, is 
reflected in the dynamic response of the RV to exercise. To our knowledge, we are the first to 
demonstrate that the ventricular mass index, as a composite index representing RV hypertrophy 
and LV atrophy, reflects the dynamic response of the RV to exercise, even in patients with 
normal resting RV function.   Hardziyenka et al showed that RVF leads to a reduction in LV 
mass, altered gene expression and atrophic remodeling.  They also demonstrated in CTEPH 
patients that post PEA, LV free wall mass index increased as RVEF improved(106, 109).  
Furthermore Gurudevan et al showed that a reduction in LV size is caused largely by a low LV 
preload and relative underfilling, as opposed to the geometric effects of RV enlargement in 
CTEPH patients (11). 
 
These studies together demonstrate that RV adaptation to an increased load is initially 
homeometric, with an increase in contractility and a reduction in RVEDVI.  However, in the 
setting of sustained pressure overload, RV contractility remains intact with RV dilatation and 
utilization of Frank-Starling mechanisms to increase RVSV and maintain cardiac output.  
Eventually, RV contractility reserves are depleted, and further RV dilatation to maintain 
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cardiac output occurs.  LV under-filling is a consequence of the reduction in RV forward flow. 
These changes lead to RV hypertrophy and LV atrophy, which are a consequence of 
biventricular remodeling to dynamic RV function.  Furthermore, we have shown this is 
demonstrable in patients with normal resting RVEF despite appearing clinically stable on 
CPET, 6MWD and resting biventricular function assessment. 
 
The response of biventricular function in patients with PAH has been described previously.  
Nootens et al using CT, demonstrated in PAH patients with impaired resting RV function and 
dilated RVs, that exercise was characterized by an increase in RVESV, a decrease in RVEF 
and a decrease in LV volumes, concluding that there is evidence of reduced RV systolic 
function leading to LV under-filling (279).  They did not show evidence of an increase in 
RVEDV.  Similarly, Holverda et al studied 10 patients with exercise MRI, and demonstrated a 
trend for an increase in RVEDVI on exercise, no change in RVESVI, and a significant decrease 
in LVEDVI (40).  However, it is important to note that both these studies included patients 
with resting RV impairment and dilated RVs, whereas we have shown these changes and in 
particular, a heterogeneity of dynamic RV response, in those with normal resting RVEF.  It 
would be expected that patients with impaired resting RV function, would lack homeometric 
reserve, to increase contractility. 
 
Excessive RV dilatation on exercise in patients with normal resting RV function, may have 
important clinical consequences.  Hsu et al studied RV contractile reserve in patients with 
iPAH and scleroderma invasively and found that invasively measured resting Ees/Ea predicted 
RV dilatation during exercise (87).  Furthermore, van de Veerdonk et at al found that patients 
considered stable long term, had subtle increases in resting RVEDVI and RVESVI before the 
onset of progressive RV dysfunction (154). Hence detecting RV dysfunction using exercise 
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MRI before it manifests as resting RV dilatation and dysfunction, could help detect otherwise 
sub-clinical ventricular-vascular uncoupling.  
 
7.5.2 Right ventricular reserve correlates with exercise capacity, but resting 
biventricular function does not 
 
We have demonstrated that resting RVEF, LVEF and exercise LVEF does not correlate with 
VO2 peak, however, exercise RVEF and right ventricular reserve do.  This is consistent with 
previous studies, which have shown that exercise capacity is not related to resting RV function 
(82-84).  Furthermore, right ventricular reserve does not correlate with haemodynamics at 
diagnosis, which is supported by other groups (41, 76-81) This supports the notion that there 
is a heterogeneity of response of the RV to afterload, and may explain why it’s been difficult 
to be able to identify which RV is destined to fail despite medical therapy. 
 
7.5.3 Average MPA Velocity does not increase 	
We have shown that in healthy volunteers, average MPA velocity increases, and we have 
hypothesised that this could be a reflection of pulmonary vascular distensibility.  We then 
shown in the acute hypoxia study, that there was a blunting of the rise in average MPA velocity, 
and when compared to normoxic exercise, there was a trend towards significance (0.059).  We 
have shown in patients, that there is a highly significant interaction between exercise and 
change in MPA average velocity, with a non-significant decrease in MPA average velocity in 
patients.  This is an interesting observation, and warrants further investigation, as to whether 
exercise MPA average velocity, could potentially be a tool to non-invasively and accurately 
assess pulmonary vascular distensibility and early pulmonary vascular disease.  As expected 
	 226	
MPA maximum and minimum area were significantly larger and pulsatility was significant 
lower in patients at both rest and exercise, with no significant interaction observed on exercise.  
There was a significant interaction in the change of MPA peak velocity in patients compared 
to controls, which would be expected given a failure of RV contractility and a reduction in RV 
forward flow in patients. 
 
7.5.4 Exercise CMR as a tool to assess RV reserve 
 
Right ventricular reserve in patients with pulmonary arterial hypertension, has been assessed 
by other groups using dobutamine or exercise echocardiography and invasive haemodynamics 
(87, 280) demonstrating a reduction in RV contractile reserve (85, 88, 164, 281).  However as 
outlined in Chapter 1, echocardiography lacks the ability to accurately measure biventricular 
volumes, with a heterogeneous approach to measure RV function indirectly using TAPSE, 
strain, fractional area change, isovolumic acceleration time and change in sPAP (103, 104).  
Claessen et al have recently demonstrated a moderate correlation between exercise TAPSE and 
RVEF as assessed by exercise CMR, and a strong correlation between RV FAC and RVEF 
(282).  However, even in their study, 13% of subjects did not have adequate acoustic windows, 
reaching up to 40% of cases in other studies (101, 102), and sPAP was in accurate in up to 50% 
in other studies (100, 101).  Furthermore, exercise provides a true physiological stress, 
eliminating any bias that dobutamine may introduce, on the response of RV volumes and 
ejection fraction (96, 97) such as an increase in contractility or a decrease in afterload.  While 
invasive haemodynamics can provide direct assessment of ventricular-vascular coupling, it has 
been shown that this does not add any further benefit, on top of SV/ESV or RVEF, as a method 
of assessing response to afterload in the assessment of prognosis (55, 56).   
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We have also shown that the timing of imaging is important, when assessing key physiological 
changes to exercise.  When imaging was performed immediately after exercise, mean RVESV 
decreased with an increase in mean RVEF.  As discussed in Chapter 1, previous groups using 
exercise CMR have performed imaging either immediately after exercise, during short breaks, 
or prior to reaching steady state exercise.  This may miss important changes in right ventricular 
volumes and function. 
 
7.5.4 Limitations 
 
We chose to exercise patients at one level of watts that was submaximal.  This was chosen in 
particular, so we could complete imaging during steady state exercise, and have a protocol that 
patients were more likely to complete.  This means that patients were not imaged at peak VO2 
that may explain why right ventricular reserve correlated moderately, rather than strongly with 
VO2.  However, as imaging would take 2 minutes to complete, it would be unlikely that patients 
would be able to sustain the level of watts at peak VO2 for that period of time. 
 
There was variability in patient treatments, as well as the time from diagnosis and hence time 
from initial right heart catheterisation.  The number of patients in the analysis was also small, 
and hence particularly in the subgroups who increased vs. decreased RVEF on exercise.  
Despite that, there were clear and highly significant differences in right ventricular reserve 
between patients and healthy controls, and delineation of those who increased versus those who 
decreased RVEF on exercise. 
 
7.6 Conclusions 
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1. We have demonstrated that continuous, steady state exercise MRI provides an accurate, 
direct and non-invasive method of assessing, biventricular response to exercise, in 
patients with pulmonary arterial hypertension. This could add valuable information in 
the treatment of patients with pulmonary arterial hypertension, and may be the key to 
identifying those RVs which are at more risk of progressive RV failure, before resting 
dysfunction becomes manifest. 
 
2. There is a heterogeneous response of right ventricular reserve amongst patients.  
Clinical tests such as 6MWD, TAPSE, VO2 peak and NYHA class and resting CMR 
biventricular parameters, as well as resting invasive haemodynamics on diagnosis 
cannot predict which RV lack homeometric reserve. 
 
3. Right ventricular reserve correlates with exercise capacity, while resting RV function 
does not. 
 
4. MPA average velocity does not increase on exercise in patients with PAH, while it 
does in healthy volunteers.  This could be a novel parameter on CMR to assess 
pulmonary vascular distensibility and warrants further investigation.  
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Chapter 8 - Future Directions: An Exercise CMR Study in patients with Inoperable 
Chronic Thromboembolic Pulmonary Hypertension 
 
8.1 Introduction 
 
We are now planning to progress our work to study patients with inoperable CTEPH, before 
and after treatment with Riociguat.  CTEPH, defined as a mean pulmonary artery pressure 
(mPAP) >25mmHg with a pulmonary capillary wedge pressure (PCWP) <15mmHg and at 
least one segmental perfusion defect following three months of adequate anticoagulation, is an 
important, treatable cause of persistent pulmonary hypertension (133, 134).  In selected cases 
with centrally located anatomic obstruction in one or both branch pulmonary arteries, surgical 
pulmonary thromboarterectomy (PEA) can be performed often, but not always, with excellent 
clinical outcomes.  A subset of patients has predominantly small vessel arteriopathy and are 
not surgical candidates with medical therapy being the standard of care for these patients.  This 
disease is often progressive with poor outcomes.  With a positive clinical trial of Riociguat in 
inoperable CTEPH (283), the ability to determine the extent of response early would be 
clinically relevant and might guide decisions to initiate more intensive therapy in these patients.  
 
The nitric oxide (NO) pathway is impaired in patients with PAH and Sildenafil and Tadalafil 
increase cycle guanosine monophosphate (cGMP) by inhibiting phosphodiesterase type-5 
(PDE-5).  However, this is not effective in all patients, possibly because of impaired baseline 
NO production.  Recently, a 4th class, the soluble guanylate cyclase (sGC) stimulator Riociguat, 
has been shown to be safe, tolerable, improve 6 minute walk distance (6MWD) and decrease 
mean pulmonary arterial pressure (mPAP) after 12 weeks of therapy in patients with CTEPH 
	 230	
and PAH (283-285).  Specifically, in patients with inoperable CTEPH, Riociguat significantly 
improved 6MWD at 16 weeks while Bosentan did not (286).   
 
Change in RV ejection fraction (EF) 1 year after medical therapy has been shown to be 
prognostic in patients with PAH (75).  As we have also demonstrated in our study, RV 
remodeling has been shown to occur post operatively in patients with operable CTEPH (287-
289), but its prognostic impact has not been assessed and the use of resting imaging and pre-
operative haemodynamic evaluation does not necessarily predict exercise capacity (82, 83).  
We have also demonstrated these points in our studies that have been outlined in this thesis. 
 
More recently, Blumberg et al demonstrated in a group of PAH and inoperable CTEPH subjects 
that peak VO2 was the strongest predictor of survival and amongst haemodynamic variables, 
only exercise cardiac index and the slope of the pressure flow relationship were significant 
prognostic indictors.  This suggests that RV reserve on exercise is an important determinant of 
exercise capacity, predicts prognosis and hence could potentially be used in the clinical 
assessment of these patients (94). 
 
Claessen et al studied 14 CTEPH patients with exercise CMR with concurrent invasive 
haemodynamic monitoring, before and after acute administration of Sildenafil.  They 
demonstrated that Sildenafil decreased RVESVi during resting and exercise, increased LVEF 
and RVEF at rest and exercise and increased SVi that was greater during peak exercise than at 
rest.  Furthermore, resting RV and LV parameters did not correlate with CPET but RVEF 
reserve correlated moderately with peak VO2, VE/VCO2 and PETCO2.  They also found that 
the reduction in total PVR during peak exercise correlated highly with the increase in peak 
exercise SVi and RVEF after Sildenafil (161).   
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Surie et al similarly studied 18 patients and demonstrated, using exercise CMR, an 
improvement in exercise SVi post pulmonary endarterectomy in 14 patients while resting SVi, 
HR and cardiac index were unchanged (162). The studies, together, demonstrate how 
assessment of the RV and LV function during exercise may add important clinical and 
potentially prognostic information.   Furthermore, our studies outlined in this thesis show that 
our approach is reproducible and feasible in patients, and that we are able to assess 
pathophysiological changes, which are otherwise, not present at rest. 
 
We believe that the use of CMR in the assessment of RV function at rest and during exercise, 
before and after treatment, will provide better and more accurate appraisal.  We hypothesize 
that treatment with Riociguat will improve RVEF, reduce RVH and increase CO 
predominantly on exercise, as assessed by CMR.  Given the particular impact of Riociguat on 
cardiac output, evaluation of the impact of therapy on this at rest and during exercise would be 
useful. 
 
8.2 Aims 
To determine the impact of Riociguat on right and left ventricular (RV and LV) function at rest 
and on exercise using cardiac magnetic resonance imaging (CMR) in patients with non-
operable Chronic Thromboembolic Pulmonary Hypertension (CTEPH). 
 
8.2.1 Primary Study Objective 
To assess the impact of treatment with Riociguat on exercise cardiac function using CMR after 
12 weeks of optimal dose Riociguat therapy.  The primary outcome variable at 12-20 weeks 
will be change in exercise right ventricular reserve, as measured by CMR from baseline. 
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8.2.3 Secondary Study Objective 
To assess the impact of treatment with Riociguat on cardiac function at rest using CMR, 
6MWD, NYHA functional class, CPET and BNP at 12 weeks.  Secondary outcome variables 
at 12-20 weeks will be change in exercise RVEF, RVSVI and LVSVI, and change in resting 
biventricular parameters.   
 
8.3 Proposed Study Design 
 
8.3.1 Study Organisation 
The PH service at Hammersmith hospital is part of the designated national pulmonary 
hypertension service for England. We have a programme of clinical and basic science research 
in pulmonary hypertension and exercise physiology.  Diagnosis is made according to current 
European guidelines. (186).  In 2014 the service saw 1162 patients; 361 were new referrals of 
whom 40 had CTEPH. 
 
8.3.2 Study Population 
 
Inclusion Criteria 
35 patients undergoing routine assessment and treatment by the Pulmonary Hypertension team 
at Hammersmith Hospital will be recruited.  All patients will undergo cardiopulmonary 
exercise testing, 6MWD, echocardiography, computed tomography of the pulmonary arteries, 
ventilation perfusion scanning and lung function tests and right heart catheterization. Inclusion 
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criteria will include: Age ≥18 with a diagnosis of inoperable or operable CTEPH.  Investigation 
and treatment follow the current European guidelines (186). 
 
Exclusion Criteria 
Exclusion criteria will include contraindication to CMR such as implanted ferrous devices, 
pregnancy, claustrophobia, PAH that is unstable and deteriorating and any joint condition 
limiting exercise capacity. 
 
8.3.3 Test Treatment 
Riociguat with increments at 2 week intervals of 0.5mg, from a starting dose of 1mg to a 
maximum of 2.5mg tds.(286) 
 
8.3.4 CMR Protocol: 
Imaging will be carried out using a 1.5T Siemens Aera with a 60 cardiac channel coil.  This is 
a newly acquired research CMR machine in our department in the Robert-Steiner Unit. 
Continuous heart rate and oxygen saturations will be monitored.  We will use a resting and 
exercise protocol to acquire the following data for analysis and validation. 
 
RV and LV structure and function:  Real time cine acquisitions of a stack of contiguous 
short axis cines to allow calculation of RV and LV end systolic/diastolic volumes (ESV/EDV), 
myocardial wall thickness and systolic interventricular septal curvature will be acquired.  
Image acquisition will be performed during free breathing.  Cardiac output, stroke volumes, 
left and right ventricular mass can be accurately and reproducibly calculated from these values 
and indexed to body surface area (193). 
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Pulmonary vascular haemodynamics:  Real time flow quantification will be performed using 
high temporal resolution phase contrast imaging.  Pulmonary arterial (PA) cross sectional area 
between diastole and systole using cross sectional imaging with high-resolution rapid frame 
acquisition will be acquired.  Mean and peak velocities in the PA, net PA blood flow, 
acceleration time and ejection time will be derived from the flow curves.  Pulse wave velocity 
will be derived using the flow-area method.  Using both right heart catheterization (RHC) and 
CMR data, PVR, PA fractional area change, compliance, capacitance and distensibility will be 
calculated (139). 
 
Strain:  Analysis of LV and RV strain will be analysed using TomTec software, of the resting 
and exercise cine images. 
 
Supine Exercise Bicycle Protocol 
Exercise will be performed with an MR-compatible bicycle ergometer (MRI cardiac ergometer 
Bicycle, Lode, Groningen, Netherlands) in the MRI machine.  An exercise protocol will be 
tailored for subjects according to their CPET results, set at 40% of the watts achieved.  A 
Cardiologist will supervise the test and exercise will be terminated either at completion of the 
protocol, by the subject, or if any concern is raised during the procedure.   During exercise 
CMR, continuous heart rate and oxygen saturations will be monitored. 
 
8.3.4 Follow up period and Visit Schedule 
Baseline exercise CMR will be performed at diagnosis, prior to treatment.  Subjects will be 
treated with Riociguat with routine follow up at 12 weeks after optimal therapy with repeat 
resting and exercise CMR.  Exercise CMR will be separated from other routine tests, such as 
CPET and 6MWD, by at least 4 hours.  Drug titration will be carried out by the Pulmonary 
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Hypertension service or the referring physician at 2 weekly intervals.  Exercise CMR will be 
carried out once the patient has been on 12 weeks of optimal dose therapy.  Clinical outcomes 
will be assessed at 1, 2 and 5 years. 
 
8.3.5 Statistical and Analytical Plan and Methodology 
Descriptive data will be expressed as mean ± standard deviation.  The analysis of the data 
requires Linear Mixed Models applied to longitudinal data.  Longitudinal data require special 
statistical methods because observations made on each subject are correlated.  This correlation 
must be taken into account to draw valid statistical inferences.  Longitudinal analysis allows to 
estimate the marginal effect of the main intervention and other subject’s characteristics as well 
to assess changes over time (e.g. before and after the intervention.)  A two tailed p-value <0.05 
will be considered statistically significant.  An interim analysis will be carried out after 
recruitment of half of the subjects. 
 
Power Calculation: 
The sample size (N) was calculated for both groups (rest and exercise). The power and level of 
significance used were, respectively, 80% and 5 %. Because measurements before and after 
are correlated, the methodology used was a paired T-Test which requires the input of the SD 
of the difference between before and after.  To detect a 3% increase in resting RVEF and a 5% 
increase in exercise RVEF, a sample size of 35 subjects will be required. 
 
8.4 Discussion 
 
We have demonstrated that assessment of dynamic biventricular function using CMR during 
submaximal, steady state exercise is reproducible, feasible in patients, and can detect subtle 
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pathophysiological changes that are otherwise not apparent at rest.  In particular, assessment 
of right ventricular reserve may add important clinical information in addition to the current 
available tests, which could influence treatment decisions.  A key challenge to this study is 
recruitment.  We are currently liaising with the exercise CMR group in Leuven, with a potential 
to collaborate with them on this study. 
 
This study in patients with inoperable CTEPH, carried out before and after treatment with 
Riociguat, offers the opportunity to study the impact of treatment on the change of right 
ventricular reserve at early follow up, and furthermore, follow up on the clinical outcomes.  If 
we were demonstrate that change in right ventricular reserve at early follow up after treatment 
could predict a positive clinical response at longer term follow up, this could have an important 
impact on how we view end-points in clinical trials in the treatment of subjects with pulmonary 
hypertension. 
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Chapter 9 – Overview of Thesis 
 
The right ventricle is anatomically and structurally different as compared to the left ventricle 
and has traditionally been difficult to assess functionally.  Hence the gold standard of 
measuring ventricular-vascular coupling has been through invasive haemodynamics, with 
manipulation of preload or more recently, through exercise haemodynamics.  However, 
developments in non-invasive imaging techniques are safer and potentially more clinically and 
prognostically relevant, and CMR is now the gold standard for measuring resting RV function 
and is superior technically to echocardiography.  Demonstrating and developing the ability to 
assess RV and biventricular changes in response to changes in afterload, could potentially offer 
new insight and detect subclinical ventricular-vascular uncoupling, which is otherwise not 
present at rest. 
 
In Chapter 3, we aimed to develop a feasible and reproducible approach to exercise CMR.  
Exercise CMR comes with several, unique challenges.  These include the type of exercise, the 
timing of image acquisition, the analysis of images particularly in relation to the respiratory 
cycle and ensuring the correct balance between temporal and spatial resolution.  We 
demonstrated that our approach is not only feasible, but shows intra-observer, inter-observer, 
inter-study and inter-test reproducibility.  There are important differences in stroke volume 
between flow and cine acquisitions, as well as the left and right ventricle, which have technical 
and physiological explanations.   Further work includes developing software that can 
incorporate respiratory bellow information so that flow analysis can be carried out during 
expiration, rather than being an average of 5 heart-beats.   
 
In Chapter 4, we demonstrated the ability of CMR to detect RV remodeling in response to a 
decrease in afterload, in patients with operable CTEPH, before and after PEA.  We also showed 
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that biventricular interactions, expressed in a composite RVEDV to LVEDV ratio, correlated 
with exercise capacity while parameters of right and left ventricular function alone did not.  
Left ventricular under-filling as a consequence of elevated RV pressure, was thought to be the 
predominant mechanism of increased RV size as compared to LV size, given that left atrial 
size correlated with LVEDVI. 
 
We went on to demonstrate dynamic biventricular function and interactions using exercise 
CMR in Chapter 5, establishing a set of normal parameters and describing normal supine 
exercise physiology.   LVEDVI increased on exercise, demonstrating that LV filling as well as 
increases in contractility contributed to an increase in LV SVI.  Furthermore, we also 
demonstrated that the normal heart remodels in response to the amount of exercise per week, 
with an increase in biventricular size, and that biventricular size correlates with a higher VO2 
peak.  It was important to establish normal parameters, and the normal biventricular response 
to exercise before studying the effects of acute and chronic pulmonary hypertension. 
 
In Chapter 6, we showed that acute pulmonary hypertension induced by acute normobaric 
hypoxia, leads to a reduction in LV size at rest, with no changes in RV function.  However, on 
exercise, there was evidence of a reduction in RV forward flow, blunting of the rise in RVEF 
and a reduction in RVEDVI.  This lead to LV under-filling and a consequent reduction in 
LVSVI.  These changes were not captured, when imaging was performed immediately after 
exercise, showing the importance of continuous, steady state acquisitions during exercise. 
 
Finally, we went on to demonstrate important feasibility of exercise CMR in patients with 
pulmonary arterial hypertension, and describe important pathophysiological changes that were 
otherwise not present at rest.  In Chapter 7, we showed exercise CMR could detect an 
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impairment in right ventricular reserve, in subjects with otherwise normal resting RVEF.  This 
was characterized by a reduction in RV forward flow, but contrasting to the healthy hearts in 
Chapter 6, there was an increase in RVEDVI and no rise in RVEF, with LV underfilling and 
no rise in LVSVI.  Cardiac output increased driven by an increase in heart rate.  Importantly, 
we were able to show that some patients increased while others decreased RVEF on exercise, 
but there were no discriminating factors at rest to predict this.  It is this information that could 
be clinically and prognostically important. 
 
This work is leading on to a project in patients with inoperable CTEPH, before and after 
treatment, to test our hypothesis that change in right ventricular reserve as measured by 
exercise CMR will be more clinically relevant, and linked to outcomes, over and above 
traditional parameters such as 6MWD or those measured on exercise testing, echocardiography 
or invasive haemodynamics.  Our research and the research of other groups could potentially 
have a significant impact on how we assess response to treatment in PAH, as well lead to a 
review of the end-points we use in clinical trials. 
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